Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),A1BG,Alpha-1B-glycoprotein,24305,112,0.82 [0.29-2.30],0.7066066962862171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AAMDC,Mth938 domain-containing protein,23595,112,0.93 [0.66-1.30],0.6548730206526839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AARSD1,Alanyl-tRNA editing protein Aarsd1,27812,130,1.05 [0.80-1.39],0.7084985771722003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABCA2,ATP-binding cassette sub-family A member 2,23494,110,1.58 [1.03-2.42],0.0344366677210713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABHD14B,Protein ABHD14B,27651,130,0.99 [0.76-1.30],0.9701642279666812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABL1,Tyrosine-protein kinase ABL1,27812,130,1.12 [0.90-1.39],0.3061211665268852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABO,Histo-blood group ABO system transferase,24295,113,0.98 [0.87-1.11],0.7648258486994428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABRAXAS2,BRISC complex subunit Abraxas 2,23494,110,1.12 [0.86-1.47],0.388357441074633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27252,129,1.09 [0.91-1.30],0.3415913608044021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23825,109,1.08 [0.85-1.38],0.5138008414839053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24272,114,1.04 [0.86-1.27],0.6933609380382469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAN,Aggrecan core protein,27684,128,0.88 [0.51-1.52],0.6338326825043439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE,Angiotensin-converting enzyme,24295,113,2.23 [1.13-4.42],0.0208340003318099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,27432,126,1.21 [0.92-1.59],0.1673851709535321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACHE,Acetylcholinesterase,23725,107,0.95 [0.55-1.65],0.862194434343122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOT13,Acyl-coenzyme A thioesterase 13,24177,111,1.10 [0.94-1.29],0.2203274241556256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27938,130,1.13 [0.84-1.52],0.4192344081453782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,23581,108,0.70 [0.45-1.09],0.1118452936974596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP5,Tartrate-resistant acid phosphatase type 5,28039,130,1.51 [0.97-2.37],0.0701349096409733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP6,Lysophosphatidic acid phosphatase type 6,28152,131,0.99 [0.78-1.24],0.9104686329031452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRBP,Acrosin-binding protein,24157,113,1.25 [0.81-1.93],0.3075879369693953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRV1,Acrosomal protein SP-10,23581,108,1.09 [0.86-1.39],0.4742824308842037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACSL1,Long-chain-fatty-acid--CoA ligase 1,23494,110,1.02 [0.62-1.69],0.9234192090449912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",27432,126,1.22 [0.89-1.68],0.2141477867498821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,23494,110,1.14 [0.86-1.51],0.3782770348034429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN4,Alpha-actinin-4,27416,127,1.25 [0.82-1.90],0.3057384099671107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,27700,130,2.82 [1.58-5.02],0.0004511848546464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY1,Aminoacylase-1,27938,130,1.06 [0.84-1.34],0.6247296119734471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23494,110,1.29 [0.96-1.74],0.093283969416423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACYP1,Acylphosphatase-1,23634,107,0.99 [0.75-1.31],0.9383210947346656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA,Adenosine deaminase,28273,130,1.32 [0.87-1.98],0.1892367332626299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,27757,131,2.14 [1.54-2.96],5.14593163490015e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23581,108,1.64 [1.24-2.16],0.0004483345634334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27432,126,1.30 [0.78-2.15],0.3179642239769616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27748,130,1.30 [0.84-2.01],0.2391864392036404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28273,130,1.23 [0.78-1.94],0.3651671485779084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28161,133,1.50 [0.89-2.52],0.127527039078583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24177,111,2.36 [1.50-3.70],0.0001986941844352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23581,108,1.40 [0.86-2.26],0.1732804745783733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28281,131,1.11 [0.58-2.14],0.7528032022070726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27812,130,1.64 [1.13-2.38],0.0098675063287751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27432,126,1.06 [0.67-1.69],0.8094309907801152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23581,108,1.16 [0.71-1.88],0.5505739505510092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28005,132,0.74 [0.54-1.03],0.0759545523003617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,24262,111,2.10 [1.33-3.33],0.0015159731429331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL4,ADAMTS-like protein 4,23595,112,0.99 [0.47-2.08],0.9855223585405876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL5,ADAMTS-like protein 5,24272,114,1.17 [0.76-1.82],0.4695876587363563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27252,129,0.82 [0.48-1.41],0.4716863445873278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,23725,107,0.94 [0.72-1.23],0.672559563190892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRB3,Adhesion G protein-coupled receptor B3,27700,130,1.32 [0.84-2.10],0.2320846242273571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRD1,Adhesion G-protein coupled receptor D1,23725,107,1.58 [1.02-2.43],0.0400600623747177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,24177,111,1.58 [1.16-2.14],0.0034687099729331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,28061,132,1.63 [0.97-2.73],0.067087292412402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE5,Adhesion G protein-coupled receptor E5,28130,131,1.72 [1.07-2.77],0.024513954628366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRF5,Adhesion G protein-coupled receptor F5,24272,114,1.50 [0.81-2.78],0.1961299556889882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,27812,130,1.34 [1.11-1.62],0.0024732863227098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG2,Adhesion G-protein coupled receptor G2,27938,130,0.87 [0.50-1.53],0.6369204545182722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRV1,Adhesion G-protein coupled receptor V1,23493,107,1.17 [0.94-1.46],0.1602911514707727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH1B,All-trans-retinol dehydrogenase,23725,107,0.98 [0.78-1.24],0.8734347022679325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27432,126,0.92 [0.76-1.10],0.3572129997565726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADIPOQ,Adiponectin,24305,112,0.98 [0.76-1.28],0.9071458044641664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,28189,131,2.71 [1.51-4.85],0.00082359252376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADRA2A,Alpha-2A adrenergic receptor,23494,110,1.03 [0.81-1.31],0.7934770601551827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,23725,107,0.94 [0.75-1.17],0.5945608291706879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFM,Afamin,24305,112,1.34 [0.54-3.32],0.5256661144262127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFP,Alpha-fetoprotein,27660,130,0.98 [0.78-1.25],0.8897525156620556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,23493,107,1.16 [0.94-1.43],0.1600742992461056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,27869,131,1.72 [1.19-2.47],0.0035026670998134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,27059,124,1.22 [1.04-1.42],0.0127536587870637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR3,Anterior gradient protein 3,27215,129,1.16 [0.90-1.48],0.2511195963976919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,28061,132,1.77 [1.21-2.61],0.0035349891238896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRP,Agouti-related protein,28273,130,1.27 [0.95-1.70],0.1023505082842078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGT,Angiotensinogen,24295,113,1.29 [0.61-2.70],0.5056942460294716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,27938,130,0.99 [0.82-1.21],0.9399977187322498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHCY,Adenosylhomocysteinase,27938,130,1.03 [0.83-1.30],0.7670580297052721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK,Neuroblast differentiation-associated protein AHNAK,23595,112,1.67 [1.03-2.71],0.0361987521342856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK2,Protein AHNAK2,23595,112,1.71 [0.99-2.94],0.0532407079773989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24157,113,1.25 [1.01-1.54],0.0375805980367246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSG,Alpha-2-HS-glycoprotein,24295,113,1.16 [0.60-2.25],0.662967856733454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSP,Alpha-hemoglobin-stabilizing protein,27888,131,1.04 [0.87-1.23],0.6757328944760648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIDA,"Axin interactor, dorsalization-associated protein",23599,110,1.14 [0.94-1.38],0.1707793572083264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1,Allograft inflammatory factor 1,27252,129,1.24 [0.93-1.65],0.1438345053293952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1L,Allograft inflammatory factor 1-like,23595,112,1.30 [1.01-1.66],0.0387204820026783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27761,130,1.09 [0.94-1.25],0.2512320847221818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK1,Adenylate kinase isoenzyme 1,27938,130,0.90 [0.70-1.14],0.3769164521413918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK2,"Adenylate kinase 2, mitochondrial",24203,112,1.16 [0.98-1.37],0.087462533592801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKAP12,A-kinase anchor protein 12,23725,107,0.95 [0.39-2.27],0.8991159069665757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B1,Aldo-keto reductase family 1 member B1,27252,129,1.13 [0.93-1.38],0.2182446948972711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B10,Aldo-keto reductase family 1 member B10,23599,110,1.19 [0.92-1.54],0.1783875974758396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,27432,126,1.17 [0.91-1.50],0.2344471662380674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR7L,Aflatoxin B1 aldehyde reductase member 4,23581,108,1.20 [0.95-1.50],0.1242642033497406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT1S1,Proline-rich AKT1 substrate 1,27277,126,1.05 [0.83-1.33],0.7120894806812401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT2,RAC-beta serine/threonine-protein kinase,24236,113,1.00 [0.87-1.15],0.993761910472694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT3,RAC-gamma serine/threonine-protein kinase,27111,128,1.10 [0.85-1.44],0.4666836195707486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,28281,131,3.56 [1.74-7.31],0.0005284438169533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH1A1,Retinal dehydrogenase 1,27929,131,0.92 [0.70-1.22],0.5636626139561938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",24157,113,1.18 [0.87-1.60],0.2785550548654499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27887,130,1.04 [0.83-1.29],0.7476092551001576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24236,113,1.43 [1.03-1.96],0.0302102637851118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALMS1,Alstrom syndrome protein 1,23825,109,1.26 [0.90-1.76],0.1817682146059093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPI,Intestinal-type alkaline phosphatase,23581,108,1.00 [0.86-1.16],0.9494116284323352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPP,"Alkaline phosphatase, placental type",27812,130,0.96 [0.83-1.10],0.5332537760494818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBN,Ameloblastin,27416,127,0.86 [0.46-1.60],0.6363777103430339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,28153,131,3.83 [1.82-8.04],0.0003964994785497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24262,111,1.02 [0.51-2.04],0.9558947002232696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,27277,126,1.16 [0.93-1.45],0.1874887203807623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO1,Amphoterin-induced protein 1,23599,110,1.33 [1.03-1.72],0.0303557396876938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,27812,130,3.00 [1.60-5.60],0.0005880191916324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,27416,127,0.96 [0.69-1.33],0.8038932746172447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOT,Angiomotin,23725,107,1.43 [0.93-2.19],0.1040294775527454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOTL2,Angiomotin-like protein 2,24077,112,1.24 [0.89-1.71],0.200158868459751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,24203,112,0.89 [0.70-1.14],0.3605158206779452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22776,107,0.77 [0.52-1.14],0.1952632137589418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2A,Pancreatic alpha-amylase,26890,127,0.91 [0.65-1.27],0.5732458447856874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2B,Alpha-amylase 2B,26048,124,0.89 [0.64-1.25],0.5068381711618616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANG,Angiogenin,27838,131,1.45 [0.95-2.20],0.0839283867283753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT1,Angiopoietin-1,27855,131,1.05 [0.88-1.26],0.5698475698712128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,28189,131,1.51 [1.02-2.23],0.0375056772744728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL1,Angiopoietin-related protein 1,27518,127,1.51 [0.89-2.55],0.1272801705198912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL2,Angiopoietin-related protein 2,27968,130,1.64 [1.12-2.38],0.0100341393414581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL3,Angiopoietin-related protein 3,27937,131,1.44 [0.93-2.22],0.0988083891717827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,28018,132,1.21 [0.87-1.69],0.2568425025394544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL7,Angiopoietin-related protein 7,28189,131,1.47 [1.01-2.14],0.0416045289680289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANK2,Ankyrin-2,23494,110,0.97 [0.75-1.27],0.8468779675228538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23581,108,1.14 [0.91-1.43],0.2565440888663525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRA2,Ankyrin repeat family A protein 2,23409,107,0.94 [0.67-1.32],0.7018424868559614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRD54,Ankyrin repeat domain-containing protein 54,27252,129,1.12 [0.87-1.44],0.3746358168704939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23595,112,0.80 [0.47-1.35],0.4023740470237307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,27969,131,1.79 [1.08-2.95],0.0227651607711479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA1,Annexin A1,23588,106,1.11 [0.76-1.61],0.6020429649113537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,27277,126,1.37 [1.17-1.61],0.000143691721819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA11,Annexin A11,27878,130,1.08 [0.85-1.36],0.5489457462391538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA2,Annexin A2,23250,107,1.17 [0.92-1.48],0.2132038824579738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA3,Annexin A3,28161,133,1.07 [0.86-1.32],0.5623910763721387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA4,Annexin A4,27794,130,0.95 [0.77-1.18],0.6626214750737089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,27182,126,1.34 [0.81-2.23],0.2505197093227215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC1,Amiloride-sensitive amine oxidase [copper-containing],27416,127,1.09 [0.85-1.41],0.4980281520606173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC3,Membrane primary amine oxidase,28016,131,1.75 [1.06-2.88],0.0286392394067859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP1G2,AP-1 complex subunit gamma-like 2,24157,113,1.11 [0.90-1.38],0.3223432308446384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP2B1,AP-2 complex subunit beta,23599,110,1.06 [0.74-1.52],0.7408189583032242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3B1,AP-3 complex subunit beta-1,24177,111,1.13 [0.90-1.42],0.2774219149730186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3S2,AP-3 complex subunit sigma-2,24203,112,1.28 [0.91-1.80],0.164456403922277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27812,130,1.27 [0.95-1.70],0.1078564526168776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APCS,Serum amyloid P-component,24100,110,0.59 [0.35-0.97],0.0386531568808807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28112,131,1.08 [0.83-1.40],0.5692289170792442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,27938,130,0.61 [0.45-0.83],0.001832906051123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,24305,112,0.34 [0.16-0.73],0.0054716667929129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA2,Apolipoprotein A-II,24295,113,1.43 [1.00-2.05],0.0525841140016516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA4,Apolipoprotein A-IV,24305,112,0.86 [0.51-1.45],0.5661257175884792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOB,Apolipoprotein B-100,24295,113,2.11 [0.93-4.79],0.0735126268232829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOBR,Apolipoprotein B receptor,23595,112,1.09 [0.71-1.68],0.685527325720132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,24254,111,0.60 [0.37-0.97],0.0364076683461605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOD,Apolipoprotein D,23166,103,0.57 [0.32-1.01],0.0556340667385686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOE,Apolipoprotein E,24305,112,1.01 [0.79-1.29],0.9513870833069532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,24295,113,0.56 [0.35-0.89],0.0136855144314924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,27929,131,1.17 [0.77-1.78],0.4537266608343221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOL1,Apolipoprotein L1,24295,113,1.20 [0.93-1.54],0.1590618902548594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOM,Apolipoprotein M,27982,131,0.84 [0.48-1.46],0.5262100647180796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,27879,131,1.01 [0.81-1.27],0.9109996715750364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APPL2,DCC-interacting protein 13-beta,23725,107,1.02 [0.86-1.20],0.8319334221609509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APRT,Adenine phosphoribosyltransferase,27715,130,1.18 [0.85-1.64],0.3303127019169094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARAF,Serine/threonine-protein kinase A-Raf,23825,109,1.32 [1.05-1.66],0.0156067544538005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,27812,130,1.82 [1.39-2.39],1.242789603808258e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARF6,ADP-ribosylation factor 6,24177,111,0.98 [0.83-1.16],0.8301442143256675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARFIP1,Arfaptin-1,24236,113,1.20 [0.94-1.54],0.144087096105044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,27797,130,0.72 [0.54-0.96],0.0259214298538795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG2,"Arginase-2, mitochondrial",24157,113,1.08 [0.72-1.61],0.7208769732864443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP1,Rho GTPase-activating protein 1,27252,129,0.95 [0.68-1.32],0.7455474035061819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP25,Rho GTPase-activating protein 25,27252,129,0.97 [0.75-1.26],0.8286374031340866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP30,Rho GTPase-activating protein 30,23825,109,1.23 [0.82-1.85],0.312984505679039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP45,Rho GTPase-activating protein 45,23725,107,1.09 [0.87-1.36],0.4602747551322786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP5,Rho GTPase-activating protein 5,23409,107,1.04 [0.82-1.33],0.7457607990146171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF1,Rho guanine nucleotide exchange factor 1,24203,112,1.09 [0.89-1.33],0.4203283252452234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF10,Rho guanine nucleotide exchange factor 10,24236,113,1.05 [0.87-1.27],0.5914242379631663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF12,Rho guanine nucleotide exchange factor 12,27925,130,1.05 [0.90-1.22],0.5201496187965099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF5,Rho guanine nucleotide exchange factor 5,23493,107,1.06 [0.84-1.35],0.6119456909764938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID3A,AT-rich interactive domain-containing protein 3A,23493,107,1.49 [1.00-2.21],0.0501352389296796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID4B,AT-rich interactive domain-containing protein 4B,27277,126,0.85 [0.56-1.29],0.4459595289797561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL13B,ADP-ribosylation factor-like protein 13B,23494,110,1.18 [0.93-1.50],0.170278373162631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23494,110,1.01 [0.65-1.59],0.9481770916028884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARMCX2,Armadillo repeat-containing X-linked protein 2,23493,107,1.16 [0.90-1.50],0.2509254075014461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNT,Aryl hydrocarbon receptor nuclear translocator,27416,127,1.08 [0.73-1.60],0.7091299056450391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23494,110,0.89 [0.60-1.32],0.5700546118928009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSA,Arylsulfatase A,27929,131,1.15 [0.83-1.59],0.3967714760543891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSB,Arylsulfatase B,27812,130,1.15 [0.88-1.51],0.3014954465177716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART3,Ecto-ADP-ribosyltransferase 3,28016,131,1.00 [0.63-1.56],0.9854221577884332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART5,Ecto-ADP-ribosyltransferase 5,23493,107,1.15 [0.90-1.47],0.2669562906684002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARTN,Artemin,27416,127,1.21 [0.93-1.57],0.1634001053397522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH1,Acid ceramidase,24060,111,1.34 [0.96-1.86],0.0863856549998757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,27748,130,0.94 [0.71-1.24],0.6485514572784234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,27748,130,1.95 [1.21-3.14],0.0059444852701144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR2,Asialoglycoprotein receptor 2,24295,113,1.78 [0.92-3.43],0.0858102120721554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPN,Asporin,24272,114,0.87 [0.45-1.70],0.6933160332194135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPSCR1,Tether containing UBX domain for GLUT4,24236,113,1.04 [0.80-1.35],0.7459720244321789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASRGL1,Isoaspartyl peptidase/L-asparaginase,23595,112,0.99 [0.83-1.19],0.9335423072084912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASS1,Argininosuccinate synthase,23494,110,0.85 [0.67-1.07],0.1621305979918667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF2,Cyclic AMP-dependent transcription factor ATF-2,27277,126,0.90 [0.69-1.17],0.4419164966278525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF4,Cyclic AMP-dependent transcription factor ATF-4,23409,107,1.05 [0.61-1.82],0.8565612684439977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG16L1,Autophagy-related protein 16-1,24177,111,1.15 [0.93-1.41],0.1934696396253859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG4A,Cysteine protease ATG4A,27252,129,1.00 [0.77-1.29],0.9952970759301756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,28005,132,1.09 [0.88-1.35],0.4458246601216239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23494,110,1.03 [0.72-1.48],0.8608166017098066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23494,110,0.73 [0.39-1.35],0.3175568686678824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23494,110,1.02 [0.66-1.59],0.9235053212760408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,23409,107,1.41 [0.98-2.04],0.0659035116986812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP2B4,Plasma membrane calcium-transporting ATPase 4,23494,110,1.02 [0.77-1.36],0.8761271909649844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5F1D,"ATP synthase subunit delta, mitochondrial",23494,110,1.08 [0.78-1.51],0.6425852770287159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5IF1,"ATPase inhibitor, mitochondrial",28061,132,1.04 [0.91-1.20],0.5477543099349451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",27277,126,0.99 [0.69-1.44],0.9740391607946688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,27252,129,1.41 [1.06-1.88],0.0194184520423219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1D,V-type proton ATPase subunit D,27812,130,1.13 [0.64-1.99],0.6668050912412432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1F,V-type proton ATPase subunit F,27229,126,0.93 [0.73-1.18],0.5388050594586311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G1,V-type proton ATPase subunit G 1,23595,112,1.07 [0.84-1.37],0.5740942013477173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G2,V-type proton ATPase subunit G 2,23494,110,1.00 [0.82-1.20],0.9679544655284597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,24177,111,1.60 [1.28-2.01],3.847377710776225e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRN,"Attractin, Isoform 2",24305,112,1.64 [0.56-4.80],0.365130444959906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN10,Ataxin-10,27277,126,1.10 [0.88-1.37],0.3978654373713689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2,Ataxin-2,23493,107,1.11 [0.95-1.28],0.1932432349303705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2L,Ataxin-2-like protein,24236,113,1.05 [0.73-1.50],0.791893117445846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,24203,112,1.02 [0.77-1.36],0.8663986580640146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXIN1,Axin-1,27925,130,1.09 [0.93-1.28],0.2856266805179521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,28016,131,1.62 [0.94-2.79],0.0827301958203938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZI2,5-azacytidine-induced protein 2,24236,113,1.14 [0.84-1.54],0.4005606785760573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZU1,Azurocidin,27097,123,1.11 [0.92-1.34],0.2958904391249587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,24305,112,1.57 [1.21-2.02],0.0005653935392951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23494,110,0.92 [0.37-2.26],0.8541901388610691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23595,112,2.07 [1.28-3.37],0.0031356497647588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",28061,132,2.26 [1.36-3.77],0.0016937671083501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GAT1,"Beta-1,4-glucuronyltransferase 1",27929,131,0.73 [0.39-1.36],0.319109516119918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BABAM1,BRISC and BRCA1-A complex member 1,23581,108,1.01 [0.54-1.88],0.9788680138975988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BACH1,Transcription regulator protein BACH1,27925,130,1.08 [0.88-1.33],0.4423891723646441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,27700,130,1.34 [0.90-1.99],0.1513256628452202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG4,BAG family molecular chaperone regulator 4,23581,108,1.29 [0.93-1.79],0.1296433031354016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG6,Large proline-rich protein BAG6,27432,126,0.90 [0.59-1.39],0.6433678648289876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27252,129,1.42 [1.15-1.76],0.0009818748377781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,27252,129,2.02 [1.37-2.97],0.0003982644167385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BANK1,B-cell scaffold protein with ankyrin repeats,27925,130,1.06 [0.92-1.23],0.4145083029178456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAP18,Chromatin complexes subunit BAP18,24203,112,1.20 [0.97-1.50],0.0923436964127753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BATF,Basic leucine zipper transcriptional factor ATF-like,23599,110,1.15 [0.97-1.38],0.1169825125863291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAX,Apoptosis regulator BAX,27227,126,1.02 [0.86-1.21],0.8142964562050926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAM,Basal cell adhesion molecule,27929,131,2.09 [1.16-3.79],0.0147872834501874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,27748,130,0.47 [0.30-0.73],0.0008844670149748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24272,114,1.61 [0.99-2.60],0.0530196214634404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23493,107,1.19 [0.88-1.61],0.2512143379993111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCHE,Cholinesterase,23836,110,1.90 [0.97-3.73],0.062718041698487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2,Apoptosis regulator Bcl-2,24177,111,1.31 [1.01-1.70],0.0428320426360339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L1,Bcl-2-like protein 1,24203,112,1.06 [0.88-1.27],0.5355501729379607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27925,130,1.36 [0.94-1.98],0.1051564790751871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L15,Bcl-2-like protein 15,23581,108,1.26 [0.97-1.63],0.0831196698502712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7A,B-cell CLL/lymphoma 7 protein family member A,23409,107,1.06 [0.81-1.40],0.6670372248970113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7B,B-cell CLL/lymphoma 7 protein family member B,24157,113,1.17 [0.82-1.67],0.3912126812739889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCR,Breakpoint cluster region protein,27925,130,1.06 [0.90-1.25],0.5007589543941526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BDNF,Brain-derived neurotrophic factor,24262,111,1.00 [0.81-1.24],0.9845090370852831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BECN1,Beclin-1,23595,112,1.11 [0.83-1.48],0.4833779127231752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,23409,107,1.06 [0.73-1.54],0.7671719568438629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,24262,111,1.58 [1.29-1.93],1.1297141516632352e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGN,Biglycan,27214,129,0.97 [0.85-1.10],0.6213035680027701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHLHE40,Class E basic helix-loop-helix protein 40,23493,107,1.18 [0.94-1.48],0.1465717423400112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23494,110,0.85 [0.42-1.74],0.6640269471300813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BID,BH3-interacting domain death agonist,27925,130,1.12 [0.90-1.39],0.3238909637978304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIN2,Bridging integrator 2,27929,131,1.03 [0.87-1.22],0.7489736634871336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIRC2,Baculoviral IAP repeat-containing protein 2,27252,129,1.10 [0.86-1.40],0.4434378406136946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLMH,Bleomycin hydrolase,28281,131,1.12 [0.70-1.80],0.6301396004612398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,23581,108,1.04 [0.66-1.65],0.8538501547025493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23493,107,0.98 [0.76-1.26],0.8702375915895126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24203,112,1.23 [0.82-1.85],0.3228065419570967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLVRB,Flavin reductase,27929,131,0.85 [0.67-1.09],0.198535952886271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP10,Bone morphogenetic protein 10,23725,107,1.52 [0.78-2.95],0.2170406318986059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP4,Bone morphogenetic protein 4,27700,130,1.12 [0.81-1.54],0.4856554411119187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP6,Bone morphogenetic protein 6,27382,126,1.08 [0.74-1.58],0.6830506791392024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,23725,107,2.27 [1.25-4.11],0.0070619177657556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24272,114,1.25 [0.78-2.02],0.3581109587288984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23581,108,1.52 [1.07-2.15],0.0192352876440155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOC,Brother of CDO,27432,126,1.52 [0.78-2.95],0.2202426063848261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA1,BolA-like protein 1,23493,107,1.26 [0.94-1.68],0.1259011784715011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,23595,112,1.04 [0.74-1.44],0.8351300214304447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFA2,BPI fold-containing family A member 2,22751,108,0.99 [0.84-1.17],0.9030878578040435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB1,BPI fold-containing family B member 1,27884,130,0.97 [0.77-1.23],0.8207016581000205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB2,BPI fold-containing family B member 2,24232,114,1.22 [0.95-1.56],0.1214195989999268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRAP,BRCA1-associated protein,23948,111,1.11 [0.94-1.32],0.217501313688861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD1,Bromodomain-containing protein 1,23825,109,1.23 [0.71-2.14],0.4594228775191369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD2,Bromodomain-containing protein 2,23493,107,1.18 [0.72-1.94],0.5088372388979279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD3,Bromodomain-containing protein 3,23494,110,1.34 [1.02-1.74],0.032577938427761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRDT,Bromodomain testis-specific protein,23494,110,1.53 [0.97-2.43],0.0704755217588211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,27277,126,1.50 [1.08-2.10],0.0169091924884322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRME1,Break repair meiotic recombinase recruitment factor 1,23493,107,1.39 [1.04-1.86],0.0260825823179264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRSK2,Serine/threonine-protein kinase BRSK2,24236,113,0.91 [0.57-1.44],0.6809943127984268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,28223,128,4.41 [2.24-8.70],1.7954330607058997e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSND,Barttin,23409,107,1.21 [0.75-1.97],0.438853238175259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28203,133,1.02 [0.73-1.43],0.8994614789260398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,28203,133,1.54 [1.25-1.90],5.373368321641501e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTC,Probetacellulin,27252,129,1.09 [0.89-1.34],0.3968650954892705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTD,Biotinidase,24305,112,0.83 [0.35-1.96],0.6784105988285611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTLA,B- and T-lymphocyte attenuator,23409,107,0.92 [0.72-1.17],0.4771560945619889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN1A1,Butyrophilin subfamily 1 member A1,24114,113,0.89 [0.55-1.44],0.6305784414316755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,28061,132,2.29 [1.35-3.89],0.0021028484072506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,27925,130,2.14 [1.61-2.84],1.4728129576108826e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTNL10,Butyrophilin-like protein 10,23409,107,0.57 [0.30-1.06],0.0734155254312443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,27277,126,0.96 [0.76-1.21],0.722160515174349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1GALT1C1,C1GALT1-specific chaperone 1,23494,110,1.39 [0.86-2.25],0.1819365103013108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,28128,127,1.96 [1.01-3.78],0.0459544702624344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24236,113,1.24 [1.02-1.51],0.0287950498728273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QL2,Complement C1q-like protein 2,23581,108,0.81 [0.53-1.26],0.3530565368459266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28016,131,1.15 [0.81-1.64],0.4205684245978152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23725,107,1.02 [0.62-1.66],0.951389240170372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24236,113,1.35 [0.82-2.22],0.2361696880266048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23684,106,0.87 [0.60-1.24],0.438455745886025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,24305,112,0.75 [0.27-2.10],0.5836845981439556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1RL,Complement C1r subcomponent-like protein,24266,112,1.70 [0.67-4.30],0.2652694982971973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1S,Complement C1s subcomponent,24305,112,1.66 [0.73-3.77],0.2242398857392536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,27982,131,1.82 [0.87-3.84],0.1138766894011536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2CD2L,Phospholipid transfer protein C2CD2L,27229,126,1.13 [0.80-1.60],0.4770865504584901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2orf69,UPF0565 protein C2orf69,23599,110,1.16 [0.88-1.54],0.2907193952486263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C3,Complement C3,23072,107,1.23 [0.87-1.74],0.2382132536145187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C4BPB,C4b-binding protein beta chain,28005,132,1.05 [0.72-1.53],0.8114433946699425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C5,Complement C5,24305,112,1.81 [0.64-5.13],0.2633518967495707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,23734,106,2.60 [1.51-4.47],0.0005349855107828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7orf50,Uncharacterized protein C7orf50,24203,112,1.08 [0.54-2.18],0.823680948530093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C8B,Complement component C8 beta chain,24305,112,0.98 [0.55-1.75],0.9436917284052584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9,Complement component C9,24295,113,1.13 [0.81-1.58],0.4672529338207272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,24177,111,0.96 [0.77-1.20],0.7474233812014159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,27291,129,0.82 [0.63-1.06],0.1213536677074838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA11,Carbonic anhydrase-related protein 11,27252,129,1.29 [0.87-1.93],0.2080837586503116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,27812,130,1.94 [1.36-2.76],0.0002305418260361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA13,Carbonic anhydrase 13,27609,128,1.01 [0.87-1.17],0.9384587453533332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA14,Carbonic anhydrase 14,28189,131,0.75 [0.49-1.16],0.1989996652700705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,27849,131,0.89 [0.71-1.11],0.3006400795560416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA3,Carbonic anhydrase 3,28234,131,1.00 [0.78-1.28],0.9856433861698936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA4,Carbonic anhydrase 4,28281,131,1.30 [0.68-2.47],0.422159081768597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",27432,126,1.02 [0.86-1.21],0.7971312043926888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,27837,131,0.85 [0.67-1.08],0.1907695713433566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA7,Carbonic anhydrase 7,23825,109,1.00 [0.59-1.71],0.9948058107590356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA8,Carbonic anhydrase-related protein,23581,108,1.21 [0.65-2.26],0.5460995715438046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,28189,131,1.55 [1.15-2.09],0.0043339619768453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CABP2,Calcium-binding protein 2,23599,110,1.33 [1.05-1.67],0.0157375691423503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23493,107,1.20 [0.71-2.02],0.4998856254240548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23494,110,0.88 [0.61-1.26],0.4765041971433787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23493,107,1.25 [0.96-1.64],0.1003637895353816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24236,113,1.08 [0.87-1.32],0.4892443298022751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACYBP,Calcyclin-binding protein,23673,107,1.05 [0.88-1.26],0.5895759742779446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CADPS,Calcium-dependent secretion activator 1,23599,110,0.91 [0.58-1.43],0.6861767157336665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,27812,130,1.43 [0.99-2.08],0.0565201167978205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,27277,126,1.51 [0.95-2.39],0.0842542931892041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,27700,130,1.40 [1.13-1.74],0.0018277384240553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,24203,112,1.68 [1.22-2.31],0.0013720765953413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28107,130,1.01 [0.87-1.17],0.919458845609775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23595,112,1.07 [0.85-1.35],0.5704296682207183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALY,Neuron-specific vesicular protein calcyon,23494,110,0.91 [0.54-1.53],0.7095904315062265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27252,129,0.99 [0.70-1.40],0.9597934070259728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23599,110,1.17 [0.86-1.58],0.3153744333916926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24236,113,1.01 [0.86-1.19],0.888517598298412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,27864,129,2.39 [1.12-5.10],0.024044298574135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPG,Macrophage-capping protein,27764,129,1.21 [0.94-1.55],0.1362799652703107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,24157,113,1.42 [1.00-2.03],0.0501945972776148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPS,Calcyphosin,24203,112,1.17 [1.01-1.36],0.0427872869959774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CARHSP1,Calcium-regulated heat-stable protein 1,27277,126,0.90 [0.66-1.22],0.4892777174843419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASC3,Protein CASC3,23599,110,1.56 [1.09-2.24],0.0149434316266835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP1,Caspase-1,27277,126,1.04 [0.83-1.29],0.7583519321881829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP10,Caspase-10,27277,126,1.01 [0.81-1.26],0.936299078275093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP2,Caspase-2,27925,130,1.17 [0.94-1.45],0.1627759034200758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP3,Caspase-3,28281,131,1.02 [0.86-1.21],0.8435199644040106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP4,Caspase-4,23825,109,1.08 [0.98-1.19],0.139094675389715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP7,Caspase-7,24203,112,1.07 [0.87-1.32],0.5202283415544324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP8,Caspase-8,28116,131,1.03 [0.81-1.31],0.7849840279893985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP9,Caspase-9,23581,108,1.07 [0.81-1.41],0.6490715426876456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASQ2,Calsequestrin-2,23494,110,1.10 [0.78-1.56],0.5878150735927861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,23924,107,0.79 [0.55-1.12],0.1850926227234779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLIF,Cobalamin binding intrinsic factor,27906,130,1.23 [0.99-1.53],0.0610288240780742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN1,Cerebellin-1,23493,107,0.92 [0.74-1.14],0.4565381016290984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,28189,131,0.89 [0.55-1.44],0.6304424894990232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBS,Cystathionine beta-synthase,23595,112,1.08 [0.77-1.51],0.6668674831103529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBX2,Chromobox protein homolog 2,23494,110,0.79 [0.46-1.35],0.3891425676754722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27748,130,1.04 [0.85-1.27],0.7227402108079712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCAR2,Cell cycle and apoptosis regulator protein 2,24203,112,1.02 [0.75-1.39],0.9010743517384374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC134,Coiled-coil domain-containing protein 134,24157,113,1.19 [0.85-1.68],0.3065635622669186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC28A,Coiled-coil domain-containing protein 28A,23599,110,1.45 [0.78-2.67],0.2381162908216516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC50,Coiled-coil domain-containing protein 50,24236,113,1.22 [1.02-1.47],0.0308909715355789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,27938,130,2.27 [1.52-3.39],6.566245596122877e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23595,112,1.12 [0.85-1.48],0.4108110286233279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,28273,130,1.73 [1.17-2.57],0.0064856133170045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL13,C-C motif chemokine 13,28224,130,0.96 [0.77-1.20],0.7150490855951794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,27838,131,1.28 [0.90-1.82],0.1686476456713192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,28281,131,1.68 [1.24-2.29],0.0008634605942947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL16,C-C motif chemokine 16,28281,131,1.25 [0.94-1.67],0.1273175168263577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL17,C-C motif chemokine 17,27868,132,1.10 [0.93-1.30],0.2794284376735487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,27542,131,1.15 [0.95-1.38],0.1493378392741161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL19,C-C motif chemokine 19,28203,133,1.09 [0.97-1.21],0.1494895480070081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL2,C-C motif chemokine 2,27700,130,0.87 [0.65-1.17],0.362175066479222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,28273,130,1.17 [1.01-1.37],0.0412866192692636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,28061,132,1.65 [1.28-2.12],9.258737642027192e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,27619,130,1.46 [1.10-1.92],0.0078957770615593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL23,C-C motif chemokine 23,28061,132,1.00 [0.70-1.42],0.9867577008073736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL24,C-C motif chemokine 24,28018,132,1.02 [0.85-1.23],0.7955927877834292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,28273,130,1.62 [1.20-2.19],0.0017930437780627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL26,C-C motif chemokine 26,27925,130,1.04 [0.89-1.23],0.610033294437385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL27,C-C motif chemokine 27,27938,130,1.13 [0.88-1.45],0.3301321858300958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL28,C-C motif chemokine 28,27842,130,1.10 [0.86-1.42],0.4483124837896476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,27925,130,1.17 [1.00-1.36],0.0525687680330488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL4,C-C motif chemokine 4,27963,132,1.18 [0.96-1.44],0.1194996209471699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL5,C-C motif chemokine 5,28016,131,1.02 [0.88-1.18],0.8052466622057217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,27925,130,1.31 [1.06-1.61],0.0122151456359419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL8,C-C motif chemokine 8,28153,131,1.17 [0.91-1.50],0.2314164923019247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN1,CCN family member 1,27773,130,1.12 [0.91-1.38],0.2814914680945055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN2,CCN family member 2,27940,132,1.06 [0.81-1.37],0.679691474359267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,28235,131,2.22 [1.53-3.23],2.850096982362968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,28189,131,1.91 [1.39-2.63],7.292892282157992e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,27929,131,1.13 [0.76-1.67],0.5462082253722614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCND2,G1/S-specific cyclin-D2,23825,109,1.10 [0.67-1.81],0.706187270692789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCNE1,G1/S-specific cyclin-E1,23581,108,0.99 [0.81-1.21],0.9254150182352098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCS,Copper chaperone for superoxide dismutase,27748,130,0.80 [0.58-1.12],0.1956520671519565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCT5,T-complex protein 1 subunit epsilon,27252,129,1.14 [0.82-1.57],0.4368080271864712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD101,Immunoglobulin superfamily member 2,24177,111,1.01 [0.65-1.56],0.981123786308726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD109,CD109 antigen,27929,131,0.99 [0.63-1.55],0.9552232548066822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,27317,128,1.94 [1.38-2.73],0.0001465486096521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,28273,130,1.55 [1.14-2.12],0.0057614483662033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,28016,131,1.63 [1.17-2.27],0.003903630757646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,27929,131,1.28 [0.80-2.04],0.3087172549180887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164L2,CD164 sialomucin-like 2 protein,23599,110,1.02 [0.62-1.67],0.9509011991487902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD177,CD177 antigen,27882,131,0.96 [0.85-1.08],0.4544380220950922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD1C,T-cell surface glycoprotein CD1c,28005,132,1.80 [0.93-3.48],0.0792023930662125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2,T-cell surface antigen CD2,23494,110,1.22 [0.82-1.82],0.3346315715943591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200,OX-2 membrane glycoprotein,27925,130,1.35 [0.76-2.40],0.3080153165158897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200R1,Cell surface glycoprotein CD200 receptor 1,27824,130,1.04 [0.66-1.62],0.8752851880491916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD207,C-type lectin domain family 4 member K,27341,128,1.43 [0.96-2.14],0.0791605342868543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD209,CD209 antigen,27995,129,1.09 [0.74-1.61],0.6687587476536032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD22,B-cell receptor CD22,28273,130,1.38 [0.95-2.00],0.0871078939586701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD226,CD226 antigen,23581,108,1.21 [0.79-1.85],0.3880018527892788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,28273,130,1.50 [0.86-2.61],0.1540404703296918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD248,Endosialin,24262,111,1.25 [0.81-1.94],0.3171531018112365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,28005,132,2.26 [1.65-3.10],4.285006141034801e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,27748,130,1.72 [1.15-2.58],0.0084197530604981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,27916,132,1.90 [1.23-2.94],0.0038982098251286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,27252,129,1.68 [1.14-2.47],0.0080470152875373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2AP,CD2-associated protein,27938,130,0.99 [0.78-1.27],0.959570417040476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,23725,107,2.21 [1.23-3.97],0.007639109640646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,28203,133,1.69 [1.11-2.57],0.0137625410721863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,28100,131,2.56 [1.85-3.55],1.6616723126255436e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,28189,131,1.56 [1.19-2.05],0.0011798704490678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LG,CMRF35-like molecule 9,27929,131,1.30 [0.86-1.96],0.2187654708368709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,27812,130,2.38 [1.56-3.62],5.106865539257022e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD33,Myeloid cell surface antigen CD33,28005,132,1.02 [0.84-1.24],0.8546249792809477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD34,Hematopoietic progenitor cell antigen CD34,28106,133,0.66 [0.35-1.24],0.2017084985728491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD36,Platelet glycoprotein 4,23581,108,1.25 [0.86-1.83],0.238531069707566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27812,130,2.34 [1.49-3.67],0.0002204241603856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3D,T-cell surface glycoprotein CD3 delta chain,23493,107,1.50 [1.09-2.08],0.0138951803137402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3E,T-cell surface glycoprotein CD3 epsilon chain,23825,109,1.19 [0.78-1.80],0.4139354106306556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,23581,108,1.19 [1.03-1.37],0.0215866426416263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,27880,130,1.88 [1.45-2.43],1.4194338595499868e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,27920,132,1.33 [1.01-1.77],0.0440783005041447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40LG,CD40 ligand,28273,130,1.09 [0.90-1.33],0.3713281387357088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,27747,131,1.81 [1.13-2.89],0.0135015751102351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,28018,132,2.68 [1.65-4.36],7.410163249566114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,28153,131,2.09 [1.40-3.13],0.0003362029407941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD55,Complement decay-accelerating factor,26933,129,1.59 [0.94-2.66],0.0810896597682505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD58,Lymphocyte function-associated antigen 3,27861,132,1.18 [0.50-2.81],0.7045022925005695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,26895,125,1.72 [0.91-3.26],0.0973286213954899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5L,CD5 antigen-like,24173,111,1.24 [0.85-1.80],0.2651338412141342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD6,T-cell differentiation antigen CD6,28223,128,1.28 [0.95-1.71],0.0994693806180619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD63,CD63 antigen,27700,130,1.12 [0.82-1.51],0.47664274369782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD69,Early activation antigen CD69,27786,130,1.11 [0.93-1.33],0.2414847365137518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,23547,108,1.86 [1.32-2.62],0.0003928129110042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,27925,130,1.70 [1.21-2.40],0.0023479899463887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,23725,107,1.76 [1.17-2.64],0.0068157444579355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,28203,133,2.40 [1.62-3.57],1.406378915526813e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,28273,130,2.02 [1.50-2.71],3.122958565813328e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,24272,114,2.51 [1.65-3.81],1.6331409280231203e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD82,CD82 antigen,23825,109,1.03 [0.68-1.58],0.8744526247587208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,27925,130,2.55 [1.74-3.74],1.5371946502876386e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD84,SLAM family member 5,27925,130,1.35 [0.83-2.20],0.2235789486759148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,24177,111,1.79 [1.00-3.22],0.0513047984363972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD8A,T-cell surface glycoprotein CD8 alpha chain,28203,133,1.21 [0.89-1.65],0.2324724394004636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD93,Complement component C1q receptor,26845,127,1.73 [1.07-2.80],0.026201518945853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,27929,131,2.82 [1.33-5.99],0.0068306501593083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,27929,131,1.43 [0.76-2.68],0.2634417940660801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDA,Cytidine deaminase,24232,114,0.87 [0.59-1.27],0.4702040457150146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDAN1,Codanin-1,24203,112,0.83 [0.37-1.90],0.6662882856119421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC123,Cell division cycle protein 123 homolog,23409,107,0.88 [0.64-1.22],0.4526934543223205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC25A,M-phase inducer phosphatase 1,23409,107,0.89 [0.55-1.44],0.6447854663640149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC26,Anaphase-promoting complex subunit CDC26,24138,111,1.10 [0.85-1.41],0.4705851912248865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC27,Cell division cycle protein 27 homolog,27252,129,0.96 [0.74-1.24],0.7441566891893767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC37,Hsp90 co-chaperone Cdc37,28005,132,1.06 [0.89-1.27],0.5074497575000285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC42BPB,Serine/threonine-protein kinase MRCK beta,24177,111,1.11 [0.94-1.31],0.2335360960227738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,27748,130,1.91 [1.50-2.43],1.6429650368291497e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,26977,131,1.55 [1.18-2.04],0.0018215861926366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH15,Cadherin-15,28155,133,1.09 [0.86-1.40],0.4768942083358372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH17,Cadherin-17,27938,130,1.26 [1.02-1.57],0.0345833641221401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,27938,130,2.09 [1.38-3.17],0.0005287758325828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH22,Cadherin-22,23825,109,1.10 [0.58-2.08],0.7597411192444398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH23,Cadherin-23,24203,112,1.19 [0.62-2.26],0.6067211530403257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,28203,133,1.12 [0.74-1.72],0.5898030709998234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,23493,107,1.05 [0.71-1.54],0.8174481501656035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH5,Cadherin-5,28281,131,1.82 [1.14-2.91],0.0124502814675869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH6,Cadherin-6,27938,130,1.47 [1.00-2.17],0.0526468414355176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR1,Cadherin-related family member 1,27277,126,0.86 [0.58-1.27],0.4437954639614906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR2,Cadherin-related family member 2,27812,130,1.10 [0.89-1.36],0.3578960110411021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR5,Cadherin-related family member 5,27938,130,0.85 [0.58-1.25],0.4051066915629344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK1,Cyclin-dependent kinase 1,23409,107,0.91 [0.55-1.51],0.7133014304999337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24236,113,1.07 [0.80-1.42],0.6540117376431953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKL5,Cyclin-dependent kinase-like 5,23493,107,0.95 [0.65-1.38],0.7729453250630406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN1A,Cyclin-dependent kinase inhibitor 1,27812,130,1.02 [0.89-1.18],0.7693169009903351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27812,130,1.05 [0.89-1.24],0.5318628100598095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDNF,Cerebral dopamine neurotrophic factor,27812,130,1.33 [0.85-2.07],0.2144803997505338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27966,132,1.36 [0.77-2.40],0.2885650240022905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDSN,Corneodesmosin,28182,130,1.19 [0.83-1.70],0.343024971286727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27964,132,1.74 [0.93-3.22],0.0807952930934928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24177,111,0.92 [0.74-1.14],0.464757036446518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23825,109,1.09 [0.86-1.38],0.4671798796180909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24177,111,1.29 [0.83-2.01],0.2618144459268501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23825,109,1.77 [1.42-2.22],5.665927648246487e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27925,130,1.19 [1.01-1.42],0.0436583191350818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27252,129,1.18 [0.88-1.59],0.2597274268148491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26877,128,1.26 [0.99-1.60],0.0595802178150031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24262,111,1.35 [0.90-2.02],0.1421248096416256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27432,126,1.16 [0.86-1.56],0.3373729966420941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPA,CCAAT/enhancer-binding protein alpha,23581,108,1.23 [0.83-1.80],0.3029707177542327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPB,CCAAT/enhancer-binding protein beta,27432,126,1.03 [0.68-1.55],0.9058763198263624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,24262,111,0.69 [0.52-0.92],0.0105378112914218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA3A,Chymotrypsin-like elastase family member 3A,28231,130,0.92 [0.70-1.19],0.5134886376835364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23725,107,1.02 [0.53-1.97],0.9445665263883212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEMIP2,Cell surface hyaluronidase,23581,108,1.39 [0.92-2.10],0.1164206251739461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEND1,Cell cycle exit and neuronal differentiation protein 1,23493,107,1.01 [0.74-1.38],0.9415201961589268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPF,Centromere protein F,23825,109,1.02 [0.74-1.42],0.8875936688148238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPJ,Centromere protein J,23825,109,1.09 [0.85-1.38],0.4960419289812887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP112,Centrosomal protein of 112 kDa,23494,110,1.30 [0.97-1.73],0.0767185609875659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP152,Centrosomal protein of 152 kDa,23409,107,0.80 [0.50-1.29],0.3610792225768019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP164,Centrosomal protein of 164 kDa,27416,127,1.04 [0.82-1.32],0.750090259937422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP170,Centrosomal protein of 170 kDa,23595,112,0.97 [0.77-1.23],0.8096250597339658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,27252,129,1.12 [0.91-1.37],0.2815251700148768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP290,Centrosomal protein of 290 kDa,23825,109,1.03 [0.73-1.45],0.8537759735349758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP350,Centrosome-associated protein 350,23409,107,1.16 [0.71-1.88],0.559290685821656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP43,Centrosomal protein 43,27215,125,1.03 [0.82-1.30],0.7763660172470365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,27252,129,1.07 [0.84-1.35],0.5755367299119185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CERT,Ceramide transfer protein,27277,126,0.90 [0.69-1.16],0.4097751078170284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES1,Liver carboxylesterase 1,27985,130,1.14 [0.96-1.35],0.140256113672498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES2,Cocaine esterase,27812,130,0.98 [0.74-1.30],0.8988560923831084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES3,Carboxylesterase 3,27812,130,1.08 [0.88-1.33],0.447490630937488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN2,Centrin-2,27277,126,1.08 [0.86-1.35],0.5057384217289869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN3,Centrin-3,24177,111,1.16 [0.93-1.45],0.175170302188985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFB,Complement factor B,23853,109,1.22 [0.70-2.13],0.4776575917796617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,27252,129,1.13 [0.82-1.54],0.4576886192628506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFD,Complement factor D,24305,112,2.17 [1.16-4.08],0.0157751314322144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFH,Complement factor H,22895,108,1.69 [0.78-3.67],0.1873381904160597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR2,Complement factor H-related protein 2,24133,112,1.61 [1.11-2.32],0.011576319079238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,24257,112,1.32 [1.01-1.72],0.0409016394172286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR5,Complement factor H-related protein 5,23984,112,0.94 [0.61-1.43],0.7703546750221235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFI,Complement factor I,24305,112,1.15 [0.48-2.78],0.7518302579709039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,24305,112,0.72 [0.32-1.65],0.4374302383292416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,27929,131,1.21 [1.01-1.47],0.0430363001863006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24295,113,1.13 [0.81-1.58],0.4594556805816261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGN,Cingulin,23599,110,1.05 [0.67-1.65],0.8328379241600637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,27938,130,1.91 [1.36-2.69],0.000216682050989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27252,129,1.02 [0.78-1.32],0.908808775045602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAD,Chondroadherin,23725,107,1.08 [0.75-1.55],0.6768362101259537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24203,112,1.66 [1.16-2.38],0.0057622560538516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD6,MICOS complex subunit MIC25,24157,113,1.67 [1.10-2.53],0.0163218123496077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHEK2,Serine/threonine-protein kinase Chk2,27432,126,0.59 [0.36-0.96],0.0346343711200826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,24262,111,1.32 [1.11-1.57],0.0019298933099741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,28106,133,1.01 [0.69-1.48],0.955409058753278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,27274,130,1.27 [1.06-1.51],0.009119357945449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHIT1,Chitotriosidase-1,28046,130,1.09 [0.97-1.23],0.1598842441422374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHL1,Neural cell adhesion molecule L1-like protein,27973,131,1.01 [0.62-1.65],0.9553670317452622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHM,Rab proteins geranylgeranyltransferase component A 1,23599,110,0.95 [0.71-1.29],0.7577835699209884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP1A,Charged multivesicular body protein 1a,27748,130,1.09 [0.89-1.32],0.405207599297555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP6,Charged multivesicular body protein 6,24272,114,1.09 [0.80-1.48],0.5952687887410952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHP1,Calcineurin B homologous protein 1,23493,107,1.13 [0.91-1.41],0.2562783634210622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,28018,132,2.43 [1.52-3.89],0.0002093605039903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL2,Chordin-like protein 2,27938,130,1.13 [0.86-1.48],0.3741448598479224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRM1,Muscarinic acetylcholine receptor M1,23599,110,1.19 [0.77-1.84],0.4293586056500662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIAPIN1,Anamorsin,28005,132,1.10 [0.86-1.39],0.4586366393440898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CILP,Cartilage intermediate layer protein 1,24262,111,1.19 [0.85-1.66],0.3126877654548213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CINP,Cyclin-dependent kinase 2-interacting protein,23825,109,0.90 [0.58-1.40],0.6330688403055496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIRBP,Cold-inducible RNA-binding protein,24177,111,1.11 [0.92-1.34],0.2784426518540001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIT,Citron Rho-interacting kinase,23599,110,1.19 [0.83-1.70],0.3494618451682553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,28126,128,2.73 [1.77-4.20],5.488053856814917e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKB,Creatine kinase B-type,24262,111,1.35 [1.01-1.81],0.0453491426933469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27815,132,1.16 [0.91-1.47],0.2428524257303586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLASP1,CLIP-associating protein 1,23409,107,1.20 [0.96-1.49],0.1096655093653106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLC,Galectin-10,27899,129,1.05 [0.84-1.31],0.6667132228660673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC10A,C-type lectin domain family 10 member A,27748,130,1.13 [0.74-1.72],0.5814047417237405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,27881,131,1.38 [1.00-1.91],0.0516846151064844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC12A,C-type lectin domain family 12 member A,23581,108,1.82 [0.87-3.80],0.110683365185053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,27929,131,2.03 [1.27-3.26],0.003152172104507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1A,C-type lectin domain family 1 member A,27432,126,1.71 [1.08-2.72],0.0230346656004064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1B,C-type lectin domain family 1 member B,28203,133,1.05 [0.90-1.23],0.5084291505389276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC2L,C-type lectin domain family 2 member L,23599,110,1.28 [0.97-1.71],0.0842781157170125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC3B,Tetranectin,23740,109,0.52 [0.22-1.24],0.1397390535835698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4A,C-type lectin domain family 4 member A,27925,130,0.65 [0.43-0.97],0.0347747754346924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4C,C-type lectin domain family 4 member C,27925,130,1.48 [1.07-2.04],0.0175900834195751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,27925,130,1.43 [1.13-1.81],0.0027886619939194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,27925,130,1.75 [1.11-2.75],0.0160645845442947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4M,C-type lectin domain family 4 member M,24222,111,0.97 [0.67-1.41],0.8803056329566287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,27839,130,1.89 [1.16-3.08],0.0106730745007724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,27252,129,1.80 [1.35-2.39],5.891560391154018e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,28273,130,1.82 [1.30-2.55],0.0004704763961426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,23599,110,1.75 [1.24-2.45],0.0013007923445081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIC5,Chloride intracellular channel protein 5,23599,110,1.07 [0.62-1.85],0.7985620956215493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLINT1,Clathrin interactor 1,23409,107,0.94 [0.62-1.40],0.7514660220260301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIP2,CAP-Gly domain-containing linker protein 2,27925,130,1.07 [0.93-1.23],0.3266069027439512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,28189,131,2.76 [1.41-5.40],0.0030081363445954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLNS1A,Methylosome subunit pICln,23599,110,0.94 [0.55-1.61],0.8143252003317688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27700,130,1.14 [0.98-1.34],0.0920972159480025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPS,Colipase,27888,131,1.00 [0.80-1.24],0.9978435692203288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSPN,Claspin,27229,126,0.74 [0.43-1.27],0.274940162182662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN1,Calsyntenin-1,27277,126,0.94 [0.68-1.30],0.7042351418021777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN2,Calsyntenin-2,28273,130,1.51 [1.08-2.10],0.0161674532168498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,24203,112,2.01 [1.31-3.07],0.0013142564075015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,27432,126,1.19 [0.87-1.63],0.2751212556802012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLU,Clusterin,24305,112,0.36 [0.13-0.99],0.0484986957837175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLUL1,Clusterin-like protein 1,27891,130,0.79 [0.57-1.11],0.1806572257366996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMC1,COX assembly mitochondrial protein homolog,24272,114,1.09 [0.90-1.32],0.3636040041619708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMIP,C-Maf-inducing protein,24157,113,1.10 [0.90-1.36],0.3529240115066077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,28016,131,0.66 [0.49-0.90],0.0081520188197896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNGB3,Cyclic nucleotide-gated cation channel beta-3,23493,107,0.95 [0.66-1.36],0.7764259887643681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23551,112,1.05 [0.84-1.32],0.6607794000461515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY2,Protein canopy homolog 2,27432,126,1.09 [0.85-1.39],0.5070855082168921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY4,Protein canopy homolog 4,27812,130,1.02 [0.83-1.25],0.8609882632131134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNST,Consortin,27938,130,1.06 [0.92-1.22],0.4185978000655443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTF,Ciliary neurotrophic factor,23493,107,1.10 [0.65-1.88],0.7187400309545836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN1,Contactin-1,28281,131,0.77 [0.44-1.36],0.3728196263827259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN2,Contactin-2,28189,131,1.04 [0.74-1.47],0.8104479886130516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN3,Contactin-3,27929,131,0.69 [0.44-1.08],0.104854030320606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN4,Contactin-4,27929,131,1.61 [0.85-3.07],0.146144647302971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,28020,133,0.73 [0.47-1.11],0.140809124865591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP2,Contactin-associated protein-like 2,27925,130,0.79 [0.54-1.15],0.2196390190164209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP4,Contactin-associated protein-like 4,23599,110,1.11 [0.95-1.29],0.1767185620157643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COCH,Cochlin,24272,114,1.56 [1.11-2.21],0.0111025702108375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL15A1,Collagen alpha-1(XV) chain,24262,111,1.87 [0.98-3.55],0.0571301483031868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,28033,130,2.77 [1.46-5.27],0.0018467982469708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL1A1,Collagen alpha-1(I) chain,28281,131,1.61 [0.88-2.93],0.1222140431797352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL24A1,Collagen alpha-1(XXIV) chain,24177,111,1.00 [0.74-1.37],0.9820028153745052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,23599,110,0.76 [0.60-0.97],0.0262733022316029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL2A1,Collagen alpha-1(II) chain,23595,112,1.19 [0.96-1.48],0.1096464575197577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL3A1,Collagen alpha-1(III) chain,24262,111,1.98 [1.01-3.89],0.0469037747907715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,27938,130,1.45 [1.00-2.10],0.0496004537774145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A4,Collagen alpha-4(IV) chain,23784,109,0.91 [0.65-1.28],0.5815603705671162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,23725,107,1.80 [1.27-2.54],0.0008915497114585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,28281,131,2.92 [2.06-4.15],1.756818830690024e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A1,Collagen alpha-1(IX) chain,27925,130,1.32 [0.97-1.82],0.0807828102888151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A2,Collagen alpha-2(IX) chain,23825,109,1.36 [1.04-1.78],0.0241398043894149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,27916,132,3.22 [1.91-5.43],1.2276033658101733e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD1,COMM domain-containing protein 1,23595,112,1.11 [0.83-1.48],0.4818131800569003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD9,COMM domain-containing protein 9,24157,113,1.10 [0.72-1.68],0.6708199754951164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMP,Cartilage oligomeric matrix protein,27626,131,1.43 [0.91-2.25],0.1236537284752287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMT,Catechol O-methyltransferase,27128,126,1.10 [0.92-1.33],0.3030615983137377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',23494,110,1.04 [0.68-1.58],0.8706255281677129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPE,Coatomer subunit epsilon,27277,126,0.75 [0.50-1.12],0.154676311598797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23595,112,1.03 [0.69-1.53],0.8886212778001523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO1A,Coronin-1A,27379,124,1.09 [0.92-1.29],0.3191795368606717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO6,Coronin-6,23493,107,1.12 [0.72-1.75],0.6072078517470476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27812,130,1.19 [0.96-1.46],0.1073565128395372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX6B1,Cytochrome c oxidase subunit 6B1,24272,114,1.10 [0.65-1.88],0.7198481699028182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA1,Carboxypeptidase A1,28281,131,0.92 [0.72-1.19],0.5355698570644045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA2,Carboxypeptidase A2,28104,133,1.11 [0.88-1.39],0.3777412728029189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA4,Carboxypeptidase A4,23251,104,1.03 [0.67-1.59],0.8809807430756105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB1,Carboxypeptidase B,28281,131,0.99 [0.77-1.28],0.9690079792853482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB2,Carboxypeptidase B2,24254,111,0.89 [0.41-1.96],0.7753667444435852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,27989,130,0.66 [0.47-0.93],0.017048392329808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPLX2,Complexin-2,23409,107,1.36 [0.87-2.15],0.1814959239988869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,28077,133,1.62 [1.08-2.43],0.0203243597006153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23581,108,1.42 [0.77-2.61],0.2631452955593686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPPED1,Serine/threonine-protein phosphatase CPPED1,28203,133,1.06 [0.84-1.33],0.6215167897072676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPQ,Carboxypeptidase Q,24222,111,1.04 [0.67-1.62],0.8709173206246725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPTP,Ceramide-1-phosphate transfer protein,23494,110,1.16 [0.76-1.75],0.4934228458394883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPVL,Probable serine carboxypeptidase CPVL,28137,131,1.36 [0.92-2.00],0.1271022185903801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,28005,132,1.09 [0.87-1.35],0.4520917372285142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,24272,114,3.10 [1.83-5.24],2.54328041365764e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,24201,112,1.55 [0.99-2.41],0.0537222677343783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR2,Complement receptor type 2,28016,131,1.37 [0.98-1.91],0.0656016691821771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27252,129,1.02 [0.86-1.22],0.7936128981535335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRADD,Death domain-containing protein CRADD,27700,130,1.03 [0.84-1.27],0.7454793127147095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,23409,107,1.11 [0.81-1.51],0.5177028249074387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,23409,107,1.04 [0.51-2.11],0.9131419974662534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREG1,Protein CREG1,27547,132,1.08 [0.73-1.60],0.7038960366044709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD1,Protein disulfide isomerase CRELD1,23725,107,1.57 [0.97-2.54],0.0656873650788947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD2,Protein disulfide isomerase CRELD2,28018,132,1.23 [0.93-1.62],0.1485539573434508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRH,Corticoliberin,27207,129,1.09 [0.91-1.30],0.3413185691078672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,27916,132,2.49 [1.45-4.26],0.0008831706172612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHR1,Corticotropin-releasing factor receptor 1,27432,126,0.90 [0.68-1.18],0.4457740320642114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,28061,132,1.84 [0.88-3.83],0.1031295556975674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,27748,130,1.50 [1.03-2.19],0.0347895456915058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP2,Cysteine-rich secretory protein 2,28189,131,0.76 [0.59-0.98],0.0316376880212663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP3,Cysteine-rich secretory protein 3,24058,111,0.74 [0.38-1.43],0.3723915884160316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRKL,Crk-like protein,27963,132,1.04 [0.90-1.20],0.5896269667897533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRLF1,Cytokine receptor-like factor 1,28061,132,2.04 [1.13-3.66],0.0176235217479698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,27111,128,1.02 [0.81-1.29],0.8596587684072238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,28281,131,1.10 [0.66-1.83],0.7120951150581991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,27748,130,1.54 [1.14-2.09],0.0050495070523713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAP,Cartilage-associated protein,23599,110,1.15 [0.83-1.61],0.3964347985038343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRX,Cone-rod homeobox protein,27432,126,1.00 [0.86-1.16],0.9515782441123106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB1,Beta-crystallin B1,24272,114,1.26 [0.98-1.64],0.0750271205211655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,24203,112,1.47 [1.28-1.70],1.0983681283466269e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYGD,Gamma-crystallin D,24203,112,1.12 [0.93-1.35],0.2235959963718784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYM,Ketimine reductase mu-crystallin,23493,107,1.21 [1.00-1.48],0.0495953476701946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYZL1,Quinone oxidoreductase-like protein 1,23595,112,1.07 [0.88-1.31],0.4768379935471493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSDE1,Cold shock domain-containing protein E1,23494,110,1.11 [0.97-1.27],0.141203954344096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,28061,132,2.77 [1.67-4.62],8.514784605146141e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,24295,113,2.01 [1.41-2.88],0.0001287852671411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2,Granulocyte-macrophage colony-stimulating factor,23494,110,1.37 [0.88-2.11],0.1591087934716933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27748,130,1.45 [1.16-1.79],0.0008319810954657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RB,Cytokine receptor common subunit beta,23581,108,1.40 [0.92-2.13],0.1172054211582682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3,Granulocyte colony-stimulating factor,27416,127,0.96 [0.69-1.33],0.784688013221023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3R,Granulocyte colony-stimulating factor receptor,23581,108,1.42 [0.90-2.24],0.1304791607965676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSH1,Chorionic somatomammotropin hormone 1,24295,113,0.87 [0.48-1.60],0.6631695984439052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK1D,Casein kinase I isoform delta,23581,108,1.04 [0.79-1.38],0.7798020621167137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK2A1,Casein kinase II subunit alpha,24236,113,1.14 [0.77-1.68],0.5019803053442352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG4,Chondroitin sulfate proteoglycan 4,24262,111,1.55 [0.91-2.66],0.1096954938739698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG5,Chondroitin sulfate proteoglycan 5,23493,107,0.89 [0.60-1.33],0.5612229864829092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSRP3,Cysteine and glycine-rich protein 3,23494,110,1.13 [0.95-1.34],0.1689109118196355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST1,Cystatin-SN,21029,94,0.95 [0.77-1.17],0.6107080107442344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,27968,131,2.90 [1.84-4.58],4.655838979639767e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST5,Cystatin-D,27424,127,0.96 [0.72-1.28],0.7697001351283654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST6,Cystatin-M,27224,129,1.00 [0.72-1.39],0.9921186295671672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST7,Cystatin-F,27963,132,1.15 [1.00-1.32],0.04969248844245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,27552,126,1.71 [1.23-2.38],0.0012934507488118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTAG1A_CTAG1B,Cancer/testis antigen 1,23775,109,1.07 [0.75-1.54],0.7058268477275595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTBS,Di-N-acetylchitobiase,23960,112,1.64 [0.85-3.16],0.1411939992695779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTF1,Cardiotrophin-1,27432,126,1.02 [0.84-1.22],0.8663497649584525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,24262,111,2.00 [1.09-3.67],0.0245756405889831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTLA4,Cytotoxic T-lymphocyte protein 4,24262,111,1.49 [0.92-2.42],0.1071397214234919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTNNA1,Catenin alpha-1,23493,107,0.93 [0.54-1.60],0.7893013641497069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRB1,Chymotrypsinogen B,27929,131,0.94 [0.71-1.24],0.6441266636205629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,27917,132,0.91 [0.72-1.16],0.4476851114194515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRL,Chymotrypsin-like protease CTRL-1,24203,112,0.92 [0.71-1.19],0.5100274326105131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSB,Cathepsin B,27942,130,1.13 [0.84-1.53],0.4269674716019398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSC,Dipeptidyl peptidase 1,27871,132,0.95 [0.67-1.36],0.7945730113270216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,26055,127,1.89 [1.42-2.51],1.0618842494161263e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSE,Cathepsin E,23725,107,1.43 [1.02-1.99],0.0366796765819645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSF,Cathepsin F,28005,132,0.98 [0.67-1.42],0.9136558442904402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSH,Pro-cathepsin H,27348,125,1.24 [1.00-1.54],0.0512805693544489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,27938,130,3.17 [1.81-5.57],5.680103514894846e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSO,Cathepsin O,28273,130,1.04 [0.64-1.71],0.8671734234951425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,22050,107,2.36 [1.12-4.98],0.0242972568527306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,28097,131,0.86 [0.59-1.24],0.4070402326949679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,27915,131,2.20 [1.38-3.50],0.0009110388266592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CUZD1,CUB and zona pellucida-like domain-containing protein 1,23599,110,1.01 [0.65-1.58],0.9651005029129004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CWC15,Spliceosome-associated protein CWC15 homolog,24049,110,1.23 [0.97-1.56],0.0895374011153277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,27748,130,1.42 [0.91-2.21],0.119963023509251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,27925,130,1.35 [1.02-1.78],0.034747598660949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL1,Growth-regulated alpha protein,27874,132,1.02 [0.87-1.20],0.819425152519959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,28061,132,1.27 [1.04-1.55],0.017840469676002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL11,C-X-C motif chemokine 11,28203,133,1.20 [1.01-1.43],0.0401138478772057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL12,Stromal cell-derived factor 1,27416,127,1.31 [0.90-1.90],0.1562973936731033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,28203,133,1.32 [1.09-1.59],0.0042556626938648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,27416,127,1.04 [0.82-1.31],0.777215961287647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,28228,131,1.70 [0.90-3.22],0.0999578214450875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,28273,130,1.51 [1.12-2.03],0.0067199506007144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL3,C-X-C motif chemokine 3,27920,132,0.95 [0.81-1.12],0.5484319101753092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL5,C-X-C motif chemokine 5,27842,129,0.99 [0.87-1.13],0.8985217763428619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL6,C-X-C motif chemokine 6,28273,130,1.09 [0.90-1.33],0.3758183256007571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL8,Interleukin-8,27716,130,0.97 [0.77-1.22],0.8108217255062988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,28061,132,1.46 [1.22-1.76],5.287577830060576e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5A,Cytochrome b5,23409,107,0.96 [0.74-1.25],0.7876975358048661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5R2,NADH-cytochrome b5 reductase 2,23889,108,1.33 [0.99-1.78],0.0577984806841815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23494,110,1.18 [0.99-1.40],0.0598072664211571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTH3,Cytohesin-3,23409,107,0.82 [0.61-1.09],0.1732311113112089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTL1,Cytokine-like protein 1,24262,111,1.49 [0.71-3.12],0.297336029836413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAAM1,Disheveled-associated activator of morphogenesis 1,23725,107,1.01 [0.81-1.26],0.9424167973490748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAB2,Disabled homolog 2,28189,131,1.02 [0.89-1.17],0.7545426539173401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,28061,132,1.28 [0.93-1.74],0.1248278616038114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAND5,DAN domain family member 5,23581,108,1.11 [0.83-1.48],0.4831553611638316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPK2,Death-associated protein kinase 2,23581,108,1.16 [0.87-1.55],0.3140067644884962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27925,130,1.02 [0.90-1.16],0.7642850131857443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DARS1,"Aspartate--tRNA ligase, cytoplasmic",27700,130,0.98 [0.79-1.21],0.8214383148332687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBH,Dopamine beta-hydroxylase,24255,113,1.03 [0.88-1.22],0.7002042843805163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,27788,131,1.04 [0.86-1.26],0.6850448266418568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBN1,Drebrin,23581,108,1.07 [0.76-1.51],0.7094840367454158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBNL,Drebrin-like protein,28061,132,1.08 [0.92-1.28],0.3422620542449174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28005,132,1.24 [0.80-1.90],0.3333738975214491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCC,Netrin receptor DCC,23599,110,1.12 [0.54-2.32],0.769761562584864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCDC2C,Doublecortin domain-containing protein 2C,23409,107,1.25 [1.01-1.55],0.039714067830909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCLRE1C,Protein artemis,23409,107,1.50 [0.92-2.44],0.1015264883491005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCN,Decorin,27432,126,1.06 [0.51-2.18],0.8801790296985712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTD,Deoxycytidylate deaminase,23725,107,0.99 [0.82-1.20],0.9278724125047492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN1,Dynactin subunit 1,28189,131,1.06 [0.84-1.34],0.6066202061159496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN2,Dynactin subunit 2,27812,130,1.08 [0.92-1.27],0.348233099909973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN6,Dynactin subunit 6,27277,126,1.00 [0.80-1.25],0.9657008272686188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTPP1,dCTP pyrophosphatase 1,27938,130,1.34 [0.83-2.17],0.2356017623134705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D1,DCN1-like protein 1,23493,107,1.08 [0.86-1.36],0.5242161872426123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D2,DCN1-like protein 2,23409,107,1.02 [0.81-1.29],0.8564787802236353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCXR,L-xylulose reductase,28005,132,0.83 [0.63-1.11],0.2086033899461307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDA1,DET1- and DDB1-associated protein 1,23494,110,1.30 [0.87-1.95],0.2017378184118263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27812,130,1.42 [1.04-1.93],0.0274807211729393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDC,Aromatic-L-amino-acid decarboxylase,27906,130,0.98 [0.72-1.33],0.8913133370278413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDHD2,Phospholipase DDHD2,24236,113,1.05 [0.81-1.38],0.6968234926466533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,23725,107,0.84 [0.66-1.07],0.1541460671673794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,28203,133,2.68 [1.55-4.62],0.0004085632609068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDT,D-dopachrome decarboxylase,24262,111,1.03 [0.67-1.58],0.8887296243228027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX1,ATP-dependent RNA helicase DDX1,24177,111,1.20 [0.88-1.63],0.2519154858252981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX25,ATP-dependent RNA helicase DDX25,23599,110,1.08 [0.68-1.72],0.7502269893592322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX39A,ATP-dependent RNA helicase DDX39A,23581,108,1.00 [0.44-2.28],0.9913223559288228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX4,Probable ATP-dependent RNA helicase DDX4,23581,108,1.08 [0.79-1.47],0.647963874961911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX53,Probable ATP-dependent RNA helicase DDX53,23599,110,1.06 [0.64-1.77],0.8151313782088302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX58,Antiviral innate immune response receptor RIG-I,27252,129,0.81 [0.60-1.09],0.1591029973527131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27925,130,1.17 [1.00-1.37],0.0542436043686907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFA1_DEFA1B,Neutrophil defensin 1,27345,131,1.20 [0.92-1.57],0.1778185325326273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,23414,107,1.42 [1.03-1.96],0.0322089962882239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB104A_DEFB104B,Beta-defensin 104,23493,107,0.90 [0.64-1.28],0.5729230923303357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB116,Beta-defensin 116,23493,107,1.06 [0.84-1.33],0.6265478733462718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB118,Beta-defensin 118,23493,107,1.10 [0.84-1.46],0.4835979161090811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB4A_DEFB4B,Beta-defensin 4A,27517,130,1.03 [0.93-1.14],0.6145354562008444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENND2B,DENN domain-containing protein 2B,23494,110,1.20 [0.89-1.63],0.2345268983741976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENR,Density-regulated protein,23581,108,1.04 [0.76-1.43],0.8147257323462036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DFFA,DNA fragmentation factor subunit alpha,28273,130,1.05 [0.84-1.31],0.6720411891261484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGCR6,Protein DGCR6,23493,107,1.07 [0.72-1.60],0.7233106548628929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKA,Diacylglycerol kinase alpha,23581,108,1.17 [0.84-1.62],0.3528277970488368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKZ,Diacylglycerol kinase zeta,27416,127,0.80 [0.51-1.25],0.3275446440560638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHODH,Dihydroorotate dehydrogenase,23494,110,0.84 [0.54-1.30],0.4292190542474651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHPS,Deoxyhypusine synthase,24157,113,1.04 [0.68-1.59],0.8658481527284297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24203,112,1.19 [0.84-1.67],0.3252880508065532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIABLO,"Diablo homolog, mitochondrial",27839,130,1.04 [0.91-1.20],0.5368549851580864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK1C,Divergent protein kinase domain 1C,23599,110,1.27 [0.87-1.87],0.2147770271688974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK2B,Divergent protein kinase domain 2B,23725,107,0.89 [0.46-1.73],0.7399641487579732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK1,Dickkopf-related protein 1,28203,133,1.00 [0.78-1.29],0.9851298011317136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK3,Dickkopf-related protein 3,28281,131,0.88 [0.52-1.48],0.6253105157397411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK4,Dickkopf-related protein 4,27697,130,1.15 [0.83-1.60],0.3900641386397826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKKL1,Dickkopf-like protein 1,27812,130,1.07 [0.89-1.30],0.4572358764221474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLG4,Disks large homolog 4,24203,112,1.17 [0.92-1.48],0.2040819055014902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLGAP5,Disks large-associated protein 5,24236,113,0.77 [0.49-1.20],0.2489202842928042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLK1,Protein delta homolog 1,28281,131,1.08 [0.83-1.41],0.5563685959161146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,28005,132,2.10 [1.28-3.44],0.003256933749945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL4,Delta-like protein 4,23595,112,1.06 [0.89-1.27],0.4820238812805363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMD,Dystrophin,23595,112,1.32 [0.99-1.76],0.0567650661918427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMP1,Dentin matrix acidic phosphoprotein 1,23595,112,1.00 [0.74-1.33],0.9792179111424236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,23409,107,0.63 [0.39-1.04],0.0692399768884637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA2,DnaJ homolog subfamily A member 2,28176,130,1.06 [0.88-1.28],0.545748752136964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,24203,112,1.06 [0.83-1.35],0.6521559080516293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB1,DnaJ homolog subfamily B member 1,27812,130,1.06 [0.89-1.26],0.5324940024888725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB14,DnaJ homolog subfamily B member 14,24177,111,1.11 [0.85-1.44],0.4518418376503526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB2,DnaJ homolog subfamily B member 2,23725,107,0.96 [0.68-1.34],0.7966417385464866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB6,DnaJ homolog subfamily B member 6,23502,105,1.02 [0.82-1.26],0.8926068562882157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB8,DnaJ homolog subfamily B member 8,27432,126,1.01 [0.76-1.33],0.96211000664664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC21,DnaJ homolog subfamily C member 21,24203,112,1.12 [0.72-1.72],0.6149169059819395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC6,Putative tyrosine-protein phosphatase auxilin,23595,112,1.06 [0.86-1.30],0.6114028560188665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC9,DnaJ homolog subfamily C member 9,24177,111,1.16 [0.92-1.47],0.1970065854946902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNER,Delta and Notch-like epidermal growth factor-related receptor,27875,132,0.71 [0.40-1.28],0.2578405806436858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNLZ,DNL-type zinc finger protein,23493,107,0.92 [0.73-1.17],0.4956717250218936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM1,Dynamin-1,24177,111,1.07 [0.91-1.25],0.4299620011239163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM3,Dynamin-3,24236,113,1.22 [0.91-1.63],0.1815742281751514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNMBP,Dynamin-binding protein,27748,130,1.11 [0.87-1.40],0.4050751053334658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPEP,Aspartyl aminopeptidase,24203,112,1.01 [0.74-1.37],0.9536574634043296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28006,132,0.91 [0.68-1.22],0.5315830769477847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOC2B,Double C2-like domain-containing protein beta,23599,110,1.14 [0.74-1.76],0.5529390741691049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,23493,107,1.11 [0.97-1.28],0.1311386398129765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK1,Docking protein 1,24203,112,1.03 [0.90-1.17],0.7056341327547417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK2,Docking protein 2,27938,130,1.04 [0.92-1.18],0.5507736943247175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP1,Dipeptidase 1,27700,130,0.99 [0.72-1.36],0.9335545190225022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP2,Dipeptidase 2,27812,130,1.64 [0.99-2.71],0.0530127368171386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP10,Inactive dipeptidyl peptidase 10,27925,130,1.32 [0.88-1.98],0.1741574216768163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP4,Dipeptidyl peptidase 4,27379,130,1.17 [0.70-1.96],0.54993878256945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP6,Dipeptidyl aminopeptidase-like protein 6,27812,130,0.83 [0.53-1.31],0.4308257051216194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP7,Dipeptidyl peptidase 2,27698,129,1.02 [0.79-1.31],0.8740740033829656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,28281,131,1.87 [1.02-3.44],0.0422564553699833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,28112,131,1.28 [1.02-1.60],0.0347134704767098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRAXIN,Draxin,27748,130,1.36 [0.95-1.94],0.0921370967236246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRG2,Developmentally-regulated GTP-binding protein 2,27812,130,1.09 [0.83-1.42],0.5423341180539045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,27591,126,2.08 [1.46-2.96],5.072147193664887e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,24236,113,1.88 [1.17-3.02],0.0085746677312504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG2,Desmoglein-2,27929,131,1.18 [0.67-2.08],0.557926804511153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,28104,130,1.39 [0.89-2.16],0.1471302206103248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG4,Desmoglein-4,27718,130,0.93 [0.68-1.26],0.6291522485692845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTD1,D-aminoacyl-tRNA deacylase 1,23725,107,1.08 [0.88-1.33],0.4562926570911454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,24118,113,1.60 [1.15-2.23],0.0048692527871538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX2,Probable E3 ubiquitin-protein ligase DTX2,23599,110,0.86 [0.62-1.18],0.343196879348346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,27812,130,1.98 [1.12-3.51],0.0183734877926352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTYMK,Thymidylate kinase,24272,114,1.02 [0.79-1.31],0.8975124929031306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUOX2,Dual oxidase 2,27432,126,1.09 [0.89-1.33],0.3889167681742194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP13,Dual specificity protein phosphatase 13 isoform A,24157,113,1.01 [0.66-1.55],0.9466166914718196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP29,Dual specificity phosphatase 29,23599,110,0.86 [0.63-1.17],0.3450966576157371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,27277,126,0.99 [0.82-1.19],0.9176280202962144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24177,111,1.18 [1.00-1.40],0.0550612685361632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DXO,Decapping and exoribonuclease protein,24203,112,1.19 [0.82-1.75],0.3610087604799699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24157,113,1.03 [0.71-1.49],0.8883148955417552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT1,Dynein light chain Tctex-type 1,23599,110,0.97 [0.77-1.21],0.7784584347219651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT3,Dynein light chain Tctex-type 3,24157,113,1.14 [0.77-1.68],0.5128157670943141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27748,130,1.07 [0.91-1.26],0.3894287364375873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,28152,131,1.61 [1.02-2.54],0.0414562806987478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,27277,126,1.07 [0.68-1.68],0.7751683455586227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24272,114,1.11 [0.89-1.38],0.3468383042892271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHS1,"Enoyl-CoA hydratase, mitochondrial",23595,112,1.13 [0.94-1.35],0.1835760458646546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECI2,Enoyl-CoA delta isomerase 2,23494,110,1.14 [0.86-1.50],0.3546574644613881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECM1,Extracellular matrix protein 1,23613,105,1.01 [0.61-1.66],0.9777342793745232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECSCR,Endothelial cell-specific chemotaxis regulator,23493,107,1.09 [0.77-1.53],0.6359796309794881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,28189,131,2.43 [1.71-3.43],5.536622919342118e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDAR,Tumor necrosis factor receptor superfamily member EDAR,27925,130,0.97 [0.82-1.15],0.7560025335570764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDDM3B,Epididymal secretory protein E3-beta,24157,113,0.83 [0.58-1.20],0.320350542769777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23494,110,0.84 [0.49-1.46],0.538992156068302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDF1,Endothelial differentiation-related factor 1,24236,113,1.08 [0.84-1.37],0.5567377504141077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27432,126,0.86 [0.55-1.33],0.4935334983345415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,23595,112,2.59 [1.51-4.43],0.0005090632855539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDNRB,Endothelin receptor type B,23581,108,1.03 [0.69-1.54],0.8835090103966775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EEF1D,Elongation factor 1-delta,24272,114,1.06 [0.88-1.28],0.546265934465545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,24177,111,2.19 [1.57-3.06],4.2596756721676176e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB2,Dynein regulatory complex protein 8,23825,109,1.30 [0.81-2.10],0.2782604527807047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27963,131,2.08 [1.30-3.32],0.0022207049183779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFHD1,EF-hand domain-containing protein D1,24236,113,1.36 [0.86-2.12],0.1847810030027318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,27879,131,2.42 [1.46-4.00],0.0005726212961172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,27700,130,3.41 [2.30-5.05],9.644364090216612e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,23599,110,1.24 [1.00-1.55],0.0518636661005712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGF,Pro-epidermal growth factor,27869,131,1.05 [0.91-1.22],0.5213218690105388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFL7,Epidermal growth factor-like protein 7,27252,129,1.30 [0.90-1.87],0.169227862623987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFLAM,Pikachurin,24177,111,1.22 [0.70-2.13],0.4929644810303956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,28281,131,0.38 [0.15-0.98],0.0464059976309983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGLN1,Egl nine homolog 1,27925,130,1.21 [0.97-1.51],0.0896583183649706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHBP1,EH domain-binding protein 1,24272,114,1.07 [0.85-1.34],0.5862850558519275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHD3,EH domain-containing protein 3,23595,112,1.00 [0.86-1.17],0.9982562060245956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24203,112,1.28 [0.98-1.67],0.0735948623971451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24101,110,1.13 [0.96-1.32],0.1330723364191781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23494,110,1.07 [0.82-1.39],0.6401719880324901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23595,112,1.26 [0.86-1.85],0.2304133511612419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4B,Eukaryotic translation initiation factor 4B,27748,130,1.06 [0.81-1.40],0.6505560027635477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4E,Eukaryotic translation initiation factor 4E,23581,108,1.10 [0.90-1.35],0.3365066337152252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27938,130,1.07 [0.85-1.34],0.5843457419493356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28273,130,1.07 [0.91-1.25],0.4283438503174896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24236,113,1.05 [0.81-1.36],0.7302038217035269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5,Eukaryotic translation initiation factor 5,23494,110,1.07 [0.73-1.58],0.7137181485693593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5A,Eukaryotic translation initiation factor 5A-1,27416,127,1.33 [0.84-2.12],0.2249995019659161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAC1,Zinc phosphodiesterase ELAC protein 1,24236,113,1.02 [0.83-1.26],0.8329462470871651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAVL4,ELAV-like protein 4,23493,107,1.17 [0.98-1.41],0.0889280114002642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,24272,114,3.02 [1.91-4.77],2.340656001707862e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOA,Elongin-A,27812,130,1.05 [0.80-1.37],0.719001987063285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,23494,110,1.40 [0.98-1.99],0.0640202024393289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,27416,127,1.45 [1.09-1.94],0.0119270542911228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENDOU,Poly(U)-specific endoribonuclease,22419,102,1.11 [0.78-1.58],0.5558189539257339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENG,Endoglin,28281,131,1.98 [0.81-4.85],0.1353721324284069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO1,Alpha-enolase,27908,133,1.07 [0.88-1.31],0.4720953252903344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO2,Gamma-enolase,28203,133,1.00 [0.80-1.26],0.9826912528301234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO3,Beta-enolase,23595,112,0.89 [0.65-1.21],0.4530443243154571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOPH1,Enolase-phosphatase E1,24157,113,1.05 [0.76-1.45],0.7574074136760137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23494,110,0.87 [0.45-1.71],0.6935955716511495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPEP,Glutamyl aminopeptidase,23494,110,0.96 [0.62-1.51],0.8717393106870904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28281,131,1.93 [1.16-3.22],0.0114138525705135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28061,132,0.80 [0.59-1.09],0.1561903215705922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23595,112,0.59 [0.36-0.96],0.0333139768184075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27134,128,1.07 [0.90-1.28],0.4407535696188357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENSA,Alpha-endosulfine,24157,113,1.32 [0.99-1.76],0.0628392850088609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27252,129,1.13 [0.80-1.59],0.4966321388928143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27432,126,0.89 [0.43-1.84],0.7484025894848583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27432,126,1.69 [0.89-3.23],0.1097073293069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTR1,Endosome-associated-trafficking regulator 1,23595,112,0.97 [0.72-1.31],0.8646005355942312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EP300,Histone acetyltransferase p300,23581,108,1.68 [1.10-2.56],0.0155427240278257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPB41L5,Band 4.1-like protein 5,23599,110,0.88 [0.65-1.20],0.4267630120224195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPCAM,Epithelial cell adhesion molecule,27927,132,0.89 [0.75-1.04],0.1468227489823931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,24157,113,1.43 [1.15-1.79],0.0013900114800808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,28006,132,1.28 [0.81-2.03],0.2911994374509361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA10,Ephrin type-A receptor 10,27277,126,1.15 [0.93-1.42],0.1996102887428061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,26926,129,3.37 [2.46-4.61],3.6095302890847865e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA4,Ephrin type-A receptor 4,23725,107,1.76 [0.93-3.33],0.0825768326006059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,28281,131,2.93 [1.74-4.94],5.215992438130775e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,27700,130,2.13 [1.32-3.45],0.0019859748338962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHX2,Bifunctional epoxide hydrolase 2,27432,126,1.10 [0.86-1.39],0.4483588543304624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPN1,Epsin-1,23825,109,1.38 [1.02-1.87],0.0393813999985877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPO,Erythropoietin,27925,130,1.11 [0.93-1.33],0.256529288817362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPPK1,Epiplakin,23595,112,1.21 [0.98-1.50],0.0819955114359759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28149,131,1.61 [1.02-2.54],0.0398446551503148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB2,Receptor tyrosine-protein kinase erbB-2,28005,132,1.34 [0.74-2.45],0.3343308795070338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB3,Receptor tyrosine-protein kinase erbB-3,27813,132,1.71 [0.80-3.64],0.167608054775895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB4,Receptor tyrosine-protein kinase erbB-4,28005,132,0.68 [0.37-1.25],0.2136441743166234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBIN,Erbin,27812,130,1.06 [0.92-1.24],0.4189904869348738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERC2,ERC protein 2,23599,110,1.03 [0.81-1.30],0.8304663133784305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERCC1,DNA excision repair protein ERCC-1,23409,107,1.05 [0.59-1.84],0.8764051945262038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EREG,Proepiregulin,27700,130,1.01 [0.84-1.23],0.8890991219387879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERI1,3'-5' exoribonuclease 1,23825,109,1.27 [0.78-2.09],0.3388325902664805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,23581,108,1.66 [1.13-2.44],0.0090780965806932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24157,113,1.30 [0.84-2.02],0.2307622666798622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP29,Endoplasmic reticulum resident protein 29,23725,107,1.04 [0.89-1.21],0.6346870898881881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP44,Endoplasmic reticulum resident protein 44,27773,130,1.24 [0.69-2.22],0.472630884600561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23494,110,0.85 [0.55-1.31],0.4548720522682421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,28281,131,1.80 [1.16-2.78],0.0085643831131279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,27916,132,1.89 [1.24-2.89],0.0031545503481951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESPL1,Separin,23409,107,1.27 [0.97-1.66],0.0866745197712872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESR1,Estrogen receptor,23581,108,1.01 [0.74-1.38],0.945993015918299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESYT2,Extended synaptotagmin-2,24203,112,1.09 [0.88-1.34],0.4318493513760832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI2B,Protein EVI2B,23409,107,0.79 [0.45-1.36],0.3931557526078384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI5,Ecotropic viral integration site 5 protein homolog,23581,108,1.13 [0.92-1.37],0.2402219880431546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,23825,109,1.78 [1.20-2.63],0.0041137512007032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXOSC10,Exosome component 10,23494,110,1.08 [0.82-1.42],0.5792459205144058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXTL1,Exostosin-like 1,23494,110,0.89 [0.59-1.33],0.5655512315504767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EZR,Ezrin,28203,133,1.34 [0.73-2.45],0.3418386083441627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F10,Coagulation factor X,24295,113,0.77 [0.39-1.54],0.4602432898625953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,23943,110,0.86 [0.46-1.60],0.6362409406720178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,27929,131,1.14 [0.88-1.49],0.3251135877214219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F12,Coagulation factor XII,24305,112,0.79 [0.52-1.19],0.2607132076899421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F13B,Coagulation factor XIII B chain,24173,111,1.05 [0.52-2.10],0.8939307166787906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2,Prothrombin,24305,112,0.64 [0.19-2.13],0.4661730507568964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,28018,132,1.22 [0.94-1.58],0.1305412456476685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F3,Tissue factor,28014,130,1.21 [0.70-2.10],0.4866492381786951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F7,Coagulation factor VII,27970,131,1.19 [0.71-2.00],0.4982826063559129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F9,Coagulation factor IX,27982,131,0.54 [0.24-1.21],0.1343578461278832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",27916,132,1.23 [1.06-1.43],0.0076008057135346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",27938,130,1.17 [0.97-1.42],0.0951557435283814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",24272,114,1.58 [1.19-2.10],0.0014869545717528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",28281,131,1.58 [1.20-2.09],0.00122084356309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,28123,133,1.17 [0.94-1.45],0.1682328468065432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,27395,125,1.00 [0.75-1.33],0.9739627547342876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP9,Fatty acid-binding protein 9,27925,130,1.06 [0.81-1.39],0.6577796715032462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FADD,FAS-associated death domain protein,27938,130,1.01 [0.83-1.23],0.9154978041964184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM13A,Protein FAM13A,24177,111,1.10 [0.85-1.42],0.4867646810873682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171A2,Protein FAM171A2,24236,113,1.12 [1.02-1.24],0.0218097279646489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171B,Protein FAM171B,24157,113,1.60 [0.98-2.64],0.0623553117252683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM172A,Cotranscriptional regulator FAM172A,23595,112,1.04 [0.78-1.38],0.809962455249722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM20A,Pseudokinase FAM20A,24272,114,1.46 [0.80-2.68],0.2220598293152918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,27812,130,1.70 [1.12-2.58],0.0131869931979076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,27906,130,2.30 [1.42-3.73],0.0007119683760297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3D,Protein FAM3D,24177,111,1.30 [1.05-1.60],0.0150118667841252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,28281,131,1.19 [0.69-2.06],0.5368950233443969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FARSA,Phenylalanine--tRNA ligase alpha subunit,23599,110,1.11 [0.86-1.42],0.4172637468993072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,28182,131,1.47 [1.06-2.04],0.0211546303545044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FASLG,Tumor necrosis factor ligand superfamily member 6,28273,130,1.21 [0.80-1.83],0.3667961922349223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBLN2,Fibulin-2,24262,111,1.84 [1.08-3.16],0.0258579679189859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBN2,Fibrillin-2,23599,110,1.15 [0.85-1.54],0.3734705987428994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBP1,"Fructose-1,6-bisphosphatase 1",27938,130,1.11 [0.91-1.35],0.3253273900182581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24272,114,1.36 [1.08-1.72],0.0098321419842941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAR,Immunoglobulin alpha Fc receptor,27925,130,1.38 [1.00-1.90],0.0479591663805454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24236,113,2.29 [1.28-4.11],0.0053758043380677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER2,Low affinity immunoglobulin epsilon Fc receptor,27929,131,1.40 [1.04-1.88],0.0242368499984015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27797,131,1.16 [0.88-1.54],0.2992607987957675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27252,129,0.90 [0.68-1.18],0.4369691999370462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27927,131,0.97 [0.71-1.31],0.8286667224244599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN1,Ficolin-1,24255,113,1.30 [0.92-1.83],0.1370156843116148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN2,Ficolin-2,27801,131,1.00 [0.69-1.44],0.9992762557556568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL1,Fc receptor-like protein 1,27938,130,1.14 [0.80-1.61],0.4717216577057428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,28148,129,1.33 [0.98-1.82],0.0709521735388551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL3,Fc receptor-like protein 3,27416,127,1.18 [0.88-1.58],0.269210027661815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL5,Fc receptor-like protein 5,27929,131,1.31 [1.00-1.71],0.0462473235942254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL6,Fc receptor-like protein 6,27925,130,1.19 [0.94-1.49],0.1485136153425168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRLB,Fc receptor-like B,27252,129,1.32 [1.06-1.66],0.0153573740139537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX1,"Adrenodoxin, mitochondrial",23494,110,1.15 [0.90-1.48],0.2693545557661803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX2,"Ferredoxin-2, mitochondrial",23494,110,1.16 [0.87-1.56],0.3119403537632975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FEN1,Flap endonuclease 1,27252,129,0.93 [0.72-1.20],0.5781361199512369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FES,Tyrosine-protein kinase Fes/Fps,27252,129,1.03 [0.74-1.42],0.8714892765577857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FETUB,Fetuin-B,27982,131,0.90 [0.57-1.42],0.6519990851208413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,23721,109,0.90 [0.50-1.65],0.7426207135217282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24236,113,1.12 [0.90-1.39],0.2925061888882722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF12,Fibroblast growth factor 12,23581,108,0.92 [0.59-1.44],0.7264078561595694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF16,Fibroblast growth factor 16,23581,108,1.04 [0.71-1.52],0.8334275993583642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF19,Fibroblast growth factor 19,28061,132,1.17 [0.96-1.42],0.112956758315265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,27925,130,1.12 [0.90-1.40],0.3015226937417339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF20,Fibroblast growth factor 20,23581,108,1.29 [0.90-1.84],0.1655253778822877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,28152,131,1.17 [1.04-1.32],0.0080525070660301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,28138,130,1.42 [1.18-1.71],0.0001647394656536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF3,Fibroblast growth factor 3,23581,108,0.71 [0.35-1.44],0.3408746207470581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,27416,127,1.83 [1.23-2.71],0.002706693015806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF6,Fibroblast growth factor 6,23581,108,0.80 [0.47-1.35],0.4007151271690168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF7,Fibroblast growth factor 7,23409,107,1.12 [0.92-1.37],0.2722066112093029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,23363,107,0.69 [0.44-1.08],0.1030872719412445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,28005,132,0.64 [0.41-1.00],0.051609627715796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP2,Fibroblast growth factor-binding protein 2,24262,111,0.94 [0.65-1.34],0.7148854849162662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP3,Fibroblast growth factor-binding protein 3,24203,112,1.48 [0.92-2.39],0.106516898380926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,28005,132,3.15 [1.76-5.66],0.0001143836434081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR4,Fibroblast growth factor receptor 4,23725,107,0.94 [0.67-1.33],0.7305716800325264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,24295,113,1.36 [1.03-1.80],0.0314831788306363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGR,Tyrosine-protein kinase Fgr,27277,126,1.03 [0.80-1.33],0.8017490875338638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FH,"Fumarate hydratase, mitochondrial",23493,107,0.96 [0.76-1.21],0.7126271930597756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIP2A,FHF complex subunit HOOK interacting protein 2A,23494,110,1.12 [0.79-1.58],0.5210005849968761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIT,Bis(5'-adenosyl)-triphosphatase,27277,126,0.91 [0.73-1.13],0.3870999232909639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FIS1,Mitochondrial fission 1 protein,27908,132,1.07 [0.89-1.30],0.4728695033212285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24236,113,0.98 [0.82-1.17],0.8201027100056077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28049,127,1.02 [0.89-1.17],0.764847056320593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27748,130,1.37 [0.96-1.96],0.0785861870434136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27748,130,1.09 [0.93-1.29],0.2983252464828513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27229,126,0.98 [0.70-1.37],0.898735449840564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBPL,FK506-binding protein-like,24177,111,1.20 [0.89-1.62],0.221514454759782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,27252,129,1.05 [0.91-1.20],0.5288170864975524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27748,130,2.50 [1.54-4.07],0.0002019456898187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT1,Vascular endothelial growth factor receptor 1,27767,130,1.64 [0.97-2.78],0.0661481953473434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3,Receptor-type tyrosine-protein kinase FLT3,27252,129,0.80 [0.47-1.37],0.425958415915589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3LG,Fms-related tyrosine kinase 3 ligand,28273,130,1.09 [0.69-1.72],0.7021272372587226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT4,Vascular endothelial growth factor receptor 3,28005,132,1.36 [0.86-2.14],0.1884955559320694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMNL1,Formin-like protein 1,27277,126,0.97 [0.75-1.24],0.7831766899680459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMR1,Synaptic functional regulator FMR1,27252,129,1.45 [0.96-2.18],0.0779745715616872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FN1,Fibronectin,24305,112,1.03 [0.53-2.00],0.9214857333509904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,24203,112,1.72 [1.18-2.52],0.0050976542995997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24157,113,1.70 [1.20-2.41],0.0031233607491319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLH1,Glutamate carboxypeptidase 2,23581,108,0.98 [0.82-1.17],0.8191692944294731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,27872,131,2.19 [1.35-3.56],0.0015920172905328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,28203,133,1.46 [0.88-2.44],0.1449739580744085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR3,Folate receptor gamma,27914,132,0.98 [0.91-1.07],0.6763230651438965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOS,Proto-oncogene c-Fos,23363,107,1.09 [0.65-1.81],0.7472198925577351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOSB,Protein fosB,27277,126,1.01 [0.68-1.50],0.9716064636253644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXJ3,Forkhead box protein J3,23581,108,1.14 [0.79-1.66],0.4830838910882716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO1,Forkhead box protein O1,27925,130,1.08 [0.90-1.29],0.4092591971438417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO3,Forkhead box protein O3,27252,129,1.00 [0.85-1.17],0.9777737082765064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD4B,FERM domain-containing protein 4B,23494,110,0.93 [0.71-1.21],0.5709674618596876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD7,FERM domain-containing protein 7,23599,110,1.17 [0.71-1.94],0.5379019572236892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRZB,Secreted frizzled-related protein 3,27652,130,1.17 [0.66-2.10],0.58953401979115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSHB,Follitropin subunit beta,23595,112,1.20 [0.90-1.59],0.213299767112292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FST,Follistatin,28018,132,1.02 [0.75-1.37],0.9148364354178588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,23595,112,2.82 [1.46-5.44],0.001949106984495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,27879,131,2.62 [1.74-3.95],4.077142242909067e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FTCD,Formimidoyltransferase-cyclodeaminase,24164,112,1.03 [0.84-1.26],0.774338027998529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUCA1,Tissue alpha-L-fucosidase,28088,130,0.84 [0.70-1.00],0.0458271367288979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUOM,Fucose mutarotase,23725,107,1.21 [0.92-1.58],0.1756524468807261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FURIN,Furin,28005,132,1.00 [0.64-1.55],0.9961624772660131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUS,RNA-binding protein FUS,27201,128,1.21 [0.83-1.75],0.326117469132051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23785,108,0.97 [0.72-1.31],0.8576887227903818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28203,133,1.63 [1.17-2.26],0.0035739360800629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT8,"Alpha-(1,6)-fucosyltransferase",27748,130,0.91 [0.70-1.19],0.5005381402821021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXN,"Frataxin, mitochondrial",28189,131,1.15 [0.94-1.41],0.1749988266161228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXYD5,FXYD domain-containing ion transport regulator 5,27416,127,0.95 [0.74-1.21],0.6667562064153159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FYB1,FYN-binding protein 1,27888,131,1.04 [0.88-1.22],0.6807220791014872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,23599,110,0.95 [0.68-1.32],0.7644857576845431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD8,Frizzled-8,23493,107,0.96 [0.61-1.51],0.8680185356117094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAP,Gamma-aminobutyric acid receptor-associated protein,24157,113,1.36 [1.02-1.82],0.0382944546984329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23825,109,1.10 [0.85-1.41],0.4717026472304215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23493,107,1.04 [0.80-1.36],0.7573666982633718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD1,Glutamate decarboxylase 1,23409,107,1.37 [0.68-2.78],0.3767827508799003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD2,Glutamate decarboxylase 2,23581,108,1.07 [0.73-1.57],0.7383342644595198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23825,109,0.99 [0.68-1.44],0.9721677751305003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23595,112,1.23 [0.89-1.68],0.2057032190442217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAGE2A,G antigen 2A,23409,107,0.82 [0.57-1.17],0.2693625960451734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAL,Galanin peptides,28061,132,0.84 [0.66-1.06],0.1455242018707544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27812,130,1.79 [1.06-3.03],0.02851646472369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28189,131,1.13 [0.63-2.03],0.691721053439556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27416,127,1.06 [0.73-1.55],0.7451524583634437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24272,114,2.11 [1.16-3.84],0.0139544151382975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT7,N-acetylgalactosaminyltransferase 7,27812,130,1.27 [0.60-2.66],0.5295753321808556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAMT,Guanidinoacetate N-methyltransferase,23494,110,1.31 [0.88-1.95],0.1854074285126795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23221,104,1.13 [0.61-2.08],0.697244312440767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GART,Trifunctional purine biosynthetic protein adenosine-3,24236,113,1.01 [0.52-1.97],0.9757194517102428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS2,Growth arrest-specific protein 2,23825,109,1.13 [0.83-1.54],0.4284669439244783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,28083,131,2.11 [1.17-3.79],0.0125236338550549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GASK1A,Golgi-associated kinase 1A,23494,110,0.87 [0.57-1.33],0.5301024308436522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,24203,112,1.28 [1.14-1.43],3.245725969905234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23409,107,0.53 [0.26-1.08],0.0819709314687929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23595,112,1.12 [0.90-1.40],0.3148231858277904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBA,Lysosomal acid glucosylceramidase,23599,110,1.32 [0.98-1.77],0.0693459221329961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,24158,112,1.42 [1.11-1.83],0.0053642856162163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP2,Guanylate-binding protein 2,27416,127,1.04 [0.80-1.35],0.7745765564429704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,27277,126,1.44 [1.10-1.89],0.0078474116053533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP6,Guanylate-binding protein 6,23494,110,1.15 [0.80-1.65],0.448286354046268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GC,Vitamin D-binding protein,24305,112,1.10 [0.55-2.20],0.7828506697901854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCC1,GRIP and coiled-coil domain-containing protein 1,24203,112,1.05 [0.89-1.24],0.5437441289676432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCG,Pro-glucagon,27252,129,1.12 [0.99-1.27],0.0792037730320116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23139,102,0.95 [0.65-1.39],0.8044145501263738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCLM,Glutamate--cysteine ligase regulatory subunit,23494,110,1.04 [0.70-1.54],0.8502659531525506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27812,130,2.32 [1.53-3.51],7.777733381417718e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,28281,131,1.79 [1.47-2.18],9.941940870169773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF2,Growth/differentiation factor 2,27938,130,1.25 [0.82-1.92],0.2987604706960722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,27277,126,1.68 [1.17-2.43],0.0053846602850103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GET3,ATPase GET3,24272,114,1.05 [0.77-1.42],0.7780587523086753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,27210,129,1.16 [0.82-1.64],0.4083806404966844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,27252,129,1.20 [0.95-1.51],0.1224531191735219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27252,129,1.00 [0.88-1.13],0.9816128829234128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,28152,131,3.29 [2.02-5.35],1.7903174697875956e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA2,GDNF family receptor alpha-2,27812,130,2.44 [1.21-4.91],0.0125709927385917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,27656,130,2.02 [1.19-3.42],0.0093486452479888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRAL,GDNF family receptor alpha-like,23498,106,0.81 [0.59-1.09],0.1655432216724559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGA1,ADP-ribosylation factor-binding protein GGA1,27277,126,1.02 [0.82-1.27],0.8346908401101159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGACT,Gamma-glutamylaminecyclotransferase,24272,114,1.22 [0.96-1.55],0.1119486534067296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGCT,Gamma-glutamylcyclotransferase,24231,114,1.03 [0.72-1.48],0.8556570530840807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,27421,130,2.09 [1.45-3.00],7.012578348414355e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,27879,131,1.51 [1.16-1.96],0.0018908862967903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,27748,130,1.78 [0.98-3.22],0.0562125740456128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH1,Somatotropin,27906,130,0.97 [0.89-1.06],0.5638325490708128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH2,Growth hormone variant,27252,129,0.98 [0.89-1.08],0.7265323363908942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,23725,107,0.47 [0.25-0.88],0.0176432388663739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRHR,Growth hormone-releasing hormone receptor,27277,126,0.89 [0.65-1.21],0.4488385013515031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,27938,130,0.87 [0.72-1.05],0.156216015072376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GID8,Glucose-induced degradation protein 8 homolog,24236,113,1.18 [0.74-1.89],0.4762375770938989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIGYF2,GRB10-interacting GYF protein 2,24236,113,1.12 [0.90-1.40],0.3219384341540352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP7,GTPase IMAP family member 7,23725,107,1.16 [0.69-1.96],0.5751865899004261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP8,GTPase IMAP family member 8,23409,107,1.03 [0.71-1.48],0.893120055805656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIP,Gastric inhibitory polypeptide,23595,112,1.16 [0.78-1.72],0.4655381725920028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC2,PDZ domain-containing protein GIPC2,24203,112,1.10 [0.61-2.00],0.7497704541064261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC3,PDZ domain-containing protein GIPC3,24177,111,1.07 [0.89-1.29],0.4577623090115582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPR,Gastric inhibitory polypeptide receptor,23581,108,0.96 [0.64-1.45],0.8428429754110736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIT1,ARF GTPase-activating protein GIT1,23581,108,1.10 [0.91-1.33],0.3277481143574279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GJA8,Gap junction alpha-8 protein,23409,107,1.06 [0.79-1.41],0.6904706525226354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,26754,123,0.89 [0.50-1.59],0.6975426456280938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLA,Alpha-galactosidase A,23673,107,1.30 [0.81-2.09],0.2843780704057486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLB1,Beta-galactosidase,27748,130,1.04 [0.73-1.50],0.8148967060371798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLI2,Zinc finger protein GLI2,23581,108,0.95 [0.55-1.66],0.86724850609607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLO1,Lactoylglutathione lyase,27432,126,1.15 [0.88-1.50],0.3194410893534164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLOD4,Glyoxalase domain-containing protein 4,27865,132,1.18 [0.77-1.81],0.4557344421163805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLP1R,Glucagon-like peptide 1 receptor,23493,107,1.31 [0.87-1.99],0.2018014031155584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,27765,129,1.01 [0.77-1.31],0.9650174859198722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23725,107,1.10 [0.90-1.35],0.3490708306449923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27277,126,0.98 [0.70-1.38],0.9116749157549328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLYR1,Putative oxidoreductase GLYR1,24157,113,1.04 [0.78-1.38],0.8097488274222784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,23692,108,1.55 [1.15-2.10],0.0042100004643417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMFG,Glia maturation factor gamma,24272,114,1.06 [0.83-1.36],0.6270058647791067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR,GMP reductase 1,28273,130,1.01 [0.74-1.38],0.95492361563499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR2,GMP reductase 2,23725,107,0.96 [0.73-1.27],0.7989726150715275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNAS,Neuroendocrine secretory protein 55,24236,113,1.04 [0.86-1.26],0.6547205733884829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27252,129,1.18 [0.94-1.48],0.1654431443441318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23599,110,1.03 [0.73-1.45],0.8817723362961761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNLY,Granulysin,27929,131,1.45 [1.08-1.94],0.0123430269355847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA1,Glucosamine-6-phosphate isomerase 1,23595,112,1.12 [0.67-1.86],0.668001030022626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA2,Glucosamine-6-phosphate isomerase 2,23725,107,0.99 [0.61-1.63],0.9807217643671556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLGA3,Golgin subfamily A member 3,24236,113,1.02 [0.81-1.28],0.896156686056933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLM2,Protein GOLM2,28203,133,1.28 [0.66-2.50],0.4695255966874186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27925,130,1.07 [0.92-1.24],0.3959112164568253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GORASP2,Golgi reassembly-stacking protein 2,24177,111,1.47 [1.03-2.08],0.0327124116899151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOT1,"Aspartate aminotransferase, cytoplasmic",24262,111,1.35 [0.92-1.97],0.1229305945125714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BA,Platelet glycoprotein Ib alpha chain,27801,131,1.28 [0.81-2.02],0.2973899513862278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BB,Platelet glycoprotein Ib beta chain,23494,110,1.05 [0.80-1.37],0.7198889841235668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27074,124,0.94 [0.78-1.14],0.5592809063726389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP5,Platelet glycoprotein V,23725,107,1.18 [0.70-1.98],0.5291943908901637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP6,Platelet glycoprotein VI,27888,131,1.05 [0.89-1.25],0.5598716878635935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPA33,Cell surface A33 antigen,27812,130,0.92 [0.82-1.04],0.1828554252479208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC1,Glypican-1,28189,131,1.37 [0.82-2.31],0.2315572247804218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC5,Glypican-5,27748,130,0.87 [0.66-1.14],0.3031537659511626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPD1,Glycerol-3-phosphate dehydrogenase,24157,113,1.32 [0.97-1.78],0.0744575652107036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPHA2,Glycoprotein hormone alpha-2,24177,111,1.04 [0.72-1.51],0.8331750757154257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPI,Glucose-6-phosphate isomerase,24295,113,1.17 [0.82-1.67],0.3854845199567619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24177,111,0.94 [0.74-1.19],0.5982373763267628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,27277,126,1.16 [0.71-1.89],0.5504319660376644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,27182,126,1.37 [0.78-2.38],0.2723115353114403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR101,Probable G-protein coupled receptor 101,23493,107,1.03 [0.77-1.38],0.8304201957129503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR158,Probable G-protein coupled receptor 158,24236,113,1.45 [0.99-2.12],0.0550012050172058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,24177,111,1.63 [1.25-2.11],0.0002455306016513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,27432,126,1.52 [1.20-1.93],0.0006181618594996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,24157,113,1.30 [1.02-1.66],0.0363693949249063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRAP2,GRB2-related adapter protein 2,27938,130,1.03 [0.91-1.16],0.6512002506140968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24272,114,1.17 [0.89-1.53],0.2737079975678634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIK2,"Glutamate receptor ionotropic, kainate 2",24236,113,1.30 [0.89-1.91],0.1798909665464737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23493,107,1.15 [0.87-1.52],0.3270739011439574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRK5,G protein-coupled receptor kinase 5,27432,126,0.92 [0.67-1.27],0.6287409015737759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,27788,129,2.50 [1.43-4.38],0.0013055922771785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRP,Gastrin-releasing peptide,23595,112,0.86 [0.61-1.20],0.3795363146668716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",27812,130,1.22 [0.97-1.53],0.0837385596565659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRSF1,G-rich sequence factor 1,23277,107,1.05 [0.84-1.31],0.6732002420738539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSAP,Gamma-secretase-activating protein,27252,129,1.09 [0.93-1.28],0.2677244163367621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSN,Gelsolin,24195,112,0.82 [0.32-2.11],0.6775106846800676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSR,"Glutathione reductase, mitochondrial",24161,112,1.76 [0.82-3.78],0.148139753786381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA1,Glutathione S-transferase A1,27899,129,0.92 [0.76-1.10],0.3336538856102839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA3,Glutathione S-transferase A3,27252,129,0.96 [0.78-1.16],0.6498061121829557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTM4,Glutathione S-transferase Mu 4,23494,110,0.89 [0.67-1.18],0.4134625435169581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTP1,Glutathione S-transferase P,27102,123,1.08 [0.86-1.35],0.5220607141055045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTT2B,Glutathione S-transferase theta-2B,24203,112,0.99 [0.92-1.07],0.8277891502222625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23825,109,1.00 [0.77-1.29],0.9708385762276496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTPBP2,GTP-binding protein 2,23599,110,1.09 [0.87-1.36],0.4382365829052514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,27796,130,2.22 [1.44-3.41],0.0003042653560469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCY2C,Heat-stable enterotoxin receptor,23825,109,0.96 [0.76-1.20],0.7159311932835799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUK1,Guanylate kinase,23494,110,1.10 [0.72-1.67],0.6532395439646299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUSB,Beta-glucuronidase,28039,130,1.30 [1.02-1.66],0.0335774560461663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GYS1,"Glycogen [starch] synthase, muscle",27432,126,1.10 [0.93-1.29],0.2873346620284286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,28273,130,1.45 [0.96-2.19],0.080401699495756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMB,Granzyme B,27925,130,1.07 [0.85-1.34],0.5586069395604302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMH,Granzyme H,27432,126,1.15 [0.96-1.37],0.1219055371032802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),H2AP,Huntingtin-interacting protein M,23409,107,1.06 [0.75-1.51],0.7437864335158502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23494,110,1.08 [0.83-1.40],0.5578647949610098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28116,131,0.95 [0.77-1.18],0.644101456620064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,28189,131,1.05 [0.93-1.17],0.4532900522240817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HARS1,"Histidine--tRNA ligase, cytoplasmic",27929,131,1.02 [0.84-1.24],0.8630872309973927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,28153,131,1.32 [1.05-1.66],0.0163527908181239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,27929,131,2.22 [1.51-3.28],5.571578148555289e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBEGF,Proheparin-binding EGF-like growth factor,28116,131,1.06 [0.86-1.30],0.5973012016913044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,28189,131,0.80 [0.62-1.03],0.0880793061360543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBZ,Hemoglobin subunit zeta,24272,114,0.95 [0.80-1.12],0.5293926047452789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,23494,110,0.93 [0.64-1.34],0.6962945902238191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCLS1,Hematopoietic lineage cell-specific protein,28273,130,1.15 [0.87-1.53],0.3142429991386107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC8,Histone deacetylase 8,23581,108,0.89 [0.64-1.24],0.4864347784285735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC9,Histone deacetylase 9,23493,107,0.93 [0.68-1.28],0.6694443871181179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDDC2,5'-deoxynucleotidase HDDC2,24177,111,0.99 [0.66-1.48],0.949767322727941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGF,Hepatoma-derived growth factor,28157,131,1.09 [0.92-1.28],0.3073095749271017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGFL2,Hepatoma-derived growth factor-related protein 2,24203,112,1.05 [0.80-1.38],0.7279000172654306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEBP1,Heme-binding protein 1,27432,126,0.88 [0.65-1.21],0.4438683673856952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEG1,Protein HEG homolog 1,23725,107,1.57 [0.81-3.06],0.1807629051620312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,24203,112,0.72 [0.47-1.10],0.130871169705816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPH,Hephaestin,24272,114,1.96 [0.99-3.90],0.0544647114469138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEXIM1,Protein HEXIM1,27925,130,1.08 [0.90-1.31],0.4161717497933404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,28273,130,2.01 [1.36-2.97],0.0004725779386791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGFAC,Hepatocyte growth factor activator,24065,110,0.74 [0.39-1.38],0.3430816536606744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27252,129,1.05 [0.86-1.28],0.6120736473167724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HHEX,Hematopoietically-expressed homeobox protein HHEX,24203,112,1.22 [0.97-1.53],0.0873447894840928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIF1A,Hypoxia-inducible factor 1-alpha,23581,108,1.11 [0.88-1.40],0.3775378885372094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1,Huntingtin-interacting protein 1,23494,110,0.94 [0.54-1.62],0.8108252991066958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,24165,111,1.50 [1.18-1.90],0.0009262465837793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HJV,Hemojuvelin,24236,113,1.21 [0.83-1.77],0.3116413505649373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HK2,Hexokinase-2,27432,126,0.62 [0.34-1.11],0.1060216045208996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24236,113,1.67 [0.95-2.91],0.072287277955374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27837,130,2.16 [1.48-3.16],7.001023583244343e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27925,130,2.58 [1.65-4.04],3.440601452294952e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,28189,131,0.98 [0.69-1.39],0.8960549378464725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMCN2,Hemicentin-2,23678,107,0.92 [0.67-1.26],0.5933781656708893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23595,112,1.18 [0.85-1.65],0.3292321304997466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23494,110,1.02 [0.68-1.53],0.9190796735990878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMMR,Hyaluronan mediated motility receptor,23370,107,1.10 [0.77-1.58],0.588416784663836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX1,Heme oxygenase 1,27623,129,1.33 [0.98-1.82],0.0690555388113301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,27277,126,1.19 [0.88-1.60],0.2554286944417288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNF1A,Hepatocyte nuclear factor 1-alpha,23599,110,0.92 [0.70-1.21],0.5672502776109469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,27615,130,1.57 [1.16-2.13],0.003169053392365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27334,126,0.97 [0.79-1.18],0.7304510520391746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24236,113,1.14 [0.82-1.60],0.4334722278558627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPCAL1,Hippocalcin-like protein 1,28273,130,1.05 [0.85-1.30],0.6343805102851248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,27252,129,0.63 [0.41-0.96],0.0324670750478204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPSE,Heparanase,23948,109,1.06 [0.88-1.29],0.5441057913904412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRAS,GTPase Hras,23792,109,0.86 [0.68-1.09],0.2150053346444224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23595,112,1.54 [1.04-2.29],0.0307685014893142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRG,Histidine-rich glycoprotein,24173,111,0.82 [0.47-1.45],0.5016153485392749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS1BP3,HCLS1-binding protein 3,23595,112,1.12 [0.92-1.37],0.2497266998865734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27812,130,1.19 [0.80-1.78],0.3886848704423026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28189,131,1.27 [0.82-1.94],0.2817789319886326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23581,108,1.68 [1.02-2.77],0.0411804848242639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSBP1,Heat shock factor-binding protein 1,23595,112,0.99 [0.82-1.20],0.9197441223665712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27925,130,1.13 [0.78-1.65],0.5125070596929631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24203,112,1.33 [1.01-1.75],0.0414033577130216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B3,Testosterone 17-beta-dehydrogenase 3,23494,110,1.03 [0.71-1.50],0.8732692151756658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23595,112,1.00 [0.69-1.45],0.9910888018204688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSP90B1,Endoplasmin,27147,126,1.07 [0.86-1.33],0.5420175288021858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA1A,Heat shock 70 kDa protein 1A,28006,132,1.08 [0.88-1.32],0.4864623688664045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA2,Heat shock-related 70 kDa protein 2,24157,113,1.37 [0.91-2.05],0.127759232259967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB1,Heat shock protein beta-1,27470,128,1.01 [0.81-1.27],0.920268753574671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,28189,131,1.46 [1.01-2.12],0.0433920065903837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27708,131,2.67 [1.71-4.17],1.5632794182226847e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1A,5-hydroxytryptamine receptor 1A,23493,107,0.98 [0.77-1.26],0.8929375674389362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1B,5-hydroxytryptamine receptor 1B,23493,107,1.17 [0.78-1.76],0.4469079310357108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",28005,132,1.09 [0.86-1.39],0.4748566890395049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,27750,131,2.30 [1.27-4.16],0.0059311651554228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,28281,131,1.89 [0.96-3.75],0.0672609898270399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICA1,Islet cell autoantigen 1,27416,127,1.09 [0.90-1.32],0.3656151620472888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,27804,131,3.13 [2.00-4.89],6.061644175841985e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,28281,131,2.04 [1.24-3.35],0.0051204115789901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,28281,131,3.26 [1.97-5.37],3.775434043732149e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM4,Intercellular adhesion molecule 4,27925,130,1.10 [0.82-1.48],0.5054921147903675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM5,Intercellular adhesion molecule 5,27938,130,1.18 [0.84-1.67],0.3342577662913429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICOSLG,ICOS ligand,27812,130,1.51 [0.67-3.37],0.3184798522806574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ID4,DNA-binding protein inhibitor ID-4,23825,109,1.07 [0.73-1.57],0.7189725153556519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,27277,126,1.31 [0.97-1.77],0.0818387218569938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDO1,"Indoleamine 2,3-dioxygenase 1",23595,112,1.32 [1.02-1.69],0.0327249500636325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDS,Iduronate 2-sulfatase,28273,130,0.33 [0.07-1.57],0.1645098273073229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDUA,Alpha-L-iduronidase,28189,131,1.30 [0.93-1.81],0.1254732409419158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23607,109,2.25 [1.54-3.29],2.582052825278772e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23825,109,1.26 [0.91-1.74],0.1689776609308203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23825,109,1.28 [0.83-1.96],0.2621151904747071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNAR1,Interferon alpha/beta receptor 1,24177,111,1.37 [0.72-2.61],0.3359918490420755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNG,Interferon gamma,27416,127,1.17 [1.02-1.34],0.0233321144054028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,28061,132,2.47 [1.50-4.06],0.0003560903879888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,27748,130,1.56 [1.19-2.05],0.0011319385115823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,27277,126,1.42 [1.04-1.94],0.0287902918418573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL2,Interferon lambda-2,23493,107,1.06 [0.80-1.40],0.671418864716312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,27925,130,1.61 [1.19-2.18],0.0019175032209875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNW1,Interferon omega-1,23494,110,1.02 [0.62-1.69],0.9249863100819696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFT20,Intraflagellar transport protein 20 homolog,23599,110,1.30 [0.89-1.90],0.1716082814592941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGBP1,Immunoglobulin-binding protein 1,24236,113,1.12 [0.84-1.49],0.4371465999868925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23493,107,0.96 [0.66-1.41],0.8339038448587949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24262,111,0.79 [0.40-1.56],0.4979968741196264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,27812,130,2.02 [1.38-2.95],0.000272624754839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23494,110,1.46 [1.10-1.92],0.0078284815328607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,27929,131,1.83 [0.97-3.45],0.0607666339647205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP1,Insulin-like growth factor-binding protein 1,28234,131,1.04 [0.92-1.17],0.5679716016344118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,28229,131,1.36 [1.07-1.72],0.0121994780066122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,28016,131,0.64 [0.40-1.04],0.0716226133050964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,27576,130,1.79 [1.30-2.46],0.0003238575835972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,27807,131,1.77 [1.13-2.78],0.0128793488429969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,28281,131,2.21 [1.59-3.07],1.992193698781067e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,27938,130,1.84 [1.23-2.73],0.002831728986056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFL4,Insulin growth factor-like family member 4,23581,108,1.18 [0.98-1.42],0.0776509284572736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGHMBP2,DNA-binding protein SMUBP-2,23494,110,1.09 [0.80-1.47],0.5863749259123036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,24267,112,1.93 [1.41-2.65],4.340565596716809e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLON5,IgLON family member 5,23409,107,1.09 [0.92-1.30],0.3323538628614569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF21,Immunoglobulin superfamily member 21,23595,112,0.93 [0.59-1.47],0.762495401995305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,27812,130,1.75 [1.30-2.36],0.000213846668236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,27938,130,1.85 [1.16-2.96],0.0103223530624246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF9,Protein turtle homolog A,24272,114,1.18 [0.97-1.44],0.0950401441541521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKBKG,NF-kappa-B essential modulator,27925,130,1.11 [0.94-1.31],0.2323592047235008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKZF2,Zinc finger protein Helios,27252,129,0.96 [0.80-1.15],0.6538854973013039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10,Interleukin-10,27416,127,1.13 [0.94-1.34],0.1865672539815836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RA,Interleukin-10 receptor subunit alpha,27416,127,1.20 [0.98-1.49],0.0841642158327724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,28061,132,2.45 [1.72-3.48],5.731736565074523e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL11,Interleukin-11,27416,127,0.99 [0.77-1.27],0.9184662552386532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,27812,130,1.36 [1.13-1.65],0.0015713877381612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,28273,130,1.49 [1.13-1.98],0.0050311740374292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,27416,127,1.70 [1.14-2.55],0.010078836398754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB2,Interleukin-12 receptor subunit beta-2,23581,108,1.49 [1.04-2.14],0.0301888592270775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13,Interleukin-13,27416,127,0.77 [0.51-1.16],0.2055507718035229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA1,Interleukin-13 receptor subunit alpha-1,27565,132,1.67 [0.85-3.30],0.1388976195503718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA2,Interleukin-13 receptor subunit alpha-2,23493,107,1.06 [0.56-2.02],0.8515631769164105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15,Interleukin-15,27925,130,1.43 [0.92-2.23],0.1111311278956207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,27416,127,1.99 [1.28-3.10],0.0023939486302947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL16,Pro-interleukin-16,28273,130,1.32 [0.96-1.81],0.0832162874001181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17A,Interleukin-17A,27373,126,1.00 [0.70-1.44],0.99378630272651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,27416,127,1.28 [1.05-1.57],0.0151931227984635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17D,Interleukin-17D,27416,127,1.14 [0.75-1.74],0.5441698300559049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17F,Interleukin-17F,27416,127,1.04 [0.86-1.26],0.7020346386415738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RA,Interleukin-17 receptor A,27929,131,1.35 [0.96-1.90],0.0867824864492061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RB,Interleukin-17 receptor B,27558,127,1.02 [0.76-1.35],0.9027329928583752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,27818,132,1.75 [1.32-2.33],0.0001075834161716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,28016,131,2.67 [1.75-4.05],4.568897383753257e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,28273,130,1.64 [1.06-2.54],0.0265624229991856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18RAP,Interleukin-18 receptor accessory protein,27570,130,0.99 [0.91-1.09],0.8891687009395058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,27249,128,1.27 [1.04-1.55],0.0171013297946033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1A,Interleukin-1 alpha,27416,127,0.87 [0.64-1.20],0.4058244776142606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1B,Interleukin-1 beta,27278,127,1.10 [0.85-1.43],0.4589146982789428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,27879,131,1.83 [0.96-3.46],0.0646475814780936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R2,Interleukin-1 receptor type 2,27870,132,1.76 [0.81-3.81],0.1507316925569495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RAP,Interleukin-1 receptor accessory protein,27929,131,1.01 [0.71-1.44],0.9562697428092388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,28182,131,1.48 [1.06-2.06],0.0211597057339547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL2,Interleukin-1 receptor-like 2,27416,127,0.82 [0.55-1.21],0.3060781366426959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,27866,132,1.36 [1.09-1.71],0.0076689758820991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2,Interleukin-2,27416,127,1.30 [0.78-2.17],0.3079259704887932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20,Interleukin-20,27416,127,1.04 [0.76-1.41],0.8184542647426587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RA,Interleukin-20 receptor subunit alpha,27416,127,0.85 [0.57-1.26],0.4185912946539017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RB,Interleukin-20 receptor subunit beta,23581,108,1.14 [0.75-1.73],0.5331817032255852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL21R,Interleukin-21 receptor,23581,108,1.07 [0.78-1.48],0.6772589388659758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,24157,113,1.38 [1.11-1.72],0.0040113223629427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22RA1,Interleukin-22 receptor subunit alpha-1,27416,127,0.95 [0.65-1.39],0.8044978041004816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL24,Interleukin-24,27416,127,1.08 [0.78-1.49],0.6338134068964687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL25,Interleukin-25,23326,107,0.59 [0.35-1.01],0.0525767565449103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,27759,131,2.06 [1.49-2.85],1.3654025191803752e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RB,Interleukin-2 receptor subunit beta,27416,127,0.60 [0.37-0.99],0.0439573078364667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,24157,113,1.46 [1.07-1.99],0.0156756840253993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3,Interleukin-3,23409,107,1.16 [0.84-1.61],0.3673231571621688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31,Interleukin-31,23581,108,1.00 [0.73-1.38],0.987257341736714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31RA,Interleukin-31 receptor subunit alpha,23500,108,1.15 [0.73-1.82],0.5442527371157966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL32,Interleukin-32,27925,130,1.26 [0.91-1.75],0.1709693106578965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL33,Interleukin-33,27416,127,1.01 [0.68-1.51],0.9475121732103264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL34,Interleukin-34,27227,126,1.58 [1.00-2.51],0.0516111663690667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36A,Interleukin-36 alpha,23581,108,0.95 [0.68-1.32],0.7375135740869769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36G,Interleukin-36 gamma,23503,106,1.22 [0.97-1.53],0.0885363928295135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,27416,127,2.29 [1.50-3.49],0.0001131975993929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4,Interleukin-4,27416,127,1.01 [0.85-1.21],0.8939523940801581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,27925,130,2.16 [1.50-3.11],3.6040914019642105e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5,Interleukin-5,27416,127,1.04 [0.94-1.16],0.4417813792016262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5RA,Interleukin-5 receptor subunit alpha,27925,130,1.26 [0.96-1.65],0.0965295991191046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,27812,130,1.22 [1.03-1.45],0.0209490801225377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6R,Interleukin-6 receptor subunit alpha,27750,131,1.35 [0.86-2.11],0.1959910638025374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,27938,130,2.53 [1.20-5.30],0.0142593703843283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7,Interleukin-7,27925,130,1.13 [0.89-1.42],0.3159502691517116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7R,Interleukin-7 receptor subunit alpha,27929,131,1.09 [0.81-1.47],0.5548475259367692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL9,Interleukin-9,23825,109,1.23 [0.97-1.58],0.0918806453034169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27238,126,0.86 [0.65-1.15],0.3124727826369994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,24157,113,1.46 [1.07-1.99],0.0166683512098757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPA1,Inositol monophosphatase 1,27748,130,1.04 [0.81-1.34],0.7490903510321315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPACT,Protein IMPACT,24203,112,1.07 [0.78-1.47],0.6779756976856588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPG1,Interphotoreceptor matrix proteoglycan 1,23493,107,0.88 [0.46-1.68],0.7081070043573072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ING1,Inhibitor of growth protein 1,27229,126,0.93 [0.65-1.32],0.6929874901253321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,23725,107,1.95 [1.41-2.68],4.762304167861354e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,27929,131,1.68 [1.13-2.49],0.0097923105077308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP1,Inositol polyphosphate 1-phosphatase,27812,130,1.06 [0.80-1.40],0.6830882444088997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23595,112,1.15 [0.85-1.57],0.3587404964928242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24236,113,1.41 [1.01-1.97],0.0432012986061706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27812,130,1.05 [0.90-1.23],0.5337890808180477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,24203,112,0.75 [0.60-0.94],0.0121882975520308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL4,Early placenta insulin-like peptide,24157,113,1.27 [1.01-1.61],0.0431968664599818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,24177,111,1.21 [1.02-1.44],0.0257287450941791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,23581,108,5.02 [1.86-13.57],0.0014696446970348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IPCEF1,Interactor protein for cytohesin exchange factors 1,27700,130,1.04 [0.88-1.24],0.6474958413355391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IQGAP2,Ras GTPase-activating-like protein IQGAP2,27812,130,1.11 [0.84-1.46],0.4532212963591639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27432,126,1.00 [0.84-1.19],0.9679293208212432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK1,Interleukin-1 receptor-associated kinase 1,27416,127,1.07 [0.86-1.33],0.5500079615597766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK4,Interleukin-1 receptor-associated kinase 4,27925,130,1.06 [0.91-1.23],0.4362018882698379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26871,124,1.38 [0.91-2.09],0.1250787444484468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM1,Isthmin-1,27925,130,1.46 [1.01-2.11],0.0457460902240203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM2,Isthmin-2,24262,111,1.13 [0.79-1.64],0.5025754022633722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IST1,IST1 homolog,24003,111,1.09 [0.91-1.31],0.3356182050617481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,27925,130,0.91 [0.58-1.42],0.6817909134090232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA2,Integrin alpha-2,23725,107,1.22 [0.71-2.10],0.4752985759325644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,27929,131,3.05 [1.73-5.37],0.0001102675554668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA6,Integrin alpha-6,27925,130,1.12 [0.85-1.47],0.4179000485346086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAL,Integrin alpha-L,23581,108,1.72 [1.12-2.65],0.0140775134957911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAM,Integrin alpha-M,27929,131,1.26 [0.78-2.02],0.3397161453067681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,28189,131,0.61 [0.25-1.47],0.2683599000000137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAX,Integrin alpha-X,23825,109,1.11 [0.80-1.55],0.5343083872387491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1,Integrin beta-1,27878,131,1.65 [0.85-3.21],0.1368047707707595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP1,Integrin beta-1-binding protein 1,27252,129,1.00 [0.69-1.47],0.9841858830126032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP2,Integrin beta-1-binding protein 2,27432,126,1.04 [0.91-1.20],0.558610024613547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,27770,129,2.14 [1.34-3.42],0.0014084736455539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB5,Integrin beta-5,28005,132,1.07 [0.73-1.57],0.7393790521932944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB6,Integrin beta-6,27416,127,1.31 [0.77-2.23],0.3169523981249796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,28189,131,1.66 [1.23-2.25],0.0009510902203488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,24262,111,1.87 [1.26-2.78],0.0019074328332742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24305,112,1.21 [0.48-3.03],0.688607631054754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28016,131,1.43 [0.96-2.13],0.0806837411745106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24305,112,1.04 [0.53-2.04],0.90778902736682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24157,113,0.92 [0.61-1.40],0.7019572634671206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITM2A,Integral membrane protein 2A,27925,130,1.21 [0.94-1.57],0.1441039280530107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPA,Inosine triphosphate pyrophosphatase,23494,110,1.10 [0.85-1.43],0.4735957846752553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23595,112,1.10 [0.87-1.40],0.4238348533652598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23493,107,0.96 [0.64-1.43],0.83076252934035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27277,126,0.86 [0.61-1.20],0.3686513941417768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IZUMO1,Izumo sperm-egg fusion protein 1,23409,107,0.99 [0.68-1.45],0.9735517569048296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,28203,133,1.75 [1.00-3.09],0.0508820866290823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM3,Junctional adhesion molecule C,23725,107,1.26 [0.90-1.76],0.171332707093868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JCHAIN,Immunoglobulin J chain,27416,127,1.24 [0.96-1.60],0.1019400894730269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23409,107,0.85 [0.59-1.22],0.376804377652604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JPT2,Jupiter microtubule associated homolog 2,24177,111,1.09 [0.89-1.34],0.422549925430988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,27416,127,1.18 [0.91-1.52],0.2059649046032652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27812,130,1.29 [0.90-1.84],0.1732266047491653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZN,Kazrin,24177,111,1.11 [0.94-1.32],0.2284032078694566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNC4,Potassium voltage-gated channel subfamily C member 4,23493,107,0.85 [0.57-1.24],0.3949024455431654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNH2,Potassium voltage-gated channel subfamily H member 2,23599,110,1.06 [0.85-1.33],0.6051221223983163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNIP4,Kv channel-interacting protein 4,27277,126,1.11 [0.85-1.45],0.4520105947959695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCTD5,BTB/POZ domain-containing protein KCTD5,23736,110,1.27 [0.89-1.81],0.1817954441806222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDM3A,Lysine-specific demethylase 3A,23581,108,1.00 [0.82-1.22],0.9753917583846662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDR,Vascular endothelial growth factor receptor 2,28005,132,1.26 [0.69-2.31],0.450586671496072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KEL,Kell blood group glycoprotein,27277,126,0.88 [0.57-1.37],0.5699425836198342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHDC3L,KH domain-containing protein 3,23409,107,0.90 [0.66-1.23],0.5234724954935764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHK,Ketohexokinase,23595,112,1.16 [0.88-1.53],0.292121635112452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA0319,Dyslexia-associated protein KIAA0319,24203,112,0.95 [0.53-1.71],0.8617287909258678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549,UPF0606 protein KIAA1549,23825,109,0.85 [0.65-1.11],0.2262930593034989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549L,UPF0606 protein KIAA1549L,23825,109,1.20 [0.63-2.27],0.5807272741149719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA2013,Uncharacterized protein KIAA2013,24157,113,1.05 [0.77-1.42],0.7637976058807516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF1C,Kinesin-like protein KIF1C,23494,110,1.44 [1.00-2.07],0.0489289306100388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF20B,Kinesin-like protein KIF20B,23493,107,1.01 [0.79-1.29],0.9467927573156938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF22,Kinesin-like protein KIF22,23494,110,1.08 [0.93-1.26],0.3098336321744996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIFBP,KIF-binding protein,27812,130,1.09 [0.90-1.32],0.3693924949616076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24157,113,1.35 [1.11-1.66],0.0033286099766376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27252,129,1.27 [1.05-1.55],0.0163081571135088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24177,111,1.06 [0.95-1.17],0.285009343387767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27252,129,1.05 [0.93-1.20],0.4142447155480153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23409,107,0.95 [0.75-1.21],0.6963523525148156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,23493,107,1.13 [0.87-1.48],0.3613849490327411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL2,Kin of IRRE-like protein 2,27277,126,1.35 [0.92-1.99],0.1238121743669151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIT,Mast/stem cell growth factor receptor Kit,27982,131,0.53 [0.31-0.88],0.0143335370776428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KITLG,Kit ligand,27938,130,0.78 [0.53-1.15],0.2092455040174752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLB,Beta-klotho,27277,126,1.02 [0.83-1.27],0.8298601223619344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,23493,107,1.62 [1.16-2.26],0.0050533313952571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLHL41,Kelch-like protein 41,24236,113,1.05 [0.75-1.47],0.7574178620703452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK1,Kallikrein-1,27655,131,1.07 [0.96-1.21],0.2281613274763911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,27917,132,1.76 [1.25-2.48],0.0012176839469161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,27732,132,2.11 [1.45-3.08],0.0001044195935917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK12,Kallikrein-12,27252,129,1.01 [0.90-1.13],0.8627791185173886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK13,Kallikrein-13,27294,128,1.21 [0.85-1.72],0.2815768312200347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK14,Kallikrein-14,28189,131,0.92 [0.66-1.28],0.6379620595064674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK15,Kallikrein-15,24119,113,0.99 [0.69-1.42],0.9426007449436176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK3,Prostate-specific antigen,24262,111,0.77 [0.62-0.97],0.0286572121507859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,28189,131,1.40 [1.13-1.74],0.0022407764606757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,27966,132,0.76 [0.46-1.26],0.2881421300561467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK7,Kallikrein-7,23110,105,0.88 [0.54-1.43],0.6015969654524103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,26988,128,1.52 [0.99-2.34],0.0544579337889078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLKB1,Plasma kallikrein,23826,108,0.87 [0.43-1.77],0.7047616526182299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,28273,130,2.17 [1.48-3.19],7.069197388232106e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23493,107,1.08 [0.82-1.43],0.5867754273749011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,28273,130,1.75 [1.27-2.42],0.0005978707280789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRF1,Killer cell lectin-like receptor subfamily F member 1,23581,108,1.40 [1.05-1.88],0.0230064112952006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRK1,NKG2-D type II integral membrane protein,24203,112,1.62 [1.11-2.35],0.0121009684035219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT14,"Keratin, type I cytoskeletal 14",26409,123,0.83 [0.46-1.49],0.5283858418355205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT17,"Keratin, type I cytoskeletal 17",23494,110,1.12 [0.72-1.76],0.6090458277012647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",27812,130,1.14 [0.96-1.35],0.1268785677575906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",27887,130,1.39 [1.13-1.72],0.0021845074863547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",27277,126,1.09 [0.80-1.48],0.5841518519181649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT6C,"Keratin, type II cytoskeletal 6C",23494,110,0.79 [0.47-1.35],0.3889127139105061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT8,"Keratin, type II cytoskeletal 8",23493,107,1.10 [0.89-1.36],0.3996816486483271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYAT1,Kynurenine--oxoglutarate transaminase 1,27885,130,1.00 [0.76-1.30],0.9741432272867354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYNU,Kynureninase,28273,130,1.18 [0.86-1.62],0.3063834413843697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L1CAM,Neural cell adhesion molecule L1,28005,132,1.41 [0.83-2.38],0.1985599396166104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24272,114,1.10 [0.90-1.33],0.3521698456789989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACRT,Extracellular glycoprotein lacritin,24114,113,0.96 [0.65-1.41],0.8363363780790175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACTB2,Endoribonuclease LACTB2,27938,130,1.06 [0.84-1.33],0.6205792407286608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,27812,130,1.50 [1.10-2.05],0.0102280968629466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27916,132,2.00 [1.57-2.55],1.700396106992002e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27748,130,1.03 [0.88-1.20],0.6907225997056223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA1,Laminin subunit alpha-1,23494,110,0.95 [0.66-1.35],0.7585744802505127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,28061,132,1.56 [1.02-2.38],0.0391155732718697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMB1,Laminin subunit beta-1,23595,112,1.27 [0.71-2.27],0.4252204059533593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP1,Lysosome-associated membrane glycoprotein 1,23603,108,1.09 [0.60-2.00],0.7754707099823555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP2,Lysosome-associated membrane glycoprotein 2,27090,127,1.43 [0.64-3.23],0.3849682263369166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,28223,128,1.56 [1.17-2.08],0.0025580007599898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMTOR5,Ragulator complex protein LAMTOR5,24157,113,1.25 [0.85-1.82],0.2525052415048426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,27416,127,1.24 [0.91-1.68],0.1654013698672468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LARP1,La-related protein 1,24157,113,1.14 [0.89-1.47],0.3015055957193441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT,Linker for activation of T-cells family member 1,28273,130,1.13 [0.92-1.39],0.2329147680716016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT2,Linker for activation of T-cells family member 2,27812,130,1.11 [0.98-1.25],0.1012733357772062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LATS1,Serine/threonine-protein kinase LATS1,23581,108,1.07 [0.87-1.33],0.5140048193841233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,27700,130,2.67 [1.82-3.91],5.001113967784752e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,28016,131,1.10 [0.85-1.42],0.4809545960671152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBR,Delta(14)-sterol reductase LBR,28203,133,0.96 [0.77-1.21],0.7520537987890675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,24295,113,0.46 [0.21-1.00],0.0489148653529173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,24236,113,1.43 [1.18-1.74],0.0002558813562669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN2,Neutrophil gelatinase-associated lipocalin,27048,129,1.46 [1.00-2.12],0.0473692349103885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCP1,Plastin-2,24262,111,1.34 [0.95-1.90],0.0946778967901069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,28014,129,1.06 [0.79-1.41],0.6962937326099163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLRAP1,Low density lipoprotein receptor adapter protein 1,24236,113,1.10 [0.92-1.31],0.3193369254108974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,24272,114,1.40 [1.11-1.77],0.0043265822896481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEFTY2,Left-right determination factor 2,28152,131,1.14 [0.86-1.51],0.3517622236409303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEG1,Protein LEG1 homolog,22881,102,0.93 [0.71-1.22],0.5978642095122914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LELP1,Late cornified envelope-like proline-rich protein 1,23493,107,0.91 [0.69-1.20],0.508162562975349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,24236,113,1.16 [0.69-1.97],0.5741228354411141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,27938,130,1.17 [0.93-1.47],0.1879266482021324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEPR,Leptin receptor,27938,130,0.94 [0.57-1.54],0.7921097714974518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,24236,113,1.23 [0.90-1.67],0.1887246507936085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,27938,130,1.13 [0.72-1.76],0.6069005075472165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,28009,131,1.45 [0.88-2.40],0.1496480255328554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3BP,Galectin-3-binding protein,24305,112,1.65 [1.03-2.64],0.0372727338556554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,27916,132,1.74 [1.36-2.23],1.1463336762970388e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,27888,131,1.24 [0.87-1.76],0.2303837209887314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS8,Galectin-8,28203,133,1.01 [0.79-1.30],0.9096891473247468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,27920,132,2.73 [1.79-4.17],2.84166304561227e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGMN,Legumain,28061,132,1.45 [0.96-2.17],0.0748951513744397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHB,Lutropin subunit beta,27252,129,0.98 [0.82-1.18],0.841772652596442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27964,132,0.97 [0.75-1.26],0.8372170577157174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIF,Leukemia inhibitory factor,27277,126,1.07 [0.80-1.43],0.633938923761727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIFR,Leukemia inhibitory factor receptor,27925,130,2.01 [1.16-3.49],0.0130868694429447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27929,131,2.02 [1.30-3.16],0.0019149409819694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24262,111,1.09 [0.93-1.29],0.2710294493198669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23494,110,1.02 [0.72-1.46],0.902129717931514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27906,130,2.34 [1.49-3.66],0.0002089177861493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24272,114,1.15 [0.90-1.46],0.2575747557160737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28281,131,1.99 [1.15-3.46],0.0145596136493978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28130,131,1.92 [1.21-3.05],0.0057151741047439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27416,127,2.39 [1.73-3.30],1.2049599782223784e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28281,131,1.00 [0.80-1.25],0.9978617202701962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,23595,112,0.84 [0.62-1.14],0.2625180233302702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB1,Lamin-B1,24128,111,1.02 [0.76-1.36],0.9181468709957497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,24203,112,2.20 [1.32-3.67],0.0026071224188728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD1,Leiomodin-1,24236,113,1.58 [1.11-2.23],0.0101424590607703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD2,Leiomodin-2,23493,107,1.19 [0.91-1.54],0.1992435118063574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LONP1,"Lon protease homolog, mitochondrial",23595,112,1.12 [0.92-1.37],0.2496200782825004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPA,Apolipoprotein(a),23707,108,0.90 [0.81-1.00],0.0404981700623703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPCAT2,Lysophosphatidylcholine acyltransferase 2,27812,130,1.11 [0.81-1.51],0.5116808915520936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPL,Lipoprotein lipase,27938,130,0.85 [0.63-1.15],0.2922619012280729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPO,Lactoperoxidase,27046,126,1.30 [1.01-1.66],0.0401918531416849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPP,Lipoma-preferred partner,23494,110,0.99 [0.75-1.30],0.9457139879732251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23494,110,1.28 [1.01-1.63],0.0434448884838469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23599,110,1.24 [0.92-1.68],0.1605341800670969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRG1,Leucine-rich alpha-2-glycoprotein,24305,112,1.44 [0.73-2.86],0.2946364655559127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28116,131,1.44 [0.93-2.23],0.1034960279252102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23498,108,1.63 [1.01-2.62],0.0468423558530137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP1,Prolow-density lipoprotein receptor-related protein 1,27812,130,0.92 [0.52-1.65],0.7878762032436857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,27938,130,1.79 [1.18-2.69],0.0057342489766783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2,Low-density lipoprotein receptor-related protein 2,23599,110,1.25 [0.80-1.95],0.3336651686088498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2BP,LRP2-binding protein,23599,110,1.06 [0.86-1.31],0.5997090516820396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28203,133,0.90 [0.67-1.21],0.4838276860507048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,27812,130,1.37 [0.96-1.97],0.0857365867736822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC37A2,Leucine-rich repeat-containing protein 37A2,24177,111,1.58 [1.03-2.40],0.0346331011206288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC38,Leucine-rich repeat-containing protein 38,23599,110,1.35 [0.98-1.86],0.0649168106461955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC59,Leucine-rich repeat-containing protein 59,24272,114,1.13 [0.79-1.61],0.4956293058783215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24157,113,1.21 [0.86-1.71],0.2725103279799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRN1,Leucine-rich repeat neuronal protein 1,27416,127,0.76 [0.51-1.13],0.1707683895286764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23599,110,1.03 [0.67-1.58],0.8994311086494087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24236,113,0.69 [0.34-1.42],0.3173047330278406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM1,U6 snRNA-associated Sm-like protein LSm1,27252,129,0.98 [0.74-1.31],0.9165311473613306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM8,U6 snRNA-associated Sm-like protein LSm8,23825,109,1.08 [0.89-1.31],0.4169231690431108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSP1,Lymphocyte-specific protein 1,27925,130,1.18 [0.82-1.71],0.3750686265225172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA,Lymphotoxin-alpha,27925,130,1.18 [0.80-1.73],0.4032612236251699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,28189,131,1.14 [0.89-1.46],0.2964865959027357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTB,Lymphotoxin-beta,24157,113,1.01 [0.60-1.69],0.9682404202617404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,28281,131,2.10 [1.34-3.31],0.001327713667953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,27252,129,1.38 [1.12-1.71],0.002792232741238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,27763,132,2.57 [1.64-4.05],4.39866575622217e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTO1,Protein LTO1 homolog,27416,127,1.07 [0.74-1.54],0.726565615850868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LUZP2,Leucine zipper protein 2,24157,113,1.32 [0.93-1.86],0.1165833485304371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LXN,Latexin,27607,129,0.89 [0.70-1.13],0.3498810336354109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,27767,131,1.70 [1.20-2.40],0.002692141695399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY75,Lymphocyte antigen 75,27925,130,1.59 [1.05-2.42],0.0287067255635999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,27646,125,2.63 [1.59-4.34],0.0001527716560011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,27748,130,2.08 [1.51-2.85],7.180249776828835e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYAR,Cell growth-regulating nucleolar protein,27252,129,1.11 [0.86-1.43],0.4358892377117825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYN,Tyrosine-protein kinase Lyn,27812,130,1.12 [0.93-1.35],0.2212309497091571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD1,Ly6/PLAUR domain-containing protein 1,27277,126,0.96 [0.74-1.25],0.749297704270072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD3,Ly6/PLAUR domain-containing protein 3,27794,132,1.51 [0.98-2.32],0.0603359139006811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD8,Ly6/PLAUR domain-containing protein 8,27252,129,1.14 [0.87-1.50],0.3501941229632807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPLA2,Acyl-protein thioesterase 2,23493,107,0.99 [0.83-1.18],0.9356422925886516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23599,110,1.10 [0.94-1.30],0.2391896819624336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24305,112,2.14 [0.87-5.25],0.0979667112749774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,23409,107,0.94 [0.56-1.58],0.8190860277641882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LZTFL1,Leucine zipper transcription factor-like protein 1,23725,107,1.13 [0.88-1.45],0.3487481955339289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),M6PR,Cation-dependent mannose-6-phosphate receptor,23595,112,1.34 [0.93-1.93],0.1222313329202026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27661,130,1.29 [1.01-1.63],0.0386120324171748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAEA,E3 ubiquitin-protein transferase MAEA,27252,129,0.96 [0.64-1.42],0.8289201461071154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,23599,110,0.81 [0.55-1.20],0.296883883325016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGEA3,Melanoma-associated antigen 3,23825,109,0.97 [0.79-1.20],0.7724641369711132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGED1,Melanoma-associated antigen D1,27252,129,1.31 [0.97-1.77],0.0744765764114937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,24272,114,2.11 [1.32-3.37],0.0018942651138095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC4,Apical endosomal glycoprotein,24157,113,1.20 [0.89-1.62],0.2362279848782162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23595,112,1.77 [0.88-3.54],0.1070044241954366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN2B2,Epididymis-specific alpha-mannosidase,24272,114,1.23 [0.91-1.66],0.1860216824688123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23409,107,1.12 [0.79-1.60],0.5299122799493792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANF,Mesencephalic astrocyte-derived neurotrophic factor,28061,132,1.04 [0.91-1.18],0.5515470004649681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC1,MANSC domain-containing protein 1,28005,132,1.68 [0.98-2.87],0.0601303164561306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC4,MANSC domain-containing protein 4,23494,110,1.10 [0.83-1.46],0.4973941202492186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23493,107,0.83 [0.46-1.49],0.5303318759846135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23494,110,1.14 [0.90-1.44],0.2740292349634952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2,Microtubule-associated protein 2,24203,112,1.50 [1.09-2.06],0.0138620457867643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24177,111,1.13 [0.86-1.48],0.3850498942090202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27925,130,1.01 [0.87-1.18],0.849652554730023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27252,129,1.00 [0.85-1.17],0.9958636142907956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27700,130,1.05 [0.91-1.20],0.5044229597128773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK13,Mitogen-activated protein kinase 13,23409,107,1.24 [0.87-1.77],0.2329816463754148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK9,Mitogen-activated protein kinase 9,27925,130,1.11 [0.78-1.58],0.5482313323636343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPKAPK2,MAP kinase-activated protein kinase 2,23825,109,1.09 [0.86-1.39],0.4652519336045231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPRE3,Microtubule-associated protein RP/EB family member 3,23409,107,1.12 [1.00-1.25],0.0430125084316837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPT,Microtubule-associated protein tau,27277,126,1.41 [1.02-1.95],0.0369631120822567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,27938,130,1.74 [0.96-3.14],0.0674355309974909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARS1,"Methionine--tRNA ligase, cytoplasmic",23673,107,1.06 [0.86-1.32],0.5783317841352208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MASP1,Mannan-binding lectin serine protease 1,27700,130,1.56 [0.81-2.99],0.1828008764364392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,27966,132,2.30 [1.41-3.75],0.0008203093554166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN3,Matrilin-3,27700,130,1.26 [0.78-2.03],0.3457658420076118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAVS,Mitochondrial antiviral-signaling protein,27252,129,1.05 [0.89-1.24],0.5942774149216409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAX,Protein max,27277,126,1.06 [0.91-1.23],0.4482306437176867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,28281,131,1.03 [0.77-1.36],0.8646121598515005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,23952,110,1.29 [1.08-1.53],0.0041578681120637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCAM,Cell surface glycoprotein MUC18,28016,131,1.12 [0.71-1.77],0.6173031435460704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24236,113,1.33 [0.98-1.81],0.0630713880450321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEMP1,Mast cell-expressed membrane protein 1,23581,108,1.07 [0.88-1.31],0.4962751134825977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,27817,129,1.25 [0.89-1.74],0.2009150884694779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCTS1,Malignant T-cell-amplified sequence 1,24177,111,1.12 [0.57-2.21],0.7460091131304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27748,130,1.04 [0.84-1.29],0.7090535650094627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDH1,"Malate dehydrogenase, cytoplasmic",24158,112,1.06 [0.69-1.63],0.7976267141420523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,27913,132,1.30 [1.00-1.70],0.0486376861793587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDM1,Nuclear protein MDM1,23599,110,1.36 [0.79-2.36],0.2685985639133416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23595,112,1.16 [0.96-1.40],0.1347099575186499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED18,Mediator of RNA polymerase II transcription subunit 18,27252,129,1.03 [0.84-1.26],0.8021116571460474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED21,Mediator of RNA polymerase II transcription subunit 21,23494,110,1.15 [0.83-1.57],0.401430930691686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF10,Multiple epidermal growth factor-like domains protein 10,27916,132,0.90 [0.62-1.32],0.5971885584010714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF11,Multiple epidermal growth factor-like domains protein 11,23494,110,0.73 [0.38-1.39],0.3366555175133746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF9,Multiple epidermal growth factor-like domains protein 9,28182,131,1.30 [0.65-2.59],0.4629251754395799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MELTF,Melanotransferrin,24272,114,1.37 [0.76-2.49],0.2970532129771326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MENT,Protein MENT,23725,107,0.41 [0.19-0.89],0.0240664895066437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1A,Meprin A subunit alpha,24177,111,1.01 [0.79-1.28],0.960691729376728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,27938,130,0.88 [0.78-1.00],0.0515538625494854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEPE,Matrix extracellular phosphoglycoprotein,27916,132,1.04 [0.57-1.90],0.9014516641722036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,28273,130,1.59 [0.89-2.86],0.1195207322699228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MESD,LRP chaperone MESD,27929,131,1.06 [0.94-1.20],0.3355012994958823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,28018,129,0.64 [0.29-1.39],0.2590696897340537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1,Methionine aminopeptidase 1,27277,126,0.80 [0.46-1.40],0.4389854475111986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27925,130,1.10 [0.91-1.32],0.3270895400805181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP2,Methionine aminopeptidase 2,28152,131,1.11 [0.85-1.46],0.4483294460649875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3,Microfibril-associated glycoprotein 3,27432,126,0.91 [0.65-1.29],0.6123315994275061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3L,Microfibrillar-associated protein 3-like,23599,110,1.04 [0.80-1.36],0.7491919744162281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP4,Microfibril-associated glycoprotein 4,23725,107,1.40 [0.79-2.47],0.2450451134008352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP5,Microfibrillar-associated protein 5,28281,131,1.33 [0.92-1.94],0.1323701388598527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFGE8,Lactadherin,27929,131,1.16 [0.83-1.62],0.3768262601885762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGLL,Monoglyceride lipase,28018,132,1.05 [0.88-1.26],0.5551000287340225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGMT,Methylated-DNA--protein-cysteine methyltransferase,27925,130,0.97 [0.85-1.10],0.6249801081142135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,28005,132,1.27 [0.85-1.90],0.2435968352297539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICALL2,MICAL-like protein 2,23599,110,1.01 [0.78-1.32],0.9176639899884412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27925,130,1.03 [0.92-1.14],0.6388140320591493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIF,Macrophage migration inhibitory factor,27880,131,0.99 [0.79-1.24],0.9355513366808456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,27416,127,1.68 [1.26-2.23],0.0003697876147569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24157,113,1.03 [0.87-1.21],0.7555662105705767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINK1,Misshapen-like kinase 1,24203,112,1.06 [0.87-1.28],0.5732972038073101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MITD1,MIT domain-containing protein 1,27748,130,1.02 [0.87-1.20],0.8000122730915793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MKI67,Proliferation marker protein Ki-67,23581,108,1.34 [0.94-1.91],0.1001621898815567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLLT1,Protein ENL,23409,107,0.89 [0.66-1.19],0.4225762768893908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLN,Promotilin,27925,130,1.11 [0.94-1.32],0.2183697303461583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,27812,130,1.18 [0.98-1.41],0.0740951728658628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,26948,125,1.05 [0.88-1.25],0.5732285168352294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,27888,132,1.23 [0.96-1.57],0.0993882790825216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,27981,130,2.01 [1.56-2.59],7.586875095441954e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,27277,126,1.98 [1.21-3.25],0.0064276356456174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP15,Matrix metalloproteinase-15,24272,114,1.25 [0.96-1.62],0.0985347287698913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,27929,131,0.92 [0.67-1.27],0.6227861872838146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,27390,126,1.21 [0.87-1.69],0.2504233435089104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP8,Neutrophil collagenase,28161,133,1.14 [0.93-1.39],0.195132027803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP9,Matrix metalloproteinase-9,27890,131,1.17 [0.91-1.50],0.2218062577350036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23494,110,0.95 [0.65-1.38],0.7828998756440814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MN1,Transcriptional activator MN1,23599,110,1.04 [0.76-1.41],0.8211843155267436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNAT1,CDK-activating kinase assembly factor MAT1,23825,109,1.20 [0.84-1.71],0.3175960393117473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNDA,Myeloid cell nuclear differentiation antigen,27899,129,1.00 [0.86-1.16],0.9871195182127752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOCS2,Molybdopterin synthase catalytic subunit,23725,107,1.05 [0.80-1.38],0.7206315764764601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,28189,131,0.97 [0.61-1.55],0.8993835615783896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORC3,MORC family CW-type zinc finger protein 3,24203,112,1.15 [0.63-2.07],0.652475823967293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L1,Mortality factor 4-like protein 1,23825,109,1.33 [0.94-1.89],0.1096011302535017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L2,Mortality factor 4-like protein 2,23409,107,1.38 [0.90-2.09],0.1363725045614079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORN4,MORN repeat-containing protein 4,23409,107,0.67 [0.49-0.93],0.0148082224489912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,27432,126,1.04 [0.85-1.28],0.701100516800476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPI,Mannose-6-phosphate isomerase,27812,130,1.10 [0.92-1.31],0.2928186305312663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28018,132,1.08 [0.88-1.33],0.4512842263059012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPO,Myeloperoxidase,27929,131,1.19 [0.87-1.63],0.2641698424395341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPRIP,Myosin phosphatase Rho-interacting protein,24117,112,0.96 [0.64-1.44],0.8519879953805474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,24295,113,2.63 [1.47-4.69],0.0010601115042343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,23599,110,0.91 [0.70-1.19],0.4862342198020634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL24,"39S ribosomal protein L24, mitochondrial",23494,110,1.21 [0.83-1.76],0.3184668663110813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL28,"39S ribosomal protein L28, mitochondrial",24236,113,0.78 [0.42-1.44],0.4309532385939619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL46,"39S ribosomal protein L46, mitochondrial",27277,126,1.00 [0.56-1.78],0.9907908461442104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL52,"39S ribosomal protein L52, mitochondrial",23370,107,1.85 [1.03-3.34],0.0392384787022504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24236,113,1.02 [0.80-1.30],0.8953957759415141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPS16,"28S ribosomal protein S16, mitochondrial",23581,108,1.36 [0.86-2.15],0.1933883303584283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,27774,130,1.37 [1.05-1.78],0.0202961155909696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLNL,Mesothelin-like protein,23599,110,0.66 [0.38-1.15],0.1401081075402983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSMB,Beta-microseminoprotein,27861,130,1.13 [0.90-1.43],0.2904046856029482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,28203,133,1.86 [1.36-2.54],9.845665516479075e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSRA,Mitochondrial peptide methionine sulfoxide reductase,28005,132,1.06 [0.86-1.31],0.5687800229269455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MST1,Hepatocyte growth factor-like protein,23934,110,1.35 [0.92-1.98],0.1198356829845399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSTN,Growth/differentiation factor 8,27432,126,0.86 [0.64-1.15],0.3142718621499689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTDH,Protein LYRIC,23581,108,1.22 [1.01-1.48],0.0436389162553352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24203,112,2.04 [1.29-3.23],0.0021421239527305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23825,109,1.03 [0.87-1.20],0.7513192213498473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTIF3,"Translation initiation factor IF-3, mitochondrial",24177,111,1.17 [0.96-1.43],0.1164012649412572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTPN,Myotrophin,27432,126,0.67 [0.39-1.15],0.1470850687863826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTR,Methionine synthase,23494,110,1.11 [0.87-1.43],0.4001153205660821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS1,Protein MTSS 1,24177,111,0.94 [0.80-1.10],0.4265354261451729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS2,Protein MTSS 2,24157,113,1.05 [0.88-1.25],0.5848919245690802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTUS1,Microtubule-associated tumor suppressor 1,23825,109,1.20 [0.90-1.62],0.2183595877988483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,27277,126,0.94 [0.69-1.28],0.7026851356783486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC16,Mucin-16,27812,130,0.98 [0.91-1.07],0.6865501673184332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC2,Mucin-2,24262,111,1.06 [0.87-1.28],0.5871772115732926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUCL3,Mucin-like protein 3,23409,107,0.96 [0.62-1.48],0.8518480223932062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,27416,127,1.13 [0.94-1.37],0.1817127680098462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MXRA8,Matrix remodeling-associated protein 8,23725,107,0.98 [0.54-1.79],0.9571534033044112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",24272,114,1.14 [0.90-1.44],0.2836054737221052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC2,"Myosin-binding protein C, fast-type",23595,112,1.19 [1.00-1.41],0.0555463844077716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24236,113,1.11 [0.86-1.42],0.4207340082268466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYDGF,Myeloid-derived growth factor,24272,114,1.12 [0.94-1.33],0.2027252888601345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH4,Myosin-4,23494,110,1.07 [0.74-1.55],0.7187893336962248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,23409,107,1.54 [1.14-2.07],0.0048566318985574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH9,Myosin-9,24262,111,1.16 [0.99-1.36],0.0649840810363569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23494,110,1.11 [0.75-1.65],0.6042790820941462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,23595,112,1.08 [0.86-1.37],0.5025267077424782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL4,Myosin light chain 4,23595,112,1.09 [0.79-1.50],0.594813664857986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL6B,Myosin light chain 6B,23599,110,1.20 [1.03-1.41],0.0219324946751929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23599,110,1.15 [0.83-1.60],0.3976891400905329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO6,Unconventional myosin-VI,24236,113,1.29 [0.89-1.88],0.1781867981913738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO9B,Unconventional myosin-IXb,27416,127,1.03 [0.82-1.30],0.7988159545799864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOC,Myocilin,27929,131,1.20 [0.86-1.68],0.2784425396825871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,23493,107,1.36 [1.02-1.81],0.035550795931056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,23494,110,1.09 [0.78-1.51],0.6277437592630067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,23725,107,0.99 [0.82-1.20],0.9399553015719176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,28009,132,1.76 [1.34-2.32],5.080085384249122e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZT1,Mitotic-spindle organizing protein 1,27252,129,1.11 [0.84-1.47],0.4463687931644206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA10,N-alpha-acetyltransferase 10,23494,110,1.01 [0.71-1.44],0.9568252969825876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA80,N-alpha-acetyltransferase 80,23599,110,1.03 [0.89-1.20],0.6659334529610159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAAA,N-acylethanolamine-hydrolyzing acid amidase,27611,129,0.87 [0.67-1.13],0.2944678970519698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NACC1,Nucleus accumbens-associated protein 1,24157,113,1.30 [0.99-1.72],0.0608437027610778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NADK,NAD kinase,27938,130,0.99 [0.75-1.30],0.948847658908968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGA,Alpha-N-acetylgalactosaminidase,23547,108,0.89 [0.63-1.26],0.5156039215220086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGK,N-acetyl-D-glucosamine kinase,23551,112,1.17 [0.86-1.58],0.3154334260765266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23725,107,2.14 [0.91-5.02],0.0796146775088712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAMPT,Nicotinamide phosphoribosyltransferase,27252,129,1.17 [0.92-1.49],0.2007432635679352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAP1L4,Nucleosome assembly protein 1-like 4,24138,111,0.98 [0.63-1.51],0.9172118967669988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAPRT,Nicotinate phosphoribosyltransferase,24203,112,1.26 [0.77-2.07],0.3632560027147516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NARS1,"Asparagine--tRNA ligase, cytoplasmic",24236,113,1.03 [0.71-1.51],0.8608992935224602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,28005,132,2.59 [1.51-4.45],0.0005749604116302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBN,Nibrin,27416,127,1.00 [0.75-1.34],0.9899763427585938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM1,Neural cell adhesion molecule 1,28016,131,1.13 [0.69-1.86],0.622241953133887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,27929,131,0.89 [0.50-1.58],0.6906806548169571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,28203,133,0.42 [0.29-0.62],1.175725601507653e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCF2,Neutrophil cytosol factor 2,27873,130,1.09 [0.92-1.29],0.3156393711743545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCK2,Cytoplasmic protein NCK2,28061,132,1.03 [0.90-1.19],0.6624126553773906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCLN,Nicalin,27416,127,1.09 [0.83-1.42],0.5356539580568124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,27887,130,1.70 [1.13-2.58],0.011378817312076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24177,111,2.84 [1.85-4.37],1.9792839084833427e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,28189,131,2.08 [1.23-3.52],0.0065847204551633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDRG1,Protein NDRG1,27277,126,1.00 [0.80-1.25],0.9892663072846456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24157,113,1.06 [0.81-1.39],0.6804913493980873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23532,108,1.09 [0.66-1.80],0.7356148905916766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24177,111,1.12 [0.92-1.37],0.240052290837734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27252,129,1.08 [0.90-1.29],0.4065003298696455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEB,Nebulin,23494,110,1.20 [0.77-1.86],0.417255229107493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECAP2,Adaptin ear-binding coat-associated protein 2,23494,110,1.09 [0.84-1.42],0.5293833032923705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN1,Nectin-1,23581,108,1.32 [0.82-2.12],0.2571894764046692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,27906,130,2.69 [1.70-4.24],2.30983542519079e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,28005,132,1.67 [1.08-2.58],0.0219477751536211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23581,108,1.05 [0.71-1.56],0.7917256831618982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD9,Enhancer of filamentation 1,23581,108,1.53 [1.03-2.26],0.0354214454235608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,27189,125,2.00 [1.59-2.51],4.135020187249551e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEK7,Serine/threonine-protein kinase Nek7,23825,109,1.05 [0.83-1.34],0.664023196359174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,28005,132,0.61 [0.42-0.87],0.0071289667223241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL2,Protein kinase C-binding protein NELL2,28061,132,1.16 [0.68-1.97],0.585757846560496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NENF,Neudesin,24157,113,1.12 [0.98-1.29],0.0994681851004429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEO1,Neogenin,24236,113,1.32 [0.66-2.66],0.4288720130475164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEXN,Nexilin,24295,113,1.14 [0.89-1.46],0.3040557054995669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,28273,130,2.04 [1.23-3.38],0.0056880497466252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFAT5,Nuclear factor of activated T-cells 5,23581,108,1.06 [0.86-1.30],0.5868839520246801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27925,130,1.07 [0.91-1.25],0.4179523504291033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27416,127,0.97 [0.74-1.26],0.8145583153189059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFE2,Transcription factor NF-E2 45 kDa subunit,23595,112,1.07 [0.84-1.36],0.5975910543652392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFIC,Nuclear factor 1 C-type,24236,113,0.92 [0.58-1.45],0.7105487020248601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB1,Nuclear factor NF-kappa-B p105 subunit,23494,110,1.04 [0.81-1.33],0.7488514318114543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB2,Nuclear factor NF-kappa-B p100 subunit,23825,109,1.02 [0.75-1.39],0.8952867856486033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKBIE,NF-kappa-B inhibitor epsilon,27252,129,1.10 [0.80-1.50],0.5526598402968768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24177,111,1.13 [0.95-1.34],0.176359850656881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFX1,Transcriptional repressor NF-X1,23494,110,1.06 [0.81-1.39],0.6543329446029618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFYA,Nuclear transcription factor Y subunit alpha,23494,110,1.21 [0.81-1.81],0.3606183363625763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGF,Beta-nerve growth factor,27748,130,1.93 [0.60-6.18],0.2677606427744529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,24272,114,1.33 [0.81-2.21],0.2628072336853365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGRN,Neugrin,24203,112,1.25 [0.57-2.73],0.5736289709529607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NHLRC3,NHL repeat-containing protein 3,23176,104,1.86 [1.03-3.38],0.0408083659702761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID1,Nidogen-1,27937,131,1.05 [0.70-1.57],0.8098657286368507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,27929,131,1.00 [0.82-1.23],0.9880484745402112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NINJ1,Ninjurin-1,27252,129,1.09 [0.85-1.41],0.495111225510936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,23595,112,0.96 [0.65-1.42],0.8322763672896203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT2,Omega-amidase NIT2,24178,113,1.10 [0.87-1.40],0.4270484401079153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN1,Neuroligin-1,23599,110,1.14 [0.91-1.43],0.2392440211801602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN2,Neuroligin-2,23493,107,0.66 [0.40-1.08],0.099636077525531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME1,Nucleoside diphosphate kinase A,23581,108,1.11 [0.47-2.60],0.8114816266863742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,27966,132,2.10 [1.31-3.39],0.0022660387120922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMI,N-myc-interactor,24055,113,1.09 [0.86-1.39],0.482285029883872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27748,130,1.03 [0.84-1.26],0.7573690169289278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMRK2,Nicotinamide riboside kinase 2,23409,107,1.15 [0.77-1.73],0.4954026518436304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24236,113,1.17 [0.92-1.49],0.1989586419703825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOMO1,Nodal modulator 1,27929,131,1.49 [0.82-2.74],0.192956140882273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOP56,Nucleolar protein 56,23494,110,1.01 [0.86-1.19],0.8753648448000069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",27277,126,1.25 [0.96-1.64],0.0999041780517619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS2,"Nitric oxide synthase, inducible",23494,110,1.48 [1.00-2.21],0.0509297427849932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS3,"Nitric oxide synthase, endothelial",27277,126,1.29 [0.99-1.67],0.0594383367645751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,28281,131,3.58 [1.43-8.99],0.006545281637942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH2,Neurogenic locus notch homolog protein 2,24262,111,2.42 [1.21-4.85],0.0128489519375315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH3,Neurogenic locus notch homolog protein 3,28281,131,1.53 [1.00-2.35],0.0520518096748143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,23862,108,2.28 [1.56-3.32],1.8013979508354968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,27938,130,1.83 [1.21-2.76],0.004182465447621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS1,Nephrin,23581,108,0.98 [0.58-1.68],0.94993478870542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,23581,108,1.14 [0.98-1.33],0.0824397675083713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPL,N-acetylneuraminate lyase,24272,114,1.41 [0.97-2.04],0.0720603913967801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPB,Natriuretic peptides B,27432,126,0.95 [0.84-1.06],0.3589640836311966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,27925,130,1.58 [1.20-2.08],0.001152311440282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPR1,Atrial natriuretic peptide receptor 1,23494,110,0.85 [0.52-1.40],0.5281642930162161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTN,Neuroplastin,27252,129,1.07 [0.90-1.27],0.4258522225408689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX1,Neuronal pentraxin-1,27929,131,1.13 [0.79-1.62],0.5109770091981893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX2,Neuronal pentraxin-2,24262,111,1.41 [0.83-2.39],0.2092485926336972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTXR,Neuronal pentraxin receptor,27938,130,0.77 [0.49-1.22],0.269509653413176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPY,Pro-neuropeptide Y,28189,131,1.07 [0.85-1.35],0.5568426895217486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRCAM,Neuronal cell adhesion molecule,27938,130,1.07 [0.62-1.83],0.8126149995797649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRGN,Neurogranin,24295,113,1.04 [0.86-1.27],0.65629595666165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRN1,Neuritin,24236,113,1.23 [0.82-1.85],0.3207340247235203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,28072,131,1.97 [1.16-3.35],0.0124630867007888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP2,Neuropilin-2,27929,131,1.60 [0.98-2.63],0.0602083144145922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRTN,Neurturin,27416,127,1.07 [0.79-1.44],0.6712151429589177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRXN3,Neurexin-3,23599,110,1.02 [0.60-1.71],0.9543563661473228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NSFL1C,NSFL1 cofactor p47,28203,133,0.97 [0.77-1.22],0.8036981933332643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24272,114,1.13 [0.89-1.43],0.3098707679016674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,24203,112,2.04 [1.54-2.70],7.659540206652176e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C3A,Cytosolic 5'-nucleotidase 3A,27878,130,1.06 [0.88-1.26],0.5457976858883169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5E,5'-nucleotidase,28005,132,1.23 [0.95-1.59],0.1087427929045676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF3,Neurotrophin-3,27925,130,0.88 [0.56-1.38],0.5807498669200934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF4,Neurotrophin-4,27252,129,1.04 [0.72-1.51],0.823119429258003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK2,BDNF/NT-3 growth factors receptor,27938,130,0.99 [0.54-1.82],0.9858661310529154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK3,NT-3 growth factor receptor,28203,133,0.53 [0.27-1.06],0.0720668899576992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,27938,130,1.15 [0.99-1.34],0.0687720063196305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUB1,NEDD8 ultimate buster 1,27925,130,1.10 [0.92-1.31],0.3031283428231168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24157,113,1.11 [0.94-1.32],0.2010461209091957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,28151,131,1.60 [1.09-2.35],0.0155125021678007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDC,Nuclear migration protein nudC,28273,130,1.09 [0.86-1.39],0.4787448924546911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23595,112,1.08 [0.55-2.13],0.8238826283714159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23494,110,0.85 [0.57-1.28],0.4358864577799207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT16,U8 snoRNA-decapping enzyme,24140,111,1.17 [0.96-1.43],0.1182501607464594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27812,130,0.86 [0.65-1.14],0.2916168541905121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT5,ADP-sugar pyrophosphatase,27929,131,1.05 [0.78-1.41],0.7600111454998191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUMB,Protein numb homolog,23581,108,1.13 [0.91-1.41],0.2789116256855711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,23494,110,0.70 [0.36-1.35],0.2842785371546361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPE4,NXPE family member 4,23494,110,0.73 [0.39-1.36],0.3225239811361048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH1,Neurexophilin-1,27277,126,0.93 [0.61-1.42],0.7369084108418794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH3,Neurexophilin-3,23581,108,1.45 [0.78-2.67],0.2368953920012067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OBP2B,Odorant-binding protein 2b,27650,130,1.23 [0.96-1.57],0.1050491394742071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,24236,113,2.16 [1.57-2.96],2.0693827161484176e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ODAM,Odontogenic ameloblast-associated protein,27227,126,0.90 [0.66-1.23],0.5093089628490927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OFD1,Oral-facial-digital syndrome 1 protein,23825,109,1.19 [0.96-1.49],0.1189137304087373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGA,Protein O-GlcNAcase,24177,111,1.23 [0.96-1.58],0.0996569895052691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGFR,Opioid growth factor receptor,27812,130,1.37 [0.87-2.17],0.1779683777148361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,27929,131,2.07 [1.46-2.94],4.2990061312352175e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23825,109,1.28 [1.02-1.60],0.0329867292960459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLFM4,Olfactomedin-4,22846,100,1.03 [0.88-1.21],0.6828799990879499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLR1,Oxidized low-density lipoprotein receptor 1,27671,130,1.17 [0.92-1.48],0.2011029810463326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMD,Osteomodulin,28061,132,1.08 [0.77-1.53],0.6553908362873893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMG,Oligodendrocyte-myelin glycoprotein,27812,130,0.76 [0.60-0.96],0.0209942046302441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMP,Olfactory marker protein,23493,107,0.94 [0.63-1.39],0.7489626243224156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPHN1,Oligophrenin-1,24203,112,1.09 [0.92-1.29],0.3022479083920408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPLAH,5-oxoprolinase,23595,112,1.09 [0.84-1.40],0.5314181650197434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPTC,Opticin,27812,130,0.79 [0.54-1.14],0.2081280532703115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ORM1,Alpha-1-acid glycoprotein 1,24223,112,1.39 [0.58-3.35],0.4644027329001576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSBPL2,Oxysterol-binding protein-related protein 2,24203,112,1.19 [0.80-1.77],0.3899585681534058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,27966,132,2.96 [1.88-4.67],3.002415787962161e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSM,Oncostatin-M,27785,130,1.17 [0.95-1.44],0.1506261310937625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,28072,131,2.17 [1.03-4.53],0.0404463581352986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSTN,Osteocrin,23599,110,0.83 [0.50-1.36],0.4539125526888043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTOA,Otoancorin,23493,107,1.24 [0.94-1.64],0.1342899574306557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD6B,Deubiquitinase OTUD6B,24177,111,1.13 [0.83-1.53],0.4338084528998618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD7B,OTU domain-containing protein 7B,24236,113,1.13 [0.86-1.49],0.3622546336391435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23595,112,1.22 [0.95-1.56],0.1147318973480716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXT,Oxytocin-neurophysin 1,28203,133,0.96 [0.86-1.07],0.4583873213903766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,27784,132,1.23 [0.84-1.82],0.285584868331954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PACS2,Phosphofurin acidic cluster sorting protein 2,23494,110,1.21 [0.92-1.61],0.1778201032140944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI2,Protein-arginine deiminase type-2,27416,127,1.10 [0.86-1.41],0.4595984375026001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI4,Protein-arginine deiminase type-4,27227,126,0.94 [0.75-1.17],0.5820667563237387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAEP,Glycodelin,27748,130,1.01 [0.90-1.13],0.9021205786999468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24236,113,1.18 [1.04-1.33],0.0078226995222238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23825,109,1.66 [1.25-2.20],0.000520304459508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27432,126,1.17 [0.89-1.53],0.2600709251916732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAGR1,PAXIP1-associated glutamate-rich protein 1,23595,112,0.95 [0.63-1.44],0.8123580873742002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23363,107,1.20 [0.87-1.66],0.2642089038454151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,27277,126,0.99 [0.76-1.27],0.9162514275158608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALLD,Palladin,23581,108,0.71 [0.41-1.23],0.22701771160368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,24051,111,2.21 [1.38-3.56],0.0010717734971101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,24203,112,1.77 [1.22-2.58],0.0026097384758064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM3,Paralemmin-3,23494,110,1.11 [0.91-1.37],0.3094908375038444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAM,Peptidyl-glycine alpha-amidating monooxygenase,28143,131,1.82 [1.01-3.26],0.0452028591261586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAMR1,Inactive serine protease PAMR1,27929,131,0.97 [0.56-1.68],0.922121430859978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAPPA,Pappalysin-1,27416,127,1.06 [0.76-1.49],0.7127290072014467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARD3,Partitioning defective 3 homolog,23825,109,1.17 [0.94-1.45],0.1544265468338211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARK7,Parkinson disease protein 7,27929,131,0.99 [0.74-1.32],0.944130722024682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARP1,Poly [ADP-ribose] polymerase 1,27925,130,1.07 [0.83-1.37],0.5920090765969589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAXX,Protein PAXX,23725,107,1.09 [0.74-1.61],0.6564402191445575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBK,Lymphokine-activated killer T-cell-originated protein kinase,23409,107,0.96 [0.53-1.75],0.8892323995627255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBLD,Phenazine biosynthesis-like domain-containing protein,27277,126,1.00 [0.74-1.35],0.9970988668275615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24177,111,1.50 [0.95-2.37],0.0796023602969311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,23493,107,1.03 [0.84-1.26],0.7762192569143745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23672,106,1.02 [0.71-1.48],0.8965595339658414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBP2,Poly(rC)-binding protein 2,24236,113,1.15 [0.91-1.47],0.2467458251781691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH1,Protocadherin-1,28183,127,1.62 [0.86-3.03],0.1361048994622063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH12,Protocadherin-12,24236,113,2.03 [1.18-3.49],0.0109598395696741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,27938,130,1.74 [1.16-2.61],0.0074907750807275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH7,Protocadherin-7,24177,111,1.10 [0.67-1.80],0.7166871321564424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH9,Protocadherin-9,24177,111,1.46 [0.86-2.47],0.1566450667043495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,24157,113,1.63 [1.14-2.33],0.0069594520151881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCNA,Proliferating cell nuclear antigen,23409,107,0.97 [0.73-1.29],0.8266063191877985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,24157,113,1.08 [0.74-1.58],0.6847875186584551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,28281,131,1.31 [0.89-1.91],0.1708071035915775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCYT2,Ethanolamine-phosphate cytidylyltransferase,24177,111,1.03 [0.82-1.30],0.7918326599352394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDAP1,28 kDa heat- and acid-stable phosphoprotein,24272,114,1.06 [0.88-1.26],0.5580854934613967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,28147,131,1.84 [1.34-2.52],0.0001426851025934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,27812,130,2.07 [1.33-3.23],0.0012545880579152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD5,Programmed cell death protein 5,28203,133,1.04 [0.80-1.35],0.76588085615491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD6,Programmed cell death protein 6,27938,130,0.99 [0.80-1.23],0.9608460857652692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCL2,Phosducin-like protein 2,23409,107,0.81 [0.54-1.21],0.3038965659048606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23409,107,1.10 [0.81-1.48],0.5560082912738287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23494,110,0.65 [0.43-0.99],0.0448035175802507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23725,107,0.99 [0.83-1.18],0.9041614812758382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFA,Platelet-derived growth factor subunit A,28281,131,1.08 [0.88-1.33],0.4679210816871259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFB,Platelet-derived growth factor subunit B,28061,132,1.05 [0.88-1.26],0.5674337010834724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,27252,129,1.23 [0.73-2.07],0.4322614981391094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,27938,130,1.15 [0.67-1.96],0.6119294873701842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRB,Platelet-derived growth factor receptor beta,28281,131,1.27 [0.82-1.98],0.2815826304026857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA2,Protein disulfide-isomerase A2,23409,107,1.12 [0.71-1.77],0.6175654315405861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA3,Protein disulfide-isomerase A3,23725,107,1.58 [0.98-2.56],0.0616293064497339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA4,Protein disulfide-isomerase A4,24262,111,1.17 [0.88-1.54],0.2791466968898785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA5,Protein disulfide-isomerase A5,23409,107,0.87 [0.63-1.21],0.4053348244522808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM5,PDZ and LIM domain protein 5,24236,113,1.07 [0.92-1.24],0.3900518466969421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM7,PDZ and LIM domain protein 7,28061,132,1.06 [0.94-1.19],0.3442631304371238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27252,129,1.18 [0.91-1.54],0.2124744607801278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDRG1,p53 and DNA damage-regulated protein 1,23599,110,0.86 [0.59-1.27],0.4560061389002601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23409,107,1.05 [0.78-1.42],0.7313152783655611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,23494,110,1.01 [0.75-1.36],0.9693122035073904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23581,108,1.42 [1.02-1.98],0.0375811146393681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEAR1,Platelet endothelial aggregation receptor 1,28281,131,1.73 [0.88-3.40],0.1136065515686794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEBP1,Phosphatidylethanolamine-binding protein 1,27929,131,0.93 [0.71-1.21],0.5881956826065345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECAM1,Platelet endothelial cell adhesion molecule,27929,131,1.43 [0.87-2.33],0.1541785862836521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECR,Peroxisomal trans-2-enoyl-CoA reductase,23595,112,1.24 [0.71-2.18],0.4525095229181485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PENK,Proenkephalin-A,23725,107,1.64 [1.00-2.70],0.0519986810951499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEPD,Xaa-Pro dipeptidase,24295,113,0.58 [0.30-1.14],0.1142106767801451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PER3,Period circadian protein homolog 3,23581,108,1.06 [0.91-1.24],0.4580233825240437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PF4,Platelet factor 4,24126,111,1.02 [0.85-1.22],0.8561379113028896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN2,Prefoldin subunit 2,27277,126,0.91 [0.68-1.22],0.5338491571785338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN4,Prefoldin subunit 4,23409,107,0.99 [0.71-1.39],0.957391066734705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN6,Prefoldin subunit 6,23599,110,0.76 [0.54-1.09],0.1344872353704732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27773,130,1.06 [0.87-1.30],0.5738682342524656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGA4,Pepsin A-4,24295,113,1.15 [0.88-1.51],0.3074242648435659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24272,114,1.08 [0.79-1.49],0.6249399155208757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,28273,130,2.09 [1.48-2.94],2.615534768450137e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,28130,131,1.68 [1.22-2.30],0.0013258166117332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23985,109,0.66 [0.37-1.18],0.1589851086220207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP4,Peptidoglycan recognition protein 4,23494,110,1.07 [0.81-1.42],0.6189386601859811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGM2,Phosphoglucomutase-2,23599,110,1.18 [0.92-1.51],0.2055705932740303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGR,Progesterone receptor,23581,108,0.95 [0.79-1.15],0.6060531299208121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHACTR2,Phosphatase and actin regulator 2,24236,113,1.06 [0.91-1.24],0.4704065225847017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB1,Pleckstrin homology-like domain family B member 1,24177,111,1.27 [0.92-1.75],0.1537141441958971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB2,Pleckstrin homology-like domain family B member 2,23409,107,1.03 [0.85-1.25],0.7846889198801545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27748,130,1.88 [1.10-3.19],0.0199555070769823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23725,107,1.22 [0.79-1.87],0.3729499625405628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI16,Peptidase inhibitor 16,24295,113,1.39 [0.68-2.86],0.3706721967615954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,27549,129,1.41 [1.10-1.81],0.0063882767976162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24236,113,1.00 [0.80-1.26],0.9938448159139744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,27571,131,1.91 [1.31-2.76],0.0006768265386869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27925,130,0.96 [0.75-1.23],0.758384786480575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27929,131,2.38 [1.44-3.93],0.0006918771573223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23581,108,1.14 [0.85-1.52],0.3972862313883465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,27929,131,2.01 [1.39-2.90],0.0001861612640225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,27938,130,1.75 [1.30-2.35],0.0002131932302836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23725,107,1.02 [0.77-1.33],0.9104437827183088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PITHD1,PITH domain-containing protein 1,23363,107,1.04 [0.83-1.30],0.7579073931686373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,24272,114,2.41 [1.25-4.65],0.0090006867112672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD2,Polycystin-2,23494,110,1.14 [0.86-1.52],0.3547423502865692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKLR,Pyruvate kinase PKLR,27963,132,0.86 [0.67-1.08],0.1951828895708306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKN3,Serine/threonine-protein kinase N3,23825,109,1.18 [0.95-1.46],0.130138005277611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G10,Group 10 secretory phospholipase A2,27748,130,1.36 [1.05-1.76],0.0185264615603918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,28005,132,2.21 [1.30-3.75],0.0034743119753858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G1B,Phospholipase A2,28230,130,0.86 [0.60-1.24],0.4325768765040421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",27877,127,1.12 [0.87-1.44],0.3643523364207258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G4A,Cytosolic phospholipase A2,28061,132,1.07 [0.90-1.27],0.4499498288119049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,27929,131,0.86 [0.54-1.38],0.5264174460728948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAT,Tissue-type plasminogen activator,28182,131,1.25 [0.93-1.68],0.1465665058575314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAU,Urokinase-type plasminogen activator,27929,131,1.39 [0.94-2.08],0.1019590851546178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,27728,132,3.27 [1.99-5.38],3.086482174958563e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",24203,112,0.80 [0.60-1.08],0.1434392422499935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23581,108,1.05 [0.71-1.54],0.8045968786894333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24203,112,1.08 [0.90-1.30],0.391866743908033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLEKHO1,Pleckstrin homology domain-containing family O member 1,24203,112,1.18 [0.92-1.51],0.1950232156594836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLG,Plasminogen,23672,108,1.02 [0.45-2.30],0.9661032900522736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN1,Perilipin-1,27277,126,1.41 [0.96-2.06],0.079501082700223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN3,Perilipin-3,27938,130,1.17 [0.83-1.65],0.3730647676174052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLPBP,Pyridoxal phosphate homeostasis protein,27938,130,1.01 [0.80-1.26],0.9522963672314144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLSCR3,Phospholipid scramblase 3,24162,111,1.24 [0.93-1.67],0.1480305532823637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLTP,Phospholipid transfer protein,28181,131,0.85 [0.57-1.28],0.4436576231730735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC1,Plexin domain-containing protein 1,27252,129,1.13 [0.76-1.70],0.5435980787333408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC2,Plexin domain-containing protein 2,24203,112,1.84 [1.08-3.15],0.0257469488309245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNA4,Plexin-A4,27925,130,1.12 [0.92-1.35],0.2593224793386595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,28149,131,2.92 [1.64-5.17],0.0002521512804704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB3,Plexin-B3,27837,130,1.10 [0.80-1.51],0.5701092685737734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27826,130,1.02 [0.94-1.11],0.5645212714957426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMCH,Pro-MCH,23494,110,0.99 [0.79-1.25],0.9402404751622044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMM2,Phosphomannomutase 2,23494,110,1.11 [0.83-1.49],0.4878050085689178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMS1,PMS1 protein homolog 1,23599,110,0.83 [0.56-1.22],0.3366597292458816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMVK,Phosphomevalonate kinase,27235,125,0.98 [0.85-1.12],0.7378871018220263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,24295,113,0.88 [0.66-1.17],0.3747518651083223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP1,Inactive pancreatic lipase-related protein 1,24203,112,1.04 [0.83-1.30],0.7158435062774563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP2,Pancreatic lipase-related protein 2,27916,132,0.98 [0.93-1.03],0.4109890332016213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA1,Paraneoplastic antigen Ma1,23595,112,1.04 [0.76-1.41],0.8200090060578191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA2,Paraneoplastic antigen Ma2,23493,107,0.85 [0.54-1.34],0.4870442176692842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27416,127,0.97 [0.85-1.11],0.6267868203899121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL,Podocalyxin,27812,130,1.29 [0.47-3.52],0.6170301440191164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL2,Podocalyxin-like protein 2,28005,132,0.96 [0.56-1.64],0.877518571958412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,23581,108,1.74 [1.33-2.28],4.721005003166612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2A,DNA-directed RNA polymerase II subunit RPB1,23581,108,1.45 [0.86-2.44],0.1642851273388409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27812,130,1.40 [1.00-1.97],0.0521711743905802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,23595,112,0.99 [0.77-1.27],0.9301906223590484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,24295,113,0.47 [0.29-0.77],0.0028967265791367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON2,Serum paraoxonase/arylesterase 2,27432,126,1.09 [0.70-1.70],0.7116375723774742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,28061,132,0.82 [0.56-1.18],0.2838027253492412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POSTN,Periostin,24262,111,0.82 [0.51-1.33],0.4284352441973166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPBP,Platelet basic protein,24114,110,1.03 [0.83-1.27],0.7936128417100822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPCDC,Phosphopantothenoylcysteine decarboxylase,28203,133,1.01 [0.74-1.39],0.935687830299678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIB,Peptidyl-prolyl cis-trans isomerase B,27937,129,1.10 [0.93-1.29],0.2649306402489013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIE,Peptidyl-prolyl cis-trans isomerase E,23825,109,0.94 [0.69-1.28],0.6873873129170056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24262,111,1.20 [0.93-1.56],0.1556144289448336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPL,Periplakin,23581,108,1.27 [0.76-2.11],0.3651132155866294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1A,Protein phosphatase 1A,27252,129,0.98 [0.60-1.59],0.9278722285352052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1B,Protein phosphatase 1B,23581,108,0.89 [0.64-1.24],0.509103474720062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1F,Protein phosphatase 1F,24272,114,1.14 [0.82-1.58],0.4277289618666853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPME1,Protein phosphatase methylesterase 1,27812,130,1.04 [0.81-1.35],0.7426131234514877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24157,113,1.05 [0.85-1.30],0.6415324161866276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28005,132,1.08 [0.93-1.27],0.3191883721963867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23825,109,1.26 [1.04-1.52],0.0159343805645455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24236,113,1.01 [0.81-1.27],0.8993824177583295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24236,113,1.62 [1.12-2.35],0.0097322862524026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R2,Protein phosphatase inhibitor 2,27938,130,1.04 [0.86-1.26],0.6788860603752435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R9B,Neurabin-2,28273,130,1.05 [0.89-1.23],0.5576612866283073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24177,111,1.12 [0.97-1.30],0.1244135809279763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,27748,130,1.39 [0.97-1.99],0.0739596168957797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPT1,Palmitoyl-protein thioesterase 1,23599,110,1.10 [0.89-1.35],0.3867835000286713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPY,Pancreatic prohormone,27865,129,0.87 [0.75-1.02],0.0865552311564308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PQBP1,Polyglutamine-binding protein 1,27252,129,1.07 [0.83-1.39],0.5883861579215128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAME,Melanoma antigen preferentially expressed in tumors,23409,107,1.06 [0.52-2.15],0.8787344423032987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,24262,111,1.93 [1.22-3.05],0.0048916373996209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRC1,Protein regulator of cytokinesis 1,24157,113,1.25 [0.96-1.62],0.0919769118742573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRCP,Lysosomal Pro-X carboxypeptidase,28087,129,1.55 [0.99-2.45],0.0577522011421807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX1,Peroxiredoxin-1,27170,128,1.03 [0.87-1.23],0.7145006314704968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,23902,109,0.77 [0.57-1.05],0.0945563265991618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27416,127,1.19 [0.96-1.46],0.1085049586553697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX5,"Peroxiredoxin-5, mitochondrial",28273,130,1.02 [0.81-1.28],0.8835879643499038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX6,Peroxiredoxin-6,28189,131,0.98 [0.76-1.26],0.8792281825453028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,27416,127,1.06 [0.63-1.80],0.81899877662169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,27916,132,2.06 [0.99-4.31],0.0545119458638448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG2,Bone marrow proteoglycan,24262,111,1.30 [0.93-1.81],0.1236674830656666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG3,Proteoglycan 3,24262,111,1.05 [0.74-1.48],0.7902413607369994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27416,127,1.18 [0.90-1.54],0.2349495830833279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23599,110,1.75 [1.11-2.78],0.0166411844845327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27938,130,1.07 [0.89-1.29],0.468984783952691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24155,112,1.01 [0.81-1.26],0.9471407478095502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKCQ,Protein kinase C theta type,27416,127,1.21 [0.88-1.66],0.248412409147632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKD2,Serine/threonine-protein kinase D2,23494,110,1.23 [0.89-1.71],0.2058682383598664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKG1,cGMP-dependent protein kinase 1,23725,107,1.05 [0.91-1.22],0.4750273537122217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27252,129,0.99 [0.79-1.25],0.9475997712363616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,28203,133,1.35 [1.13-1.60],0.0007789328644624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRND,Prion-like protein doppel,24203,112,1.21 [0.87-1.67],0.26274314293021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROC,Vitamin K-dependent protein C,27982,131,0.71 [0.39-1.28],0.2509819716302395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROCR,Endothelial protein C receptor,23494,110,1.06 [0.65-1.73],0.8025489905623321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROK1,Prokineticin-1,27925,130,1.13 [0.89-1.43],0.3083729273850674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,24305,112,0.35 [0.17-0.71],0.00393846534273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR4,Proline-rich protein 4,23566,107,1.18 [0.92-1.50],0.1991770942768001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR5,Proline-rich protein 5,23581,108,1.37 [1.01-1.85],0.0426008259319018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRRT3,Proline-rich transmembrane protein 3,23595,112,1.13 [0.70-1.81],0.6149415811468283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS2,Trypsin-2,28016,131,1.19 [0.90-1.57],0.2169681382182495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS22,Brain-specific serine protease 4,23581,108,1.53 [1.03-2.29],0.036722841325666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS27,Serine protease 27,27839,130,1.30 [0.89-1.89],0.1734853184274618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS53,Serine protease 53,24203,112,1.44 [0.94-2.20],0.094147512107024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,27826,132,1.77 [1.26-2.49],0.0011064280544237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27277,126,1.01 [0.87-1.16],0.9444419072070632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTG,Protogenin,28189,131,1.52 [0.86-2.71],0.1522784847375021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTN3,Myeloblastin,27242,123,1.30 [0.98-1.73],0.0696026664580883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRUNE2,Protein prune homolog 2,23825,109,1.25 [0.69-2.26],0.4544791799121433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,24041,109,2.47 [1.64-3.71],1.3323995275955488e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAPL1,Proactivator polypeptide-like 1,24177,111,1.27 [0.90-1.79],0.1744819747002084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSCA,Prostate stem cell antigen,24177,111,1.05 [0.97-1.13],0.2054734508895415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,27748,130,1.32 [1.12-1.55],0.0007319579880848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSIP1,PC4 and SFRS1-interacting protein,27925,130,1.14 [0.92-1.41],0.2200665877340722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMA1,Proteasome subunit alpha type-1,27252,129,1.09 [0.79-1.50],0.6165116030595241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMC3,26S proteasome regulatory subunit 6A,23409,107,1.46 [0.82-2.60],0.2018043019373149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD1,26S proteasome non-ATPase regulatory subunit 1,24236,113,1.10 [0.77-1.55],0.609674435119071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD5,26S proteasome non-ATPase regulatory subunit 5,23599,110,0.74 [0.49-1.12],0.158290436465214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD9,26S proteasome non-ATPase regulatory subunit 9,27812,130,0.85 [0.64-1.14],0.2756509990963102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME1,Proteasome activator complex subunit 1,27715,130,0.98 [0.64-1.48],0.9084393439146706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME2,Proteasome activator complex subunit 2,27629,130,1.03 [0.68-1.58],0.8737976986786176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG3,Proteasome assembly chaperone 3,27925,130,0.95 [0.70-1.28],0.724591973665361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,23581,108,1.02 [0.74-1.40],0.9210750192078584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSPN,Persephin,27925,130,1.09 [0.93-1.27],0.2991104680216246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,27252,129,1.14 [0.89-1.46],0.2862246250228908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22853,101,1.02 [0.86-1.22],0.8076948861167603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27277,126,0.80 [0.47-1.35],0.4015355014120874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,27718,131,2.30 [1.53-3.44],5.614446394285337e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGES2,Prostaglandin E synthase 2,23400,107,1.45 [1.06-1.98],0.0205267656235558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGR1,Prostaglandin reductase 1,24272,114,1.12 [0.91-1.37],0.2986368480117874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH,Parathyroid hormone,23599,110,1.16 [0.94-1.44],0.1630114403846215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27925,130,1.12 [0.78-1.62],0.5420164834704235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,27277,126,1.37 [0.92-2.06],0.1258441726476878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,27432,126,1.48 [1.11-1.96],0.0068700017667997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTP4A3,Protein tyrosine phosphatase type IVA 3,23581,108,0.94 [0.66-1.36],0.7498639250387142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27748,130,1.06 [0.87-1.28],0.5779499685896992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28018,132,1.04 [0.87-1.24],0.6568496860201409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23532,108,1.27 [0.86-1.89],0.2319091690379159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRB,Receptor-type tyrosine-protein phosphatase beta,24272,114,0.84 [0.47-1.53],0.5767454839106243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,24262,111,2.74 [1.38-5.45],0.0040821541868722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRF,Receptor-type tyrosine-protein phosphatase F,28281,131,1.25 [0.74-2.13],0.4087235078398555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRH,Receptor-type tyrosine-protein phosphatase H,24177,111,1.34 [0.95-1.90],0.0935630144136508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24177,111,2.32 [1.47-3.67],0.0003265157862654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,27873,129,3.21 [1.77-5.83],0.0001278530056033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27649,130,1.56 [0.98-2.48],0.0606461428284604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRR,Receptor-type tyrosine-protein phosphatase R,24203,112,1.03 [0.64-1.67],0.8973284045027767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRS,Receptor-type tyrosine-protein phosphatase S,28281,131,2.12 [1.15-3.89],0.015312712801962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24272,114,1.93 [1.14-3.27],0.0140373384225678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23725,107,0.98 [0.72-1.33],0.9105035863674102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTS,6-pyruvoyl tetrahydrobiopterin synthase,27154,126,1.15 [0.88-1.49],0.3062361910002814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTTG1,Securin,23825,109,0.96 [0.62-1.48],0.860501879128919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTX3,Pentraxin-related protein PTX3,27925,130,0.90 [0.67-1.20],0.462849367099059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVALB,Parvalbumin alpha,28079,131,0.96 [0.84-1.09],0.5351613344745731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVR,Poliovirus receptor,28203,133,1.18 [0.81-1.74],0.3930243240607992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXDNL,Peroxidasin-like protein,24157,113,1.09 [0.84-1.43],0.5081781880531819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXN,Paxillin,27277,126,1.19 [0.90-1.56],0.2212433769528079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYDC1,Pyrin domain-containing protein 1,23595,112,0.81 [0.51-1.30],0.3894371980794672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYY,Peptide YY,23494,110,1.13 [0.94-1.35],0.2117685515277182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,24305,112,1.04 [0.75-1.44],0.817045707373444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QDPR,Dihydropteridine reductase,27803,130,0.99 [0.70-1.42],0.97345148676516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,27940,128,1.84 [1.03-3.29],0.0399843244250093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QSOX1,Sulfhydryl oxidase 1,23799,108,1.12 [0.76-1.64],0.5746563324793137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB10,Ras-related protein Rab-10,24272,114,1.21 [0.89-1.66],0.2283653169375886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB11FIP3,Rab11 family-interacting protein 3,24272,114,1.07 [0.91-1.26],0.4406404241703714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB27B,Ras-related protein Rab-27B,24272,114,1.03 [0.83-1.28],0.8127539378588047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB2B,Ras-related protein Rab-2B,24157,113,1.28 [0.98-1.67],0.0686863778376575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB33A,Ras-related protein Rab-33A,23494,110,1.02 [0.78-1.33],0.9058852674155892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB37,Ras-related protein Rab-37,27416,127,1.05 [0.88-1.26],0.5591499695338309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB39B,Ras-related protein Rab-39B,23494,110,1.14 [0.97-1.33],0.1231781073120577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23493,107,1.04 [0.77-1.41],0.7975163941455402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB44,Ras-related protein Rab-44,24157,113,1.29 [0.99-1.68],0.0607867637324612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6A,Ras-related protein Rab-6A,27925,130,0.84 [0.60-1.17],0.3048627330355615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,27277,126,1.26 [0.94-1.69],0.1198544225682066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEP1,Rab GTPase-binding effector protein 1,23725,107,1.04 [0.82-1.32],0.7226170643208926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEPK,Rab9 effector protein with kelch motifs,27252,129,1.22 [0.98-1.53],0.0775626444720333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABGAP1L,Rab GTPase-activating protein 1-like,27416,127,0.99 [0.77-1.29],0.9689349163430704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAC3,Ras-related C3 botulinum toxin substrate 3,23599,110,1.02 [0.78-1.32],0.9070188417030136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD23B,UV excision repair protein RAD23 homolog B,27252,129,1.07 [0.77-1.49],0.6700875823701392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD51,DNA repair protein RAD51 homolog 1,23825,109,1.26 [0.99-1.59],0.0556132174268499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALB,Ras-related protein Ral-B,23581,108,1.08 [0.58-2.01],0.8101322495544263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALY,RNA-binding protein Raly,24157,113,1.07 [0.77-1.49],0.6880232920639042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP1,Ran-specific GTPase-activating protein,23595,112,0.95 [0.67-1.34],0.7644410541116204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP2,E3 SUMO-protein ligase RanBP2,23493,107,1.13 [0.67-1.93],0.641679608291017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANGAP1,Ran GTPase-activating protein 1,27252,129,1.10 [0.82-1.47],0.5448211191075409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAP1A,Ras-related protein Rap-1A,23581,108,1.18 [0.95-1.47],0.13919193510921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAPGEF2,Rap guanine nucleotide exchange factor 2,23825,109,1.36 [1.00-1.85],0.0496467887374001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,27252,129,1.29 [0.88-1.89],0.1881186241648011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,28072,131,1.49 [1.14-1.94],0.0036478410094883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,27277,126,1.35 [0.88-2.06],0.1693108810756879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23409,107,0.78 [0.49-1.22],0.2767275425812943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASSF2,Ras association domain-containing protein 2,27252,129,1.08 [0.85-1.39],0.518549977103647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,24236,113,1.85 [1.37-2.50],5.288515632195435e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,27297,127,0.92 [0.68-1.24],0.5863160602932461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM17,Splicing factor 45,24236,113,1.04 [0.82-1.30],0.7693394485768094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,23494,110,1.06 [0.73-1.54],0.7712968134520453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM25,RNA-binding protein 25,23409,107,1.05 [0.70-1.57],0.8200946906167456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP1,Retinol-binding protein 1,23599,110,1.20 [0.98-1.47],0.075869549632877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,27812,130,1.26 [1.04-1.53],0.0171091969778508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,27812,130,1.22 [0.95-1.57],0.1146441632735832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,24177,111,1.38 [1.09-1.74],0.0069376437738431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS,RNA-binding protein with multiple splicing,23581,108,1.24 [1.01-1.53],0.0445647056370189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS2,RNA-binding protein with multiple splicing 2,23595,112,1.03 [0.87-1.22],0.7407194402824551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCC1,Regulator of chromosome condensation,24157,113,1.29 [0.99-1.69],0.0595922587839342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCOR1,REST corepressor 1,27432,126,1.11 [0.81-1.52],0.5252866403700126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23595,112,1.50 [0.64-3.55],0.3545079688430969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REEP4,Receptor expression-enhancing protein 4,24236,113,1.19 [0.92-1.55],0.1879113767625559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,27772,131,1.56 [1.20-2.03],0.0008012922518299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,28281,131,1.49 [1.20-1.86],0.0003571764246445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,28281,131,1.46 [1.17-1.83],0.0008468524122712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3G,Regenerating islet-derived protein 3-gamma,24157,113,1.12 [0.72-1.74],0.6098470683437428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,27966,132,1.26 [0.93-1.72],0.1352792643148646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELB,Transcription factor RelB,23581,108,1.23 [0.90-1.69],0.1900331385150129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,27929,131,2.34 [1.40-3.92],0.0011641861821552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,27938,130,1.51 [1.27-1.78],1.6911696165959822e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REPS1,RalBP1-associated Eps domain-containing protein 1,23581,108,1.27 [0.82-1.95],0.2829194784229816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REST,RE1-silencing transcription factor,23409,107,1.21 [0.76-1.93],0.4145714095504583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27812,130,1.18 [0.80-1.74],0.4120151187757647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,27865,130,1.38 [0.99-1.94],0.0586772913721126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REXO2,"Oligoribonuclease, mitochondrial",23494,110,1.15 [0.82-1.60],0.4278694177565031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RFC4,Replication factor C subunit 4,24157,113,1.79 [0.95-3.34],0.0694373520053434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGCC,Regulator of cell cycle RGCC,24236,113,1.13 [0.90-1.43],0.2903819269479211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23825,109,1.09 [0.84-1.41],0.5350254490525646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMA,Repulsive guidance molecule A,28203,133,0.87 [0.54-1.42],0.5848737230307979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMB,RGM domain family member B,28203,133,1.48 [0.83-2.62],0.1803710127364375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS10,Regulator of G-protein signaling 10,24236,113,1.10 [0.83-1.47],0.5128405583417421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS8,Regulator of G-protein signaling 8,27416,127,1.02 [0.80-1.29],0.8780686902559887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RHOC,Rho-related GTP-binding protein RhoC,27580,127,1.03 [0.90-1.18],0.6834095065804564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,23581,108,1.32 [0.99-1.77],0.0629508002933877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23725,107,0.86 [0.59-1.25],0.4237052877109132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILP,Rab-interacting lysosomal protein,28116,131,1.01 [0.78-1.29],0.9646452780116936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILPL2,RILP-like protein 2,24272,114,1.11 [0.93-1.33],0.2465763069206515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23494,110,1.35 [1.12-1.62],0.0016217652557091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN1,Prorelaxin H1,24236,113,1.13 [0.92-1.39],0.2499974638775292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN2,Prorelaxin H2,23685,107,1.08 [0.95-1.23],0.2240967697731616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,24295,113,3.21 [2.04-5.07],5.240262841409038e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE10,Inactive ribonuclease-like protein 10,23595,112,1.41 [1.05-1.89],0.0230973303034472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE3,Eosinophil cationic protein,27800,129,1.09 [0.96-1.24],0.1680411409376467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,23518,111,2.05 [1.20-3.52],0.0090214291762369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,24122,112,2.38 [1.75-3.23],2.9976631064672854e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASEH2A,Ribonuclease H2 subunit A,24236,113,1.22 [0.90-1.67],0.1976505003055629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,28135,129,2.32 [1.40-3.86],0.0011179141054024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,23595,112,2.21 [1.30-3.76],0.0035563945150053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF168,E3 ubiquitin-protein ligase RNF168,23581,108,0.93 [0.59-1.48],0.759862899369381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF31,E3 ubiquitin-protein ligase RNF31,23581,108,0.92 [0.55-1.56],0.7646641057268606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF4,E3 ubiquitin-protein ligase RNF4,23825,109,1.07 [0.82-1.40],0.6216727925443442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF41,E3 ubiquitin-protein ligase NRDP1,27252,129,1.04 [0.83-1.31],0.7393613977897623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF43,E3 ubiquitin-protein ligase RNF43,23825,109,1.23 [0.96-1.57],0.0977718778594503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF5,E3 ubiquitin-protein ligase RNF5,23595,112,1.06 [0.82-1.36],0.6599865122579917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,27966,132,3.54 [2.08-6.02],3.2954682240879906e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO2,Roundabout homolog 2,28203,133,1.56 [0.81-3.00],0.178894303037745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO4,Roundabout homolog 4,23595,112,1.25 [0.45-3.47],0.6645185050413973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27938,130,1.45 [0.89-2.36],0.1314637610655702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RP2,Protein XRP2,27812,130,1.23 [0.88-1.71],0.2193261236390035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPA2,Replication protein A 32 kDa subunit,23581,108,0.99 [0.55-1.76],0.9648871420426616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPE,Ribulose-phosphate 3-epimerase,23825,109,1.08 [0.85-1.38],0.532657863292819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPGR,X-linked retinitis pigmentosa GTPase regulator,23599,110,0.94 [0.59-1.49],0.7789865566578604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPL14,60S ribosomal protein L14,23595,112,1.11 [0.73-1.68],0.6245227106323878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,23494,110,0.93 [0.60-1.46],0.7627571218885517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRAS,Ras-related protein R-Ras,23599,110,1.10 [0.96-1.25],0.17874338869261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2,Ribonucleoside-diphosphate reductase subunit M2,27252,129,1.13 [0.85-1.50],0.4014638225345078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27252,129,0.95 [0.76-1.20],0.677114149873633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRP15,RRP15-like protein,23493,107,1.13 [0.93-1.37],0.2208631835589919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,27748,130,1.33 [0.87-2.02],0.1866108206548981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,28189,131,1.93 [1.17-3.21],0.0104594553781149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTBDN,Retbindin,27812,130,1.17 [0.69-1.97],0.558344541530025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTKN2,Rhotekin-2,23494,110,1.09 [0.80-1.50],0.5678701142680299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24236,113,1.10 [0.91-1.33],0.3321985592948723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4R,Reticulon-4 receptor,28189,131,1.20 [0.77-1.87],0.411623222988821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,27252,129,0.96 [0.82-1.13],0.638484028728739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RWDD1,RWD domain-containing protein 1,28203,133,1.05 [0.82-1.33],0.7091665563497658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RYR1,Ryanodine receptor 1,23494,110,1.46 [0.99-2.17],0.0589968740165613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A11,Protein S100-A11,27711,129,1.14 [0.85-1.53],0.3766254888248413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A12,Protein S100-A12,27548,130,1.07 [0.87-1.31],0.5356179857437366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A13,Protein S100-A13,23581,108,1.75 [1.13-2.70],0.0119544425257402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,24236,113,1.00 [0.71-1.42],0.9936509374564576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,27227,126,1.08 [0.85-1.39],0.5235740690243376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A3,Protein S100-A3,24157,113,1.17 [0.84-1.63],0.3487581599484249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,28005,132,1.00 [0.76-1.30],0.9731781569343636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100G,Protein S100-G,24236,113,1.11 [0.76-1.61],0.5881800447613065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100P,Protein S100-P,27432,126,1.17 [0.91-1.51],0.2219721278606603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAA4,Serum amyloid A-4 protein,24305,112,0.98 [0.55-1.75],0.940278840153032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAFB2,Scaffold attachment factor B2,24236,113,1.63 [0.96-2.77],0.0716322469586501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAG,S-arrestin,23493,107,0.99 [0.69-1.42],0.9451458851005704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAMD9L,Sterile alpha motif domain-containing protein 9-like,27925,130,1.00 [0.81-1.23],0.9812801140189346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAP18,Histone deacetylase complex subunit SAP18,23825,109,1.02 [0.81-1.30],0.8613574415333535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SARG,Specifically androgen-regulated gene protein,24192,114,1.07 [0.91-1.26],0.395743405325903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SART1,U4/U6.U5 tri-snRNP-associated protein 1,23494,110,1.06 [0.67-1.66],0.8111162813371777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT1,Diamine acetyltransferase 1,23494,110,1.19 [0.86-1.64],0.2966079623198621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,23825,109,1.32 [1.10-1.58],0.0033046010370518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,24236,113,1.30 [0.78-2.18],0.3152394221727741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SBSN,Suprabasin,24218,111,0.75 [0.44-1.28],0.291586109289727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCAMP3,Secretory carrier-associated membrane protein 3,27812,130,1.11 [0.93-1.33],0.2433831688470139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,28203,133,1.97 [1.19-3.25],0.0082627367462056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,27277,126,1.12 [0.87-1.43],0.381913622093936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,27214,127,2.53 [1.66-3.85],1.5998072697912426e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF1,Scavenger receptor class F member 1,28281,131,1.44 [1.02-2.03],0.0363371958368411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,28203,133,2.28 [1.35-3.85],0.0021787918116835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,28078,131,1.49 [0.93-2.38],0.1001245445149526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,27966,132,1.21 [0.76-1.92],0.4270629234916643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB1A1,Uteroglobin,27983,132,1.13 [0.85-1.48],0.4013024266204372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB2A2,Mammaglobin-A,23494,110,0.76 [0.40-1.47],0.4166434278546884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A1,Secretoglobin family 3A member 1,23725,107,1.73 [0.82-3.66],0.1477971392726479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A2,Secretoglobin family 3A member 2,28018,132,1.08 [0.91-1.30],0.3666286071286979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,27416,127,1.26 [0.90-1.78],0.1834297029498534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCIN,Adseverin,23493,107,0.96 [0.74-1.25],0.771854985523969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCLY,Selenocysteine lyase,28116,131,1.19 [0.89-1.60],0.2451229808660382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2A,Sodium channel protein type 2 subunit alpha,23493,107,0.85 [0.55-1.30],0.4467002702346203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2B,Sodium channel subunit beta-2,23599,110,1.14 [0.62-2.12],0.6707724918915405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3A,Sodium channel protein type 3 subunit alpha,23599,110,1.07 [0.67-1.69],0.7768842378366779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3B,Sodium channel subunit beta-3,23493,107,0.90 [0.58-1.39],0.6419256362703732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN4B,Sodium channel subunit beta-4,23595,112,1.26 [0.84-1.89],0.2677262495698861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCP2,Non-specific lipid-transfer protein,27252,129,0.92 [0.74-1.14],0.4623315359865838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCPEP1,Retinoid-inducible serine carboxypeptidase,23513,112,1.42 [1.02-1.98],0.0379104297136092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,24272,114,2.06 [1.38-3.07],0.0003912289655021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRIB,Protein scribble homolog,23595,112,1.08 [0.90-1.30],0.3908305583334411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRN1,Secernin-1,27925,130,1.04 [0.80-1.36],0.7673574333860249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCT,Secretin,23599,110,0.60 [0.39-0.93],0.0211224710127877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,27938,130,1.62 [1.19-2.22],0.0024780610598966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC4,Syndecan-4,27938,130,1.12 [0.80-1.57],0.4956263443937977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDCCAG8,Serologically defined colon cancer antigen 8,24157,113,1.05 [0.90-1.23],0.5600460777144691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,24177,111,1.20 [0.96-1.51],0.1075511359755154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDK2,Protein sidekick-2,23725,107,1.12 [0.68-1.82],0.6627248136997863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEC31A,Protein transport protein Sec31A,23595,112,1.06 [0.84-1.35],0.6045075996552107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEL1L,Protein sel-1 homolog 1,23595,112,1.42 [0.98-2.04],0.0635633592624543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELE,E-selectin,28281,131,1.41 [1.04-1.91],0.0252082014208346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,24305,112,0.48 [0.27-0.83],0.009177261592657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELL,L-selectin,24305,112,1.05 [0.48-2.30],0.9013337104570532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELP,P-selectin,28016,131,1.08 [0.83-1.41],0.5540312271054124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELPLG,P-selectin glycoprotein ligand 1,27925,130,1.36 [0.80-2.32],0.2560855963907711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,27938,130,1.71 [0.96-3.05],0.0665843464563435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3G,Semaphorin-3G,23725,107,1.16 [0.77-1.75],0.474898803878703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4C,Semaphorin-4C,27812,130,1.43 [0.92-2.25],0.1140156751880164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4D,Semaphorin-4D,28203,133,1.31 [0.79-2.19],0.2976077931312119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA6C,Semaphorin-6C,23581,108,1.60 [0.93-2.78],0.0920796281125542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,28182,131,2.14 [1.36-3.36],0.0010399016534539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN3,Neuronal-specific septin-3,24236,113,1.22 [0.99-1.50],0.0611382495349159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN7,Septin-7,23825,109,1.14 [0.84-1.54],0.3970383821307517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN8,Septin-8,24147,110,1.67 [1.05-2.65],0.0297635537836982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN9,Septin-9,27812,130,0.83 [0.48-1.45],0.5153892613448156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA1,Alpha-1-antitrypsin,23866,108,2.22 [0.27-18.65],0.4612397382667839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA11,Serpin A11,28281,131,1.55 [1.07-2.25],0.0212960102827628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA12,Serpin A12,27159,124,1.06 [0.94-1.19],0.3478450158790077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA3,Alpha-1-antichymotrypsin,24227,112,1.43 [0.45-4.53],0.5439874247783177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA4,Kallistatin,23862,109,0.58 [0.27-1.24],0.1571010483313124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA5,Plasma serine protease inhibitor,23951,109,0.94 [0.53-1.66],0.8220856773217657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,24305,112,1.46 [0.53-4.00],0.4662501888654478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,24305,112,1.47 [0.58-3.75],0.4208734045599269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA9,Serpin A9,27681,130,1.23 [1.00-1.51],0.0464368806193135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB1,Leukocyte elastase inhibitor,27841,131,1.04 [0.88-1.23],0.6487367920090535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB5,Serpin B5,27432,126,1.22 [0.87-1.70],0.2407424985992918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB6,Serpin B6,28107,133,1.09 [0.85-1.40],0.498614625631569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB8,Serpin B8,28273,130,1.25 [1.01-1.54],0.0357685691519086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB9,Serpin B9,27748,130,1.48 [0.94-2.33],0.0907175042517229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINC1,Antithrombin-III,24254,111,0.81 [0.24-2.70],0.728693334225827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPIND1,Heparin cofactor 2,24254,111,1.20 [0.64-2.25],0.568522111368706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE1,Plasminogen activator inhibitor 1,28281,131,1.15 [0.91-1.44],0.2357652992989417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,24272,114,1.16 [0.89-1.51],0.2721357309333471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF1,Pigment epithelium-derived factor,23944,108,1.73 [0.89-3.36],0.1052600142081965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF2,Alpha-2-antiplasmin,23854,107,0.59 [0.16-2.25],0.4429417355052711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,24254,111,0.88 [0.34-2.28],0.7881597494110073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINH1,Serpin H1,23825,109,1.10 [0.96-1.27],0.1628178431928082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI1,Neuroserpin,23673,107,1.09 [0.61-1.94],0.7811133875926564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI2,Serpin I2,24177,111,1.08 [0.80-1.45],0.6235565419548469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27277,126,1.00 [0.78-1.28],0.993706459190871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,27660,130,0.68 [0.41-1.14],0.1431774328869002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6,Seizure protein 6 homolog,23599,110,0.96 [0.53-1.72],0.8827202046605452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L,Seizure 6-like protein,28005,132,0.83 [0.48-1.45],0.5144990276237897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L2,Seizure 6-like protein 2,27812,130,1.27 [0.68-2.37],0.4574117724654714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SF3B4,Splicing factor 3B subunit 4,27812,130,1.03 [0.84-1.26],0.7851615656791104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,27649,130,1.59 [1.19-2.12],0.0016913847323988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP4,Secreted frizzled-related protein 4,23725,107,1.15 [0.74-1.78],0.5387776970410354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA1,Pulmonary surfactant-associated protein A1,27252,129,0.98 [0.74-1.29],0.8699223157471591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA2,Pulmonary surfactant-associated protein A2,27252,129,1.12 [0.83-1.51],0.4521871468973057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPD,Pulmonary surfactant-associated protein D,27938,130,1.18 [0.93-1.48],0.1688217472329179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SGSH,N-sulphoglucosamine sulphohydrolase,23891,114,1.07 [0.78-1.47],0.6592794469369008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2B3,SH2B adapter protein 3,27252,129,1.05 [0.90-1.23],0.5522022904227162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2D1A,SH2 domain-containing protein 1A,27925,130,1.15 [0.90-1.46],0.2586762711380936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23493,107,1.29 [1.03-1.61],0.0266284797593027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BP1,SH3 domain-binding protein 1,24177,111,1.06 [0.75-1.50],0.7216353498628103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GL3,Endophilin-A3,23674,109,1.06 [0.85-1.32],0.6196436553710405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GLB2,Endophilin-B2,24203,112,1.11 [0.85-1.44],0.4552471815499287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHBG,Sex hormone-binding globulin,24295,113,0.95 [0.68-1.33],0.7669093288041473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHC1,SHC-transforming protein 1,23409,107,0.93 [0.78-1.10],0.3982276344396915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHD,SH2 domain-containing adapter protein D,23459,110,1.00 [0.81-1.24],0.98983202156084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHH,Sonic hedgehog protein,23581,108,1.39 [0.98-1.97],0.065662098775033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,24262,111,2.50 [1.56-3.99],0.0001362590125515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHMT1,"Serine hydroxymethyltransferase, cytosolic",28018,132,1.06 [0.89-1.26],0.5356549022073578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHPK,Sedoheptulokinase,23825,109,1.11 [0.73-1.68],0.6325532726861012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,27956,132,1.28 [0.93-1.75],0.1244861522110405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,28061,132,1.68 [1.20-2.35],0.0025941904384011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,27925,130,2.13 [1.42-3.18],0.000245998990918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC15,Sialic acid-binding Ig-like lectin 15,27277,126,0.88 [0.71-1.11],0.2824559451330186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,27929,131,1.19 [1.02-1.39],0.0315503988311529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,28189,131,1.86 [1.24-2.78],0.0027264360688251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,27938,130,2.71 [1.66-4.42],6.570594562888693e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,23595,112,1.54 [1.06-2.24],0.0240263452803606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,28153,131,1.73 [1.05-2.83],0.0298883438976824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIL1,Nucleotide exchange factor SIL1,23595,112,0.95 [0.54-1.67],0.8603904435662264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28002,130,1.43 [1.06-1.93],0.0184740110580962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,27861,132,1.74 [1.25-2.42],0.0009869178833028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT1,NAD-dependent protein deacetylase sirtuin-1,23581,108,0.96 [0.77-1.20],0.7314175987181291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT2,NAD-dependent protein deacetylase sirtuin-2,27812,130,1.08 [0.91-1.28],0.3979809527699788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27277,126,0.94 [0.70-1.27],0.7056085533997379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIT1,Signaling threshold-regulating transmembrane adapter 1,27416,127,1.22 [0.92-1.61],0.16113713531176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP1,Src kinase-associated phosphoprotein 1,27700,130,1.02 [0.82-1.26],0.8719574177992095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP2,Src kinase-associated phosphoprotein 2,28061,132,1.06 [0.92-1.23],0.4266993062552884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKIV2L,Helicase SKI2W,23494,110,1.22 [0.82-1.81],0.3370127539080404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLA2,Src-like-adapter 2,24236,113,1.01 [0.85-1.19],0.9365276261083156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,27416,127,1.67 [1.29-2.16],8.930465798128255e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,27252,129,1.09 [0.72-1.63],0.6897889064785896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,27925,130,1.42 [1.11-1.83],0.005978480554494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,27252,129,1.38 [1.02-1.88],0.0364422484830089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC12A2,Solute carrier family 12 member 2,23494,110,1.39 [0.87-2.21],0.1693087631139929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC13A1,Solute carrier family 13 member 1,24157,113,1.14 [0.89-1.47],0.3043044350190181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,27277,126,1.20 [0.95-1.52],0.1239409898649024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC1A4,Neutral amino acid transporter A,23599,110,1.34 [1.01-1.77],0.0424044229484018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,27277,126,1.14 [0.93-1.40],0.2057023336362451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC28A1,Sodium/nucleoside cotransporter 1,23409,107,1.17 [0.89-1.54],0.251661375548767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC34A3,Sodium-dependent phosphate transport protein 2C,23409,107,0.91 [0.60-1.38],0.6658471448269785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,27277,126,1.33 [0.85-2.07],0.2156849763904101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A5,Zinc transporter ZIP5,27925,130,1.10 [0.83-1.45],0.502899863614327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC44A4,Choline transporter-like protein 4,23599,110,1.09 [0.85-1.40],0.4963670625704104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,24262,111,0.95 [0.65-1.39],0.7983300512864531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC51B,Organic solute transporter subunit beta,23494,110,1.05 [0.83-1.32],0.6962680803241523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23725,107,1.09 [0.88-1.34],0.4499166171177706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24177,111,1.34 [1.07-1.69],0.0117630655303369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23409,107,1.17 [0.89-1.54],0.2623953723818711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIT2,Slit homolog 2 protein,27277,126,0.99 [0.73-1.35],0.944536315643678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK1,SLIT and NTRK-like protein 1,23581,108,0.56 [0.32-1.00],0.0483180345432995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK2,SLIT and NTRK-like protein 2,28189,131,1.46 [0.99-2.15],0.0562226874703103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK6,SLIT and NTRK-like protein 6,27432,126,1.24 [0.80-1.95],0.3382726633064158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLK,STE20-like serine/threonine-protein kinase,23825,109,1.06 [0.85-1.32],0.611219738995358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLMAP,Sarcolemmal membrane-associated protein,24177,111,1.16 [0.95-1.42],0.14884458804833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLURP1,Secreted Ly-6/uPAR-related protein 1,24084,110,1.07 [0.67-1.69],0.7871387669847738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD1,Mothers against decapentaplegic homolog 1,27252,129,1.08 [0.90-1.30],0.4058395727938174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD2,Mothers against decapentaplegic homolog 2,24157,113,1.16 [0.91-1.48],0.2306395634324029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD3,Mothers against decapentaplegic homolog 3,24157,113,1.08 [0.77-1.52],0.6465754536329595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD5,Mothers against decapentaplegic homolog 5,27812,130,1.38 [0.64-2.99],0.4094568708438766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMARCA2,Probable global transcription activator SNF2L2,27277,126,1.02 [0.82-1.27],0.8602653831199581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMC3,Structural maintenance of chromosomes protein 3,23409,107,0.90 [0.63-1.30],0.5897296917096229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMNDC1,Survival of motor neuron-related-splicing factor 30,24177,111,1.19 [0.94-1.50],0.1508464316951884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC1,SPARC-related modular calcium-binding protein 1,28189,131,1.53 [0.98-2.40],0.0643093419523771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC2,SPARC-related modular calcium-binding protein 2,28061,132,1.51 [1.05-2.19],0.0274202377320947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD1,Sphingomyelin phosphodiesterase,28065,133,1.01 [0.75-1.37],0.9493773732102496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD3,Sphingomyelin phosphodiesterase 3,23581,108,1.04 [0.77-1.39],0.795826243575762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28006,132,0.78 [0.62-0.97],0.028421369870171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24157,113,1.01 [0.80-1.28],0.903850522722586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMS,Spermine synthase,23493,107,1.03 [0.78-1.36],0.8461860477226313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMTN,Smoothelin,24147,112,1.02 [0.85-1.23],0.7902108949274742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP23,Synaptosomal-associated protein 23,27938,130,1.08 [0.90-1.29],0.4137674805445581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP25,Synaptosomal-associated protein 25,23493,107,1.25 [0.86-1.82],0.2368661485687284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP29,Synaptosomal-associated protein 29,28005,132,1.07 [0.91-1.27],0.4158051486255647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAPIN,SNARE-associated protein Snapin,24236,113,0.89 [0.65-1.21],0.4413941070020474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCA,Alpha-synuclein,23725,107,0.99 [0.84-1.16],0.9057845150596396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCG,Gamma-synuclein,27748,130,1.08 [0.85-1.36],0.5470101886754235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23595,112,1.40 [0.85-2.30],0.1885692954584777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNRPB2,U2 small nuclear ribonucleoprotein B'',24203,112,1.17 [0.86-1.59],0.3273110924418335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNU13,NHP2-like protein 1,23494,110,1.03 [0.78-1.35],0.8420847763979131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX15,Sorting nexin-15,23725,107,1.00 [0.72-1.40],0.988742584358296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX18,Sorting nexin-18,24177,111,1.51 [1.10-2.06],0.0100978635418719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX2,Sorting nexin-2,24157,113,1.14 [0.93-1.39],0.2173757790092645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX5,Sorting nexin-5,23595,112,1.29 [0.75-2.24],0.3567998824445475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX9,Sorting nexin-9,27938,130,1.13 [0.91-1.41],0.2590713962423205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD1,Superoxide dismutase [Cu-Zn],27337,131,1.08 [0.79-1.48],0.615869853138217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",27929,131,1.28 [0.89-1.84],0.1845977789819011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD3,Extracellular superoxide dismutase,24295,113,0.93 [0.67-1.27],0.6369740414137988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORBS1,Sorbin and SH3 domain-containing protein 1,24236,113,1.40 [0.99-1.99],0.0605127219114129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,27252,129,2.00 [1.35-2.96],0.0005638857082438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORD,Sorbitol dehydrogenase,28064,130,0.90 [0.73-1.12],0.3405063307617858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORT1,Sortilin,27906,130,1.36 [0.92-2.03],0.1262361005333145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOST,Sclerostin,27906,130,0.99 [0.67-1.47],0.9640126099197452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23599,110,1.00 [0.68-1.48],0.9818449265725768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX2,Transcription factor SOX-2,24197,113,1.24 [0.60-2.59],0.5579374187118413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX9,Transcription factor SOX-9,23599,110,2.12 [1.14-3.96],0.0182772089009441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24236,113,1.23 [0.72-2.09],0.4448651783174527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPAG1,Sperm-associated antigen 1,24236,113,1.18 [0.91-1.54],0.2115559860284854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARC,SPARC,28005,132,1.02 [0.82-1.26],0.8714515932491157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARCL1,SPARC-like protein 1,27924,131,1.19 [0.69-2.06],0.5407502720636927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPART,Spartin,23725,107,1.06 [0.84-1.33],0.646862452548712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPESP1,Sperm equatorial segment protein 1,24272,114,0.88 [0.48-1.62],0.691250437698459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,27929,131,1.71 [1.26-2.30],0.0004936613824709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK2,Serine protease inhibitor Kazal-type 2,23725,107,1.58 [1.02-2.43],0.0384922248769143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK4,Serine protease inhibitor Kazal-type 4,27925,130,1.30 [1.04-1.64],0.0220394551011998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK5,Serine protease inhibitor Kazal-type 5,27929,131,1.40 [0.89-2.18],0.1449287082759567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,28189,131,1.44 [1.08-1.91],0.0122887095104499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK8,Serine protease inhibitor Kazal-type 8,23494,110,0.83 [0.48-1.44],0.5045336020833024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,27830,131,2.40 [1.55-3.73],9.56446914454059e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,28061,132,1.57 [1.09-2.26],0.0157397190005106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT3,Kunitz-type protease inhibitor 3,24177,111,0.94 [0.83-1.05],0.2778345180222964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPOCK1,Testican-1,27748,130,0.66 [0.36-1.21],0.179764339337696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,27966,132,2.24 [1.50-3.35],7.730828859589618e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,27804,130,2.83 [1.87-4.26],7.130078957911359e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,28229,131,1.66 [1.21-2.29],0.0017730062713661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23581,108,1.08 [0.73-1.60],0.6963434410271003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRING1,SREBP regulating gene protein,23409,107,1.22 [0.95-1.58],0.1213110528151035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR1B,Cornifin-B,23825,109,1.05 [0.86-1.28],0.6272761522419832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR3,Small proline-rich protein 3,24203,112,1.11 [0.85-1.43],0.4496451172702479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRY2,Protein sprouty homolog 2,27416,127,1.04 [0.88-1.22],0.6594420418589917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23493,107,1.09 [0.63-1.91],0.7562472809198809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTLC1,Serine palmitoyltransferase 1,24203,112,1.37 [0.93-2.01],0.1114368025783472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRC,Proto-oncogene tyrosine-protein kinase Src,27961,132,1.03 [0.91-1.17],0.6002178445278588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRP14,Signal recognition particle 14 kDa protein,27812,130,1.11 [0.87-1.42],0.3986121961366903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPK2,SRSF protein kinase 2,27925,130,1.08 [0.91-1.29],0.3867810871699459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,24272,114,2.00 [1.20-3.30],0.0073138206974961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSB,Lupus La protein,27277,126,0.72 [0.52-1.01],0.0571491484156315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23581,108,1.45 [0.98-2.14],0.0614169258158007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27906,130,0.96 [0.84-1.09],0.4855161499316304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28016,131,1.42 [1.00-2.03],0.0531098403191475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSH3,Protein phosphatase Slingshot homolog 3,23409,107,0.70 [0.36-1.38],0.302564295032903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSNA1,Sjoegren syndrome nuclear autoantigen 1,24177,111,1.48 [1.08-2.03],0.0136042199456268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST13,Hsc70-interacting protein,23725,107,0.92 [0.66-1.28],0.612708046893918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27812,130,0.81 [0.55-1.20],0.2971050232941654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28281,131,1.90 [1.16-3.11],0.0110278198154106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23581,108,1.07 [0.75-1.53],0.6943518487304078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAB2,Stabilin-2,24262,111,1.38 [0.74-2.58],0.3134787983846506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAM,Signal transducing adapter molecule 1,24157,113,1.13 [0.72-1.79],0.5917456492207068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAMBP,STAM-binding protein,27700,130,1.09 [0.86-1.39],0.4591691709688666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT2,Signal transducer and activator of transcription 2,23581,108,1.14 [0.91-1.44],0.2534972732961759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT5B,Signal transducer and activator of transcription 5B,27812,130,1.00 [0.89-1.12],0.9822627877630492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23409,107,1.38 [1.12-1.71],0.0029125776159315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,28203,133,1.60 [1.16-2.19],0.003719496886285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC2,Stanniocalcin-2,27891,131,1.76 [0.96-3.22],0.0683367788112728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STEAP4,Metalloreductase STEAP4,23493,107,0.96 [0.74-1.25],0.7623077207398357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STIP1,Stress-induced-phosphoprotein 1,27880,131,1.06 [0.84-1.34],0.6101421237229361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK11,Serine/threonine-protein kinase STK11,27432,126,1.01 [0.82-1.25],0.9090132275540256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK24,Serine/threonine-protein kinase 24,27277,126,0.99 [0.77-1.28],0.9381845903447302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK4,Serine/threonine-protein kinase 4,27938,130,1.04 [0.87-1.24],0.683853736538329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STOML2,"Stomatin-like protein 2, mitochondrial",23409,107,0.94 [0.77-1.16],0.5813815645632296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX16,Syntaxin-16,27252,129,1.24 [0.98-1.57],0.0689532134170483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX1B,Syntaxin-1B,23599,110,1.23 [0.88-1.72],0.219587315247112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX3,Syntaxin-3,24203,112,1.13 [0.73-1.75],0.5914540454831343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX4,Syntaxin-4,27812,130,1.21 [0.98-1.50],0.0779767843401794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX5,Syntaxin-5,23581,108,1.05 [0.69-1.62],0.8110736657224393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX6,Syntaxin-6,27252,129,1.08 [0.87-1.34],0.4862433135352869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX7,Syntaxin-7,23581,108,0.99 [0.68-1.45],0.977285680188302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX8,Syntaxin-8,27925,130,1.12 [0.83-1.52],0.4475009630289479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP1,Syntaxin-binding protein 1,24236,113,0.98 [0.78-1.24],0.8954215743041971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP3,Syntaxin-binding protein 3,27252,129,1.02 [0.72-1.44],0.915607022926105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGP1,SURP and G-patch domain-containing protein 1,24177,111,1.31 [0.88-1.95],0.180761413335301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGT1,Protein SGT1 homolog,27252,129,1.04 [0.86-1.26],0.6818789477908906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT1A1,Sulfotransferase 1A1,28203,133,1.04 [0.92-1.17],0.5654711767659377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT2A1,Bile salt sulfotransferase,27925,130,1.11 [0.87-1.41],0.4006402664403762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF1,Formylglycine-generating enzyme,23581,108,1.04 [0.81-1.34],0.7584005155309528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28203,133,1.20 [0.90-1.61],0.2122676439287726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUOX,"Sulfite oxidase, mitochondrial",24236,113,1.24 [0.96-1.60],0.0968248367554985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD1,Sushi domain-containing protein 1,27432,126,1.11 [0.80-1.54],0.5441122223106216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD2,Sushi domain-containing protein 2,27929,131,1.42 [0.87-2.32],0.1650535941042215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD4,Sushi domain-containing protein 4,24157,113,1.15 [0.76-1.72],0.5078210646412272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD5,Sushi domain-containing protein 5,23598,107,1.42 [0.84-2.43],0.1937633089038715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,23599,110,1.43 [1.13-1.81],0.0027808610722715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SWAP70,Switch-associated protein 70,24177,111,1.43 [0.95-2.16],0.0896716719785101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYAP1,Synapse-associated protein 1,23725,107,1.05 [0.76-1.43],0.7733956548842276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23493,107,1.01 [0.73-1.40],0.95836079396327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYT1,Synaptotagmin-1,24203,112,1.04 [0.64-1.68],0.8807709032210493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYTL4,Synaptotagmin-like protein 4,24272,114,1.11 [0.88-1.40],0.3613540842119093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23825,109,1.06 [0.89-1.25],0.5343834914422096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACC3,Transforming acidic coiled-coil-containing protein 3,27812,130,1.01 [0.89-1.16],0.8458290272777087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACSTD2,Tumor-associated calcium signal transducer 2,24809,119,1.26 [0.72-2.20],0.4146529482262074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TADA3,Transcriptional adapter 3,24157,113,1.31 [0.85-2.02],0.2162471163803367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,27812,130,2.17 [1.48-3.18],7.016201496083114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAGLN3,Transgelin-3,23409,107,0.91 [0.66-1.25],0.5595265964293932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TALDO1,Transaldolase,24182,111,1.20 [0.82-1.76],0.3526275990717299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TANK,TRAF family member-associated NF-kappa-B activator,27416,127,1.13 [0.91-1.41],0.257559001973403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAP1,Antigen peptide transporter 1,23825,109,0.93 [0.66-1.30],0.6678663313998108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARBP2,RISC-loading complex subunit TARBP2,27277,126,1.04 [0.85-1.27],0.69633339879857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23599,110,0.87 [0.66-1.14],0.3110367069339934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24157,113,1.33 [0.84-2.11],0.2260003754016664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAX1BP1,Tax1-binding protein 1,24203,112,1.02 [0.78-1.35],0.8690122122586303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D17,TBC1 domain family member 17,27277,126,1.19 [0.86-1.66],0.2984619454193325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D23,TBC1 domain family member 23,27812,130,1.03 [0.87-1.22],0.7543497315137025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D5,TBC1 domain family member 5,27925,130,0.99 [0.82-1.20],0.940981560404102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCA,Tubulin-specific chaperone A,23725,107,0.99 [0.80-1.23],0.9450018064472074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCB,Tubulin-folding cofactor B,27748,130,1.06 [0.90-1.23],0.4863640304762977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCC,Tubulin-specific chaperone C,27748,130,1.07 [0.88-1.29],0.5116526654700528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBL1X,F-box-like/WD repeat-containing protein TBL1X,27252,129,1.11 [0.92-1.33],0.2740365019867137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBR1,T-box brain protein 1,23599,110,1.25 [0.93-1.69],0.1346321264223293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1A,T-cell leukemia/lymphoma protein 1A,27696,130,0.96 [0.82-1.12],0.5945803100683034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1B,T-cell leukemia/lymphoma protein 1B,27432,126,0.94 [0.76-1.17],0.5962012361666368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN1,Transcobalamin-1,23814,111,1.43 [0.95-2.14],0.0868367300675847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,28229,131,2.34 [1.63-3.36],3.864963717695914e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCOF1,Treacle protein,24272,114,1.61 [1.04-2.49],0.031362488052608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCP11,T-complex protein 11 homolog,23825,109,0.90 [0.63-1.28],0.5507604008583499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCTN3,Tectonic-3,24272,114,1.11 [0.61-2.00],0.7314497417448866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDGF1,Teratocarcinoma-derived growth factor 1,27277,126,1.09 [0.98-1.21],0.1291992870076449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDO2,"Tryptophan 2,3-dioxygenase",23599,110,0.80 [0.48-1.34],0.3977226718534024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDP1,Tyrosyl-DNA phosphodiesterase 1,24157,113,1.14 [0.91-1.42],0.256597746789283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,27277,126,1.08 [0.90-1.29],0.3872489438322144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEF,Thyrotroph embryonic factor,23494,110,0.89 [0.57-1.40],0.6127344041179903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEK,Angiopoietin-1 receptor,28005,132,2.22 [1.13-4.36],0.0203964833554338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TERF1,Telomeric repeat-binding factor 1,23581,108,1.28 [0.71-2.28],0.4139183372699289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,23792,109,1.16 [1.00-1.34],0.0460126775602696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX101,Testis-expressed protein 101,23599,110,1.07 [0.74-1.54],0.7324196038136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,23825,109,1.49 [1.11-1.99],0.0076677610859574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TF,Serotransferrin,24305,112,1.00 [0.44-2.25],0.9999274301118276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFAP2A,Transcription factor AP-2-alpha,23493,107,1.11 [0.83-1.49],0.4677206500680896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,27797,131,1.27 [1.07-1.52],0.0067750458501728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,28018,132,1.52 [1.21-1.92],0.0003890404870788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,27892,130,1.30 [1.00-1.69],0.0492834870782816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI,Tissue factor pathway inhibitor,27838,131,0.81 [0.49-1.33],0.4028174825725236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI2,Tissue factor pathway inhibitor 2,27910,132,1.39 [1.06-1.82],0.0155822943517891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFRC,Transferrin receptor protein 1,28031,131,1.12 [0.76-1.65],0.5580581415905385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TG,Thyroglobulin,24157,113,1.02 [0.87-1.20],0.7868242675358612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,27925,130,1.70 [1.28-2.25],0.0002307765057368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB1,Transforming growth factor beta-1 proprotein,28223,128,1.58 [1.09-2.30],0.016545181594912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB2,Transforming growth factor beta-2 proprotein,24157,113,1.25 [0.94-1.67],0.128868866986997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBI,Transforming growth factor-beta-induced protein ig-h3,27750,131,1.09 [0.62-1.91],0.7707968405038663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR1,TGF-beta receptor type-1,23581,108,1.41 [0.73-2.73],0.3005980138047708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,28005,132,2.02 [1.37-2.99],0.0004119837188319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,28281,131,1.79 [1.09-2.92],0.0204914090846127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGM2,Protein-glutamine gamma-glutamyltransferase 2,27885,130,0.85 [0.69-1.04],0.1089684488020379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,24295,113,3.28 [1.78-6.04],0.0001401010894471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THAP12,52 kDa repressor of the inhibitor of the protein kinase,23363,107,0.90 [0.71-1.14],0.3829863862043784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,27938,130,1.67 [0.98-2.85],0.0613824440777647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,27929,131,1.89 [1.36-2.61],0.0001233157425426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS4,Thrombospondin-4,27937,131,1.53 [1.11-2.12],0.0103640602816733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THOP1,Thimet oligopeptidase,27820,130,1.04 [0.65-1.69],0.8596043929442886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,27432,126,1.07 [0.71-1.61],0.7345171067878886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,23494,110,1.14 [1.00-1.29],0.0492679174575663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THSD1,Thrombospondin type-1 domain-containing protein 1,23407,108,1.44 [0.90-2.28],0.1268206295232282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THTPA,Thiamine-triphosphatase,24105,113,1.06 [0.87-1.30],0.5734475606156484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,28203,133,1.53 [0.89-2.63],0.1211284697313202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIA1,Nucleolysin TIA-1 isoform p40,27127,124,1.00 [0.88-1.14],0.9934972537148165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIE1,Tyrosine-protein kinase receptor Tie-1,28281,131,1.50 [0.97-2.31],0.066650806633582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27229,126,1.08 [0.78-1.50],0.6430200184780356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23825,109,1.16 [0.73-1.86],0.5238529037328866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28016,131,1.39 [0.99-1.97],0.059023200602143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24272,114,1.21 [0.80-1.85],0.3657462282960279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24203,112,1.03 [0.84-1.26],0.7867008187273596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,27607,130,2.38 [1.51-3.74],0.0001777557007643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP2,Metalloproteinase inhibitor 2,24272,114,1.31 [0.79-2.18],0.2977106219412453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,28061,132,1.08 [0.97-1.21],0.170087458821589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,27929,131,1.75 [1.24-2.47],0.0014959963279415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,27856,130,1.69 [0.86-3.34],0.1295006625322734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJAP1,Tight junction-associated protein 1,28005,132,1.04 [0.86-1.25],0.6911813862042382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJP3,Tight junction protein ZO-3,23493,107,1.26 [0.87-1.82],0.2172809604096978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TK1,"Thymidine kinase, cytosolic",23825,109,1.13 [0.78-1.64],0.5284529101568542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,23581,108,1.75 [0.94-3.26],0.0773950783785146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,23825,109,3.48 [1.74-6.93],0.0004061880832531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR3,Toll-like receptor 3,28273,130,1.16 [0.90-1.50],0.2515932423085261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR4,Toll-like receptor 4,23581,108,1.07 [0.56-2.06],0.836346565621218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23599,110,1.36 [1.01-1.84],0.0395982030847137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,23825,109,1.11 [0.82-1.50],0.5006609248733034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED10,Transmembrane emp24 domain-containing protein 10,23494,110,0.85 [0.54-1.33],0.4756524592829674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,23494,110,0.80 [0.54-1.18],0.2640611334224209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED8,Protein TMED8,24177,111,1.11 [0.93-1.32],0.2624118056599357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM106A,Transmembrane protein 106A,24157,113,1.06 [0.83-1.35],0.6423817362838667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM132A,Transmembrane protein 132A,23595,112,1.16 [0.88-1.52],0.2988804100529729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM25,Transmembrane protein 25,24236,113,1.11 [0.77-1.61],0.5645190139790004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMOD4,Tropomodulin-4,23409,107,0.92 [0.58-1.46],0.7199424956774068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11B,Transmembrane protease serine 11B,23493,107,0.79 [0.59-1.07],0.1266792319756291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,24147,110,2.16 [1.48-3.15],5.924638116993745e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS15,Enteropeptidase,27812,130,1.16 [0.98-1.38],0.0927667686271298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,27603,129,1.72 [1.13-2.62],0.0112296842942492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,27929,131,1.18 [0.97-1.44],0.0950925957569281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,28016,131,1.56 [1.15-2.13],0.0041600040681651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,27383,126,1.49 [1.15-1.93],0.0028193963726657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24177,111,1.34 [0.98-1.81],0.0636200409974512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27416,127,1.18 [0.77-1.79],0.4470892811656864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23725,107,1.10 [0.84-1.45],0.49272662713438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27748,130,2.35 [1.77-3.13],4.880111645542309e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27748,130,1.39 [1.18-1.65],0.0001091428528315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27989,130,1.00 [0.73-1.37],0.9889257040359404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28273,130,2.02 [1.43-2.86],7.382381916239651e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27916,132,2.21 [1.41-3.45],0.0004939221985102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28005,132,2.08 [1.42-3.05],0.0001821765527851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27966,132,2.05 [1.47-2.87],2.563431968448332e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27416,127,0.99 [0.68-1.43],0.9455839126780552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27966,132,2.47 [1.59-3.83],5.511634248254411e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23725,107,1.51 [0.96-2.40],0.0767980081685722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28189,131,2.28 [1.56-3.32],2.008667936211606e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27929,131,2.98 [1.91-4.64],1.492235982172402e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27929,131,1.78 [1.44-2.20],9.865671565166373e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28203,133,1.84 [1.08-3.15],0.0260106105481481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28223,128,2.48 [1.81-3.38],1.1132567834278058e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27748,130,1.45 [1.13-1.85],0.0030156960674261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28203,133,1.56 [1.16-2.11],0.0036450925910317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27748,130,2.00 [1.53-2.61],3.00594604048457e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF10,Tumor necrosis factor ligand superfamily member 10,28273,130,1.00 [0.56-1.79],0.998958009151041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF11,Tumor necrosis factor ligand superfamily member 11,27925,130,0.98 [0.77-1.26],0.9030346941097764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,28273,130,0.70 [0.41-1.18],0.1780782449272798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,28061,132,1.82 [1.05-3.15],0.0322720394611354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28228,131,3.23 [2.19-4.77],3.355843964404062e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF14,Tumor necrosis factor ligand superfamily member 14,27748,130,1.24 [0.96-1.61],0.1018848924308073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,24262,111,2.06 [1.35-3.16],0.0008279467688015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,24203,112,1.03 [0.84-1.26],0.7991069564691673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNN,Tenascin-N,24262,111,1.31 [0.88-1.95],0.1895249049623517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNNI3,"Troponin I, cardiac muscle",27432,126,0.89 [0.74-1.06],0.1822005756762396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNPO1,Transportin-1,23825,109,0.85 [0.50-1.44],0.551279797560112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNR,Tenascin-R,27748,130,0.87 [0.61-1.26],0.465973025411345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNXB,Tenascin-X,27929,131,1.40 [0.79-2.48],0.2544995876780855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24272,114,1.10 [0.88-1.37],0.4258738198169867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1,DNA topoisomerase 1,24177,111,1.03 [0.88-1.20],0.7473040890659377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1MT,"DNA topoisomerase I, mitochondrial",23409,107,1.06 [0.74-1.52],0.7599309768301515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP2B,DNA topoisomerase 2-beta,23581,108,1.08 [0.86-1.36],0.487290502438662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOR1AIP1,Torsin-1A-interacting protein 1,23595,112,1.14 [0.84-1.54],0.4060602160765127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53,Cellular tumor antigen p53,27252,129,1.26 [0.90-1.77],0.1769958003879173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53BP1,TP53-binding protein 1,23581,108,1.13 [0.92-1.39],0.2500367718471149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53I3,Quinone oxidoreductase PIG3,23207,104,0.96 [0.68-1.37],0.837698844624799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53INP1,Tumor protein p53-inducible nuclear protein 1,27432,126,0.88 [0.51-1.52],0.6561901425559191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP73,Tumor protein p73,23599,110,0.95 [0.56-1.62],0.857433503230517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPBGL,Trophoblast glycoprotein-like,23599,110,0.97 [0.61-1.54],0.8926779883263859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPD52L2,Tumor protein D54,23725,107,1.04 [0.88-1.23],0.66652717397007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPK1,Thiamin pyrophosphokinase 1,24272,114,1.52 [0.82-2.83],0.1863091176144247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPM3,Tropomyosin alpha-3 chain,23494,110,0.95 [0.63-1.46],0.8303580673194472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,27252,129,0.85 [0.68-1.06],0.1441684899367625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,27736,132,1.24 [0.92-1.67],0.1638562273980387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP2,Tubulin polymerization-promoting protein family member 2,23825,109,0.86 [0.67-1.11],0.2596720330641488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP3,Tubulin polymerization-promoting protein family member 3,27277,126,0.91 [0.60-1.39],0.6772081850068883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPR,Nucleoprotein TPR,23494,110,1.31 [1.01-1.70],0.043635691111199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPRKB,EKC/KEOPS complex subunit TPRKB,23409,107,1.17 [0.92-1.48],0.2004698342227103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,28222,130,1.45 [1.08-1.96],0.0143624596608028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSD1,Tryptase delta,24236,113,1.43 [1.01-2.04],0.0460224552913654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSG1,Tryptase gamma,23581,108,1.54 [0.91-2.60],0.1106456560050589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPT1,Translationally-controlled tumor protein,27416,127,0.79 [0.59-1.07],0.1289748818967094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF2,TNF receptor-associated factor 2,27925,130,1.11 [0.89-1.37],0.3491872148427143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3,"TNF receptor-associated factor 3, Isoform 2",23581,108,1.40 [0.95-2.06],0.0933503002360212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23494,110,0.91 [0.60-1.38],0.6417832704530677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23825,109,1.06 [0.86-1.31],0.5924179458751941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREH,Trehalase,24262,111,1.02 [0.81-1.30],0.8505984734269998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,27916,132,1.62 [1.25-2.11],0.0003125744209094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML1,Trem-like transcript 1 protein,24295,113,1.17 [0.85-1.62],0.3318753911786437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,27929,131,1.65 [1.05-2.59],0.0282760390686792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,28189,131,1.21 [0.96-1.53],0.1047247333469519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM21,E3 ubiquitin-protein ligase TRIM21,27925,130,0.94 [0.77-1.15],0.5708131494633808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM24,Transcription intermediary factor 1-alpha,23775,109,1.26 [0.98-1.60],0.0685045262566247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24177,111,1.12 [0.95-1.32],0.1785778709712116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM26,Tripartite motif-containing protein 26,23409,107,0.80 [0.55-1.16],0.2413682992061724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM40,E3 ubiquitin ligase TRIM40,23599,110,1.05 [0.82-1.34],0.7140775758097849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM5,Tripartite motif-containing protein 5,27925,130,1.07 [0.89-1.27],0.4808801225659378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM58,E3 ubiquitin-protein ligase TRIM58,24157,113,1.14 [0.93-1.40],0.19394705836743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,23494,110,0.65 [0.42-1.02],0.0589785079084148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,23581,108,0.81 [0.60-1.10],0.1828182655657289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC22D1,TSC22 domain family protein 1,24236,113,1.09 [0.85-1.41],0.5017959601419424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,27938,130,0.96 [0.78-1.18],0.6858308940772089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSLP,Thymic stromal lymphopoietin,27432,126,1.13 [0.90-1.43],0.2976944295414025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSNAX,Translin-associated protein X,23494,110,0.98 [0.62-1.55],0.9358329255745133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN1,Tetraspanin-1,27432,126,1.01 [0.69-1.46],0.9780437643647129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN15,Tetraspanin-15,23494,110,1.02 [0.72-1.46],0.8948861311073995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN7,Tetraspanin-7,23493,107,0.99 [0.81-1.21],0.9121431789518568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,24177,111,1.05 [0.87-1.25],0.6276819072108675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPYL1,Testis-specific Y-encoded-like protein 1,23581,108,1.28 [0.85-1.94],0.2384138833987586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TST,Thiosulfate sulfurtransferase,27238,126,1.00 [0.81-1.23],0.9888038455666124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTF2,Transcription termination factor 2,23599,110,1.19 [0.84-1.69],0.3246484986607006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTN,Titin,23494,110,1.18 [0.94-1.48],0.1523938760189168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,24036,110,0.44 [0.22-0.87],0.0176362019318465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TUBB3,Tubulin beta-3 chain,23493,107,1.73 [1.00-2.97],0.0484892804544039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TWF2,Twinfilin-2,24262,111,1.08 [0.88-1.34],0.4459150702898312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXK,Tyrosine-protein kinase TXK,23825,109,1.07 [0.85-1.35],0.5885885458485813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXLNA,Alpha-taxilin,27748,130,1.07 [0.89-1.27],0.4757151945351218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXN,Thioredoxin,23901,110,0.95 [0.62-1.44],0.7964002534111847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,28005,132,1.97 [1.18-3.29],0.0096452628712225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,28203,133,1.23 [0.99-1.52],0.0590255377565141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC9,Thioredoxin domain-containing protein 9,24203,112,1.09 [0.79-1.51],0.6002286888721547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNL1,Thioredoxin-like protein 1,23450,107,1.15 [0.98-1.35],0.0801147285788705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27929,131,1.03 [0.75-1.43],0.8520934032202916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYMP,Thymidine phosphorylase,27763,130,1.17 [0.93-1.46],0.1816432703136642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRO3,Tyrosine-protein kinase receptor TYRO3,27938,130,1.29 [0.75-2.22],0.3611990385397464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23581,108,0.96 [0.71-1.30],0.7886287411183456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBAC1,Ubiquitin-associated domain-containing protein 1,27812,130,0.75 [0.48-1.18],0.2134799468626777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2B,Ubiquitin-conjugating enzyme E2 B,24157,113,1.72 [1.01-2.93],0.0445513388376956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24272,114,1.29 [0.98-1.70],0.0679408789692097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23581,108,1.12 [0.84-1.49],0.4484035125842974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBQLN3,Ubiquilin-3,23494,110,1.13 [0.80-1.58],0.4870691426391793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBXN1,UBX domain-containing protein 1,23725,107,1.04 [0.80-1.35],0.773232711082182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24177,111,1.04 [0.92-1.19],0.5021681714127888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,23494,110,1.16 [1.00-1.33],0.0450353566445713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UHRF2,E3 ubiquitin-protein ligase UHRF2,23494,110,0.96 [0.56-1.66],0.888063866578874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,27748,130,2.15 [1.50-3.09],3.5150610631065054e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,28185,131,0.78 [0.59-1.02],0.0648350963811087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC5D,Netrin receptor UNC5D,23581,108,0.89 [0.44-1.80],0.7461153187426921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC79,Protein unc-79 homolog,23409,107,1.13 [0.82-1.55],0.453705092206062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNG,Uracil-DNA glycosylase,24157,113,1.02 [0.61-1.70],0.9412014382631544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPB1,Beta-ureidopropionase,24272,114,1.06 [0.89-1.27],0.5197067848944343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3A,Uroplakin-3a,23493,107,1.26 [0.89-1.80],0.1925455639918872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3BL1,Uroplakin-3b-like protein 1,23786,109,1.15 [0.87-1.52],0.3362641553632007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROD,Uroporphyrinogen decarboxylase,23725,107,0.91 [0.70-1.19],0.4815220944963201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,23599,110,0.86 [0.64-1.15],0.3038161806166901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USO1,General vesicular transport factor p115,27812,130,1.08 [0.91-1.28],0.3763762815674917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP25,Ubiquitin carboxyl-terminal hydrolase 25,24157,113,1.12 [0.88-1.43],0.3615536810737232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP28,Ubiquitin carboxyl-terminal hydrolase 28,24203,112,1.44 [1.00-2.05],0.0482173681406759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP47,Ubiquitin carboxyl-terminal hydrolase 47,23494,110,0.83 [0.66-1.06],0.140748617233772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP8,Ubiquitin carboxyl-terminal hydrolase 8,27432,126,1.04 [0.88-1.22],0.651400563825017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,27252,129,1.40 [1.12-1.76],0.0034861049800439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,27432,126,1.32 [1.05-1.68],0.0195218744732865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP8,Vesicle-associated membrane protein 8,23581,108,1.17 [0.95-1.43],0.1372419034993229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASH1,Tubulinyl-Tyr carboxypeptidase 1,27925,130,1.04 [0.87-1.25],0.6698114126498317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASN,Vasorin,27489,131,1.51 [0.87-2.61],0.1422922447338776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASP,Vasodilator-stimulated phosphoprotein,24295,113,1.07 [0.85-1.36],0.5610424387158226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27812,130,1.38 [0.65-2.94],0.3982308745949962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAV3,Guanine nucleotide exchange factor VAV3,23493,107,1.09 [0.90-1.31],0.3725315154269745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,27982,131,2.37 [1.42-3.97],0.0009998032482564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,28203,133,2.01 [1.23-3.28],0.0055856371277029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCPKMT,Protein-lysine methyltransferase METTL21D,23409,107,1.11 [0.92-1.34],0.255873716791736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFA,Vascular endothelial growth factor A,28179,130,1.12 [0.86-1.45],0.4003285061950479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,23581,108,2.45 [1.39-4.31],0.0019093526446948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFC,Vascular endothelial growth factor C,28005,132,1.00 [0.76-1.31],0.988366363182142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFD,Vascular endothelial growth factor D,28224,130,1.42 [0.92-2.17],0.1106980960802284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VGF,Neurosecretory protein VGF,24236,113,1.16 [0.65-2.08],0.6190379810168711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIM,Vimentin,27432,126,1.12 [0.97-1.29],0.1295992090580799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIPR1,Vasoactive intestinal polypeptide receptor 1,23595,112,0.57 [0.25-1.29],0.1789951213925166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIT,Vitrin,24272,114,1.55 [0.97-2.46],0.0647673242023075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VMO1,Vitelline membrane outer layer protein 1 homolog,27812,130,1.18 [0.93-1.50],0.1729259637995314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN1,Pantetheinase,24295,113,0.94 [0.74-1.19],0.6149656825793892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,27812,130,1.68 [1.18-2.41],0.004420138869802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,23825,109,1.18 [0.92-1.52],0.1955535939729041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS37A,Vacuolar protein sorting-associated protein 37A,27812,130,1.06 [0.87-1.28],0.5608324096269528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS4B,Vacuolar protein sorting-associated protein 4B,24157,113,1.10 [0.91-1.32],0.33066170173441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS53,Vacuolar protein sorting-associated protein 53 homolog,27812,130,1.07 [0.88-1.30],0.4772298515928219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,24157,113,1.49 [1.06-2.09],0.0218086140765705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23494,110,2.19 [1.58-3.05],3.249299003220324e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,24157,113,1.90 [1.50-2.41],1.195758194512397e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,27891,131,2.49 [1.81-3.43],2.3804593843525185e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27899,129,1.23 [0.97-1.55],0.081838980720251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSNL1,Visinin-like protein 1,24203,112,1.32 [0.87-1.98],0.1874936358313342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,27277,126,1.22 [0.89-1.66],0.2245757331004529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2B,V-set and transmembrane domain-containing protein 2B,23825,109,1.20 [0.81-1.76],0.360346930481462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27432,126,1.02 [0.78-1.34],0.8820347570196573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28203,133,0.97 [0.79-1.20],0.7878305498766547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,27252,129,1.56 [1.01-2.40],0.0450244049698743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23725,107,1.04 [0.76-1.42],0.804670606210253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,28152,131,1.41 [0.99-2.00],0.053473766713066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA5A,von Willebrand factor A domain-containing protein 5A,23409,107,0.91 [0.70-1.18],0.4857907442283623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,27652,130,1.92 [1.31-2.83],0.0008472282348961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2L,von Willebrand factor C domain-containing protein 2-like,24236,113,1.36 [1.05-1.75],0.0181246732077812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWF,von Willebrand factor,28281,131,0.93 [0.76-1.14],0.5039925069365663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WARS,"Tryptophan--tRNA ligase, cytoplasmic",27929,131,1.54 [1.03-2.32],0.036131202911981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WAS,Wiskott-Aldrich syndrome protein,27416,127,0.94 [0.74-1.18],0.5772982671530736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF1,Wiskott-Aldrich syndrome protein family member 1,27432,126,1.02 [0.87-1.21],0.7947700687416586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,27277,126,0.79 [0.67-0.93],0.0042176275372369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASHC3,WASH complex subunit 3,24203,112,1.07 [0.85-1.34],0.5678396660483185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASL,Neural Wiskott-Aldrich syndrome protein,23581,108,1.18 [0.91-1.53],0.2117957146093851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WDR46,WD repeat-containing protein 46,24157,113,1.32 [0.89-1.98],0.172450879846241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC1,WAP four-disulfide core domain protein 1,23681,113,1.27 [0.97-1.65],0.0773054818059411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC12,WAP four-disulfide core domain protein 12,28137,131,1.12 [0.88-1.42],0.3441912090318793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,26492,124,2.69 [2.01-3.59],2.0553070453566896e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27660,130,0.67 [0.45-0.98],0.0406860472003719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27966,132,0.85 [0.55-1.33],0.4831391279436769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WIF1,Wnt inhibitory factor 1,28189,131,1.30 [0.84-2.02],0.2390636831624104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,27416,127,2.07 [1.37-3.13],0.0005683188247787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27748,130,1.04 [0.78-1.39],0.7710906690391452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,28189,131,1.29 [1.02-1.63],0.0332003058911701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,28136,130,1.80 [1.15-2.80],0.0100031933120975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XIAP,E3 ubiquitin-protein ligase XIAP,23581,108,1.18 [0.87-1.59],0.2951947368858488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XPNPEP2,Xaa-Pro aminopeptidase 2,28005,132,0.90 [0.78-1.04],0.1515895762330923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,27277,126,0.97 [0.63-1.49],0.8938038363386573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,24203,112,2.41 [1.43-4.05],0.0009507998606639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24177,111,1.09 [0.96-1.24],0.1624510680065511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YES1,Tyrosine-protein kinase Yes,27812,130,1.08 [0.94-1.23],0.2915875141138531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YJU2,Splicing factor YJU2,24157,113,1.39 [0.84-2.30],0.1954916890549685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,23494,110,0.82 [0.61-1.11],0.1954143226251287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YTHDF3,YTH domain-containing family protein 3,27416,127,1.06 [0.88-1.27],0.5210119134563987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YWHAQ,14-3-3 protein theta,23725,107,1.11 [0.87-1.42],0.4001536038361268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YY1,Transcriptional repressor protein YY1,23581,108,1.33 [0.71-2.49],0.366598943314751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBP1,Z-DNA-binding protein 1,23581,108,1.15 [0.77-1.71],0.4974574324124768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB16,Zinc finger and BTB domain-containing protein 16,27252,129,0.96 [0.77-1.20],0.7139338364976952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB17,Zinc finger and BTB domain-containing protein 17,27432,126,1.02 [0.71-1.48],0.9012808835753472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZCCHC8,Zinc finger CCHC domain-containing protein 8,23494,110,1.09 [0.82-1.43],0.5637101260120339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZFYVE19,Abscission/NoCut checkpoint regulator,24177,111,1.13 [0.93-1.38],0.2259449886898246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZHX2,Zinc fingers and homeoboxes protein 2,24203,112,1.21 [0.79-1.87],0.376652237527399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF174,Zinc finger protein 174,23581,108,1.15 [0.74-1.78],0.5348439509072764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,23825,109,1.09 [0.82-1.43],0.5604213646355686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF830,Zinc finger protein 830,24157,113,1.00 [0.80-1.25],0.9948317751437058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRD2,Protein ZNRD2,24177,111,1.09 [0.85-1.41],0.4810834687067398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24157,113,1.19 [0.87-1.62],0.2780960761694058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP3,Zona pellucida sperm-binding protein 3,23595,112,1.03 [0.96-1.11],0.4176957619514571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,23409,107,1.18 [0.73-1.91],0.5114430745904752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZPR1,Zinc finger protein ZPR1,23493,107,1.03 [0.85-1.24],0.7533226092673416
